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ABSTRACT
Platypus, Omithorhynchus anatinus, envenomation produces marked short- and long­
term sequelae, consisting of intense pain, oedema and lasting hyperalgesia. This thesis 
describes the characterisation of polypeptides and biological activities from O. anatinus 
venom (OaV) which may contribute to these effects.
SDS-polyacrylamide gel electrophoresis was initially used to compare OaV 
samples taken from excised crural glands and from live animals at different times of 
year. Most protein components were present in all samples, although the relative 
proportion of each component varied markedly, particularly between samples taken 
during and outside the breeding season. Several of the major OaV polypeptides were 
purified using high-performance liquid chromatography (HPLC) and subjected to N- 
terminal Edman sequencing. Low levels of similarity between these and other proteins 
contained in sequence databases was observed with the exception of a C-type 
natriuretic"peptide (ovCNP-39), nerve growth factor (NGF), a Kunitz-type protease 
inhibitor-like protein and two likely members of the lipocalin superfamily.
The purification, detailed structure, synthesis and pharmacological characteristics 
of ovCNP-39 (Omithorhynchus venom C-type natriuretic 39-residue peptide) are 
described in this study. The peptide was found to share a high degree of homology with 
eutherian CNPs. These peptides produce hypotension in vivo and relax smooth muscle 
in vitro but are poorly characterised in terms of physiological function. ovCNP-39 was 
equipotent with human/rat/porcine CNP-22 in eliciting cyclic guanosine 5’- 
monophosphate (cGMP) elevation in cultured vascular smooth muscle cells. This
suggests that, like CNP-22, it acts through the ANPB natriuretic peptide receptor 
subtype. The direct elevation of cGMP in vascular smooth muscle by ovCNP-39 may 
underlie the vasodilatory effects of platypus envenomation. The possibility that ovCNP- 
39 contributes to the acute effects of envenomation was also investigated and it was 
found that injection of ovCNP-39 or eutherian CNP-22 into the rat hind-paw produces 
oedema; both peptides also induced release of histamine from rat peritoneal mast cells. 
Two synthetic peptides, ovCNP-39(l-17) and ovCNP-39( 18-39), corresponding to the 
N- and C- termini respectively, were found to be equipotent histamine releasers, 
suggesting that ovCNP-39 and, by analogy, other natriuretic peptides do not act through 
conventional natriuretic peptide receptors on mast cells.
To address the possibility that OaW has a direct effect on nociceptive neurones, it 
was transiently applied (10 s) to small-medium (20-40 |im) diameter, cultured rat dorsal 
root ganglion (DRG) neurones. These cells have been shown previously to contain a 
proportion of neurones which express nociceptor properties, such as sensitivity to 
algogenic mediators and substance P-like immunoreactivity. In DRG neurones voltage- 
clamped at -60 mV, a 10 s application of OaW at pH 7.4 had little or no effect. At pH 
6.1, the venom produced a large inward current in 72 % of neurones, which was 
characterised by multiple transient events and, on average, lasted for several minutes. 
The Ca2+-ATPase inhibitor, thapsgargin (1 jiM) significantly reduced the current, 
suggesting its activation was dependent on the release of intracellular Ca2+. All OaW 
HPLC fractions which induced an inward current in DRG neurones contained a 12 kDa 
protein. This protein was shown to have a high degree of homology with NGF. An 
inhibitor of the TrkA NGF receptor, k-252a (200 nM) significantly reduced the inward 
current produced by whole OaW. However, purified mouse ß-NGF did not elicit inward 
currents, raising the possibility of a synergy between OaW NGF and another as yet 
unidentified OaW component.
v
Of the 94 residues of amino acid sequence obtained from OäW NGF, 90 % and 67 
% identity was observed with mouse ß-NGF and Cobra (Naja naja atra) venom NGF, 
respectively. The strong structural similarity with ß-NGF (and Type I snake venom 
NGFs) was supported by the comparable molecular weight of OaW NGF which was 
found to be 13,328.
The experiments described in this thesis have implicated a number of OäW 
polypeptides in the pathology associated with O. anatinus envenomation. Several novel 
and interesting findings have been made. In particular, no C-type natriuretic peptides 
have hitherto been purified and sequenced from an animal venom and, although NGF is 
found in many snake venoms, its presence in OaW is highly interesting given the 
remarkable similarity between the long-term sequelae resulting from NGF 
administration and O. anatinus envenomation in humans. In addition, evidence has 
been provided for the first time that a venom may contain factors which act directly on 
nociceptive neurones.
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CHAPTER 1
GENERAL INTRODUCTION
The male platypus (Omithorhynchus anatinus) bears a canalised, keratinous spur on 
each hind-limb which is attached, via a distensible duct, to a crural venom gland. 
Although it is clear that spurring produces excruciating, intractable pain and oedema in 
humans, very little is known about how O. anatinus venom (OaV) produces these 
effects. It was the aim of the work presented herein to identify and characterise the 
constituents of OaV which might be important contributors. Ultimately, piecing 
together how these constituents contribute to the overall envenomation pathology will 
facilitate our understanding of how OaV works. This has implications not only for our 
understanding of the role of OaV in the ecology of O. anatinus but also for our 
understanding of the processes underlying long-lasting inflammatory pain.
The following sections discuss the effects of OaV in humans and experimental 
animals, and detail previous laboratory investigations into its composition and 
biological activities. As pro-inflammatory effects, particularly prolonged pain, 
comprise the major symptoms of envenomation, current knowledge on pain-producing 
inflammatory mediators and toxins has been reviewed. In the context of this, possible 
modes of action of OaV and how these may be addressed experimentally, are 
discussed.
Venoms and natural toxins - nomenclature and general features
A large number of terrestrial and marine organisms produce “toxins”, which may be 
defined as substances of plant, animal, or bacterial origin that are both foreign and 
adversely affect the target organism (Vogt, 1970). According to this definition, the
term also depends on the relation of the substance to the victim. For example, digitalis, 
a cardioactive alkaloid from the foxglove (Digitalis purpurea), which may be fatal 
following accidental ingestion, would not be considered a toxin when used in a 
therapeutic context.
The term “venom” is commonly used to describe the complete secretion of a 
toxin-producing gland associated with specialised wounding apparatus (Temple-Smith, 
1973; Chahl and Kirk, 1975). Thus toxin-secreting fish and amphibians which lack 
such an apparatus are not considered “venomous”. While a venom may be considered 
a toxin, the term “toxin” is generally restricted to purified venom fractions which 
satisfy the definition given above.
The use of venoms both for food procurement and self-protection has arisen 
convergently over a range of phyla. Venoms appear to have a primary but not 
exclusive role in either capacity. For example, snake venoms contain neurotoxins and 
enzymes which respectively facilitate the immobilisation and digestion of prey items, 
suggesting a primary role in predation. However, the incidence of snake envenomation 
in humans is testimony to the fact that the venom is also used defensively.
The venomous characteristics of Ornithorhynchus anatinus
The platypus (Ornithorhynchus anatinus) and its venomous characteristics in 
particular, have experienced a long history of being treated with disbelief or ignored 
completely. For example, the first specimen of O. anatinus sent to Britain in 1798 was 
thought to be a fake, stitched together by a taxidermist using mammalian parts and a 
duck bill (Grant, 1995). A recent review by Dufton (1992), entitled “Venomous 
Mammals”, made no mention of O. anatinus and a recent case report of 0. anatinus 
envenomation (Tonkin and Negrine, 1994) in the British Journal of Hand Surgery was 
accompanied by the following, apparently facetious, Editor’s note: “A spate of Dodo
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bites has recently been recorded in a remote area of New South Wales, and will be 
reported by Dr Tonkin in the next issue of the Journal”. This is despite the fact that 
several publications exist which deal specifically with the subject, most notably, Martin 
and Tidswell (1895), Kellaway and LeMessurier (1935), Temple-Smith (1973) and 
Fenner et al. (1992).
O. anatinus is a rather unusual, oviparous mammal, which is indigenous to the 
river systems of eastern Australia. It has a soft bill which superficially resembles that 
of a duck; webbed feet; and a single tract for feeding, reproduction and excretion, 
which places it in the order Monotremata (Grant, 1995). However it possesses the 
following distinctly mammalian characteristics: it has hair, lactates and thermoregulates 
(although maintaining a relatively low body temperature of 32°C; Grant, 1995).
O. anatinus and three species of insectivore {Blarina brevicauda, Solenodon 
paradoxus and Neomys fodiens; see Dufton, 1992) comprise the only extant venomous 
mammals. Although the echidnas (Tachyglossus setous and Tachyglossus aculeatus) 
possess venom apparatus similar to that of the platypus, there is no evidence that it is 
functional (Calaby, 1968).
Structure of the venom apparatus
The venom apparatus of O. anatinus is restricted to the male and externally consists of 
a pair of movable calcaneus spurs (cornu calcari) on each hind-limb. Each spur 
normally lies against the limb but is attached at its base to an articulating bone (os 
calcaris), which allows it to be erected at right angles to the limb when required 
(Lewis, 1963; Temple-Smith, 1973). At the back of the tarsus is a sac or reservoir from 
which a tiny duct extends through the center of the spur (Martin and Tidswell, 1894; 
Lewis, 1963; Temple-Smith, 1973). A large distensible duct, which superficially 
traverses the biceps muscle, connects the reservoir to the crural venom gland. The
structure of the crural gland was originally described in detail by Martin and Tidswell 
(1894) who noted that it is divided into lobules containing numerous alveoli which are 
lined by a single layer of columnar epithelial cells on a basement membrane. During 
the breeding season, these cells attain their maximum size and extrude secretory 
vesicles. This period is therefore referred to as the extrusion phase. The secretory 
epithelium then undergoes sequential phases of regression, quiescence and elaboration 
before the next breeding season (Temple-Smith, 1973). These histological 
observations suggest a temporal relationship between breeding status and crural gland 
secretory activity (Temple-Smith, 1973).
Effects of envenomation
Although the clinical manifestations of O. anatinus envenomation have been 
systematically investigated in only two cases (Fenner et al., 1992; Tonkin and Negrine, 
1994), many anecdotal accounts exist and provide a useful source of detailed and 
consistent information on post-envenomation sequelae.
The earliest documented case of envenomation appears to be that of Jamieson 
(1817, cited in Martin and Tidswell, 1895), who, in a communication to the Philomatic 
Society of Paris, described the effects of envenomation: “...[the platypus] stuck its 
spurs into the palm and back of his right hand with such force, and retained them in 
with such strength, that they could not be withdrawn until it was killed. The hand 
instantly swelled to a prodigious bulk...The pain from the first was insupportable...[he] 
did not recover the perfect use of his hand for nine weeks”. The extensive oedema and 
lasting pain described by Jamieson are consistently reported in most of the subsequent 
anecdotal accounts. For example, Spicer (1876) cites a case where “...The pain was 
intense and almost paralysing. But for the administration of small doses of brandy, he 
would have fainted on the spot: as it was, it was half an hour before he could stand
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without support: by that time the arm was swollen to the shoulder, and quite useless, 
and the pain in the hand very severe...”. Martin and Tidswell (1894) report a similar 
case: “...Mr. E. all the time suffered intense pain, and presently the wounded finger, 
then the hand, and ultimately the whole arm up to the shoulder swelled to a serious 
extent...”.
Temple-Smith (1973) confirmed these anecdotal reports of the painful effects of 
O. anatinus venom by injecting a small quantity into his forearm. This resulted in 
“immediate intense pain which diminished to a dull muscular pain, impairing use of the 
arm for 48 hours”.
Fenner et al. (1992) provided the first clinical case report of O. anatinus 
envenomation in a human subject. They report that the affected patient, who received 
spur wounds to the hand, presented with oedema and lasting severe pain which did not 
respond effectively to morphine and was only alleviated following a wrist block. 
Laboratory blood tests revealed an increased erythrocyte sedimentation rate (ESR), 
indicating possible coagualopathy. The pain in this case persisted for several months 
and substantially impaired use of the affected limb. Intense pain and oedema were 
similarly described in a more recent case reported by Tonkin and Negrine (1994), 
although the symptoms in this case subsided within several weeks.
From the anecdotal accounts and the clinical case studies, it is apparent that pain 
and oedema are the major symptoms associated with platypus envenomation. There 
does not appear to be any evidence of systemic neurotoxicity, myotoxicity1, or necrotic 
effects and there have been no reported human fatalities.
‘it should be noted that Fenner et al. (1992) reported “significant” forearm muscle wasting in the affected 
patient two weeks after envenomation but it was not established whether this was due to disuse of the 
affected limb due to the severe pain or caused directly by the venom.
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Putative functions
Five major views regarding the function of the venom apparatus of O. anatinus have 
been suggested: (a) that it serves a role during copulation (Home, 1802; Burrell, 1927), 
(b) that it is used for food procurement (Fleay, 1956 cited in Calaby, 1968), (c) that it is 
merely a vestige, i.e. a remnant of an era when conditions were very different from 
those under which the animal now exists (Nicols cited in Martin and Tidswell, 1895), 
(d) :hat it is used for “toilet purposes” (Baden-Powell cited in Tidswell, 1906), and (e) 
that it serves as a weapon of offence and/or defence (Wood-Jones, 1923).
Home (1802) in his original description of the platypus suggested the spurs were 
used during copulation to prevent the female from escaping. Burrell (1927) also 
inclined to this belief, largely on the basis of the restriction of venom apparatus to the 
ma!e, the “convenient” placement for such a purpose and the alleged presence of 
coresponding hairless depressions in the female. However, as Martin and Tidswell 
(1895) point out, for the male to apply its spurs to these depressions “would involve an 
amount of gymnastic ability of which even an Omithorhynchus is incapable”. In 
addition, Temple-Smith (1973) noted the relative absence of spur wounds on females 
compared with males, further increasing the scepticism for Home’s hypothesis.
Fleay (1956, cited in Calaby, 1968) observed a platypus using its spurs on a frog 
which it eventually ate and subsequently suggested that the venom may be used to 
immobilise prey items. However, platypuses largely feed on annelids, insect larvae and 
small crustaceans and have a specialised anatomy for this type of procurement (Grant, 
1S95). The fact that the venom apparatus is restricted to the male also suggests that 
tlxs is an unlikely function.
The naturalist, Nicols (cited in Martin and Tidswell, 1895), believed the 
apparatus to be a vestigial remnant of conditions very different from those under which 
the animal now exists. This and similar suggestions (e.g. Benett cited in Martin and
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Tidswell, 1895) were based largely on observations that the animals were rather docile 
and made no attempt to use their spurs during handling. However, several cases of 
envenomation have occurred during the handling of injured animals (Spicer, 1876; 
Marin and Tidswell, 1895) and hunting dogs have been envenomed while attempting 
to retrieve wounded platypuses (Burrell, 1927). This suggests that O. anatinus has to 
be sufficiently threatened before it will deploy its spurs.
Baden-Powell suggested that the apparatus may be used for “toilet purposes” 
(cited in Tidswell, 1906). Again this appears unlikely because the apparatus is 
confined to the male, the spurs are located in an unsuitable position (Tidswell, 1906), 
and there are no reported observations of the animal using its spurs in this manner. In 
addition, the spur is canalised and attached to an exocrine gland suggesting a more 
specialised role.
The prevailing view is that the venom apparatus serves as “an offensive and 
defensive weapon” (Wood Jones, 1923). It is offensive in that it appears to be involved 
in resolving intraspecific, competitive interactions between males. This is supported by 
the following evidence: only males possess venom apparatus; secretory activity is 
temporally related to breeding status; a higher incidence of aggressive encounters 
occurs between males; and males harbour more spur wounds (Temple-Smith, 1973). 
Temple-Smith (1973) describes one particularly striking example of an aggressive 
encounter between two males: “At Bredbo during the breeding season, a large adult 
male which had shown no aggression towards three adult females held in the same 
container, fought viciously with a second male caught later that night and caged with 
them. The two males spurred each other frequently, gripping each other so tenaciously 
that it was impossible to separate them.”
Where viable in terms of defendability, males tend to occupy mutually exclusive 
home ranges, each of which may contain several females (Serena, 1994; Gardner and
Serena, 1995). Where their home ranges overlap, they largely avoid each other 
(Gardner and Serena, 1995). The venom apparatus may play an important role in 
maintaining these behavioural patterns and, as a consequence, facilitate the 
monopolisation of breeding females by dominant males.
The accounts of envenomation in humans outlined in the previous section 
suggest that the venom also serves a protective function. In several such cases, the 
animal had been injured and subsequent handling apparently induced it to use its spurs 
in defence.
Composition and physiological effects of the venom
There has been an apparent reluctance to refer to the material secreted from the crural 
gland as “venom”. It has been ubiquitously referred to as crural gland secretion (CGS) 
or crural gland extract, depending on the method of preparation (Martin and Tidswell, 
1895; Temple-Smith, 1973). Perhaps this reflects uncertainty over the function of the 
crural system. However, the crural gland is clearly associated with a wounding 
apparatus and the secretion does produce adverse effects in humans and experimental 
animals (Martin and Tidswell, 1895; Kellaway and LeMessurier, 1935; Temple-Smith, 
1973). It therefore conforms to the aforementioned definition of a venom and will be 
referred to as such in this thesis.
The earliest examination of the composition and physicochemical properties of 
the venom was conducted by Martin and Tidswell (1895). They expressed both 
“limpid”2 and “opalescent” secretion from dissected crural glands, and precipitated it 
using 92% alcohol. The precipitate was mostly soluble in water, forming an
“opalescent” liquid. It was shown to contain at least two “proteids”, one, an
“albumen”, precipitated by heat and one, a “proteose”, soluble at 100 °C. The secretion
2 Limpid = Pellucid, clear, not turbid.
was injected subcutaneously into a rabbit and resulted in localised swelling and 
tenderness which subsided over a couple of days. When three rabbits were injected 
intravenously, a rapid fall in blood pressure, respiratory distress, including “expiratory 
convulsions”, and death followed. Post-mortem examination revealed that two animals 
probably died from extensive intravascular coagulation. However, blood from the 
remaining animal, in which the material was injected more slowly (and which died 
somewhat later than the others), exhibited no signs of clotting in vessels. In fact a 
sample of this animal’s blood was found to clot abnormally slowly. Martin and 
Tidswell concluded that the effects of the venom on blood pressure, coagulation and 
tissue oedema were analogous to those produced by Australian snake venoms. Noc 
(1904, cited in Calaby, 1968) found that the material (supplied by Martin) coagulated 
plasma which had had its clotting activity reduced by decalcification with citrate, 
oxalate and other reagents, and this property was destroyed by heating at 80 °C.
Kellaway and LeMessurier (1935) extended the initial observations of Martin and 
Tidswell using material supplied by Martin which was “...probably 30 years old”. This 
was injected intravenously into two rabbits and resulted in severe dyspnoea lasting for 
7 or 8 minutes, but the animals completely recovered within 13 minutes. Some delay 
was observed in the clotting time of blood samples taken from these animals. 
However, the material promoted the coagulation of guinea pig citrated plasma in vitro. 
When injected subcutaneously, the material produced an extensive haemorrhagic 
oedema. Using freshly obtained material, Kellaway and LeMessurier demonstrated it 
to be feebly haemolytic but found that it produced a rapid and profound fall in blood 
pressure and death when intravenously injected into anaesthetised rabbits. The fall in 
blood pressure appeared to be associated with peripheral vasodilatation and was
3 dysponoea - difficult or laboured breathing
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observed following intravenous injection in a decerebrate cat, suggesting that it was not 
dependent on the use of anaesthetics. In one injected rabbit, particles of “whipped-out 
fibrin” were found in the heart upon post-mortem examination, confirming the pro- 
coagulant activity observed by Martin and Tidswell (1895). However, the fall in blood 
pressure was not dependent on intravascular coagulation (Kellaway and LeMessurier, 
1935).
Kellaway and LeMessurier further tested the material using several in vitro 
preparations. They found that the venom produced vasodilatation in the perfused rabbit 
ear and in cat mesentery, supporting the notion that the fall in blood pressure was 
peripheral in origin. The venom also contracted the isolated guinea pig uterus and 
rabbit jejunum.
The most recent and comprehensive work on O. anatinus venom was that by 
Temple-Smith (1973). This study investigated the composition and physiological 
effects of the venom as well as the seasonal dependence of its secretion. Using gel 
electrophoresis, Temple-Smith demonstrated that the venom contains from 7 to 10 
proteins, depending on the sample analysed. These were mainly “prealbumins” (Mr < 
70 kDa) and “postalbumins” (Mr = 70-80 kDa) although the material also contained 1 - 
5 larger proteins (Mr > 90 kDa). There was some seasonal variation in the relative 
expression of these proteins, with “postalbumin” proteins predominating in material 
taken from extrusion-phase glands but being absent or present in decreased 
concentrations in quiescent glands. The “postalbumin” components were probably 
mucoproteins as they were strongly PAS (periodic acid-Schiffs reagent)-positive, 
indicating the presence of carbohydrate. When the venom was injected subcutaneously 
into mice, some individuals squealed and were observed to lick, scratch and bite the 
injection site. These behavioural symptoms are typical indicators of pain and are
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sometimes used quantitatively in behavioural studies of nociception (Bjorkman et al., 
1994; Narita et al., 1996).
In Temple-Smith’s (1973) investigation, the venom was fractionated by gel 
permeation chromatography and the fractions assayed for both lethality (following i.v. 
injection) in mice and “cutaneous activity” (plasma extravasation). Lethality was 
associated with high-molecular weight material which eluted in the first and apparently 
most concentrated (as judged by absorbance at 280 nm) fraction. This fraction and a 
lower molecular weight fraction also produced plasma extravasation in the skin of the 
rabbit. Lyophilisation of the venom dramatically reduced both of these activities and 
resulted in the loss of high molecular weight components. Temple-Smith (1973) 
therefore proposed that the lethal fraction was a high molecular weight component. 
This fraction was turbid and contained what was believed to be membrane and cell 
debris. However, this interpretation is equivocal as neat venom did not appear to be 
turbid and only became so upon dilution, which “reduced the viscosity of the secretion 
so that suspended material was precipitated” (Temple-Smith, 1973). It was perhaps 
more likely due to protein aggregation which may have been exacerbated by the low 
ionic strength of the diluent (distilled water was used). This notion is supported by the 
observation that gel electrophoresis of the lethal fraction failed to resolve any proteins 
apart from one band of “proteinaceous material” at the origin of the gel (Temple-Smith, 
1973).
Temple-Smith (1973) found that mice which had received lethal or sub-lethal 
doses of venom typically exhibited hyperventilation, convulsions, cyanosis and 
apparent hind-limb paralysis. Post-mortem examination revealed no tissue or vascular 
damage except in the lungs where vascular damage, constricted alveoli and oedematous 
interalveolar septae were evident. In addition, large accumulations of erythrocytes 
were observed in alveolar capillaries, suggesting that the flow of blood through the
lungs had been reduced by obstruction or constriction of the pulmonary arteries. Thus, 
the behavioural and post-mortem observations of Temple-Smith suggested that death 
resulted from respiratory failure, although probably indirectly given that the venom 
lacks curare-like activity (Kellaway and LeMessurier, 1935; Temple-Smith, 1973). 
Blood samples from animals receiving lethal doses of venom took longer to clot than 
controls, confirming the result of Kellaway and LeMessurier (1935). The venom was 
also shown to contain hyaluronidase and protease activities (Temple-Smith, 1973).
The work of Temple-Smith (1973) has contributed to our understanding of the 
seasonal activity of the crural gland and has identified lethal, cutaneous and enzymatic 
activities of the venom. However, none of the constituents have been structurally 
characterised and their physiological and pharmacological properties remain unknown. 
After 30 years, the conclusion of a review on the venomous characteristics of O. 
anatinus by Calaby (1968), that “The whole subject is in need of further study with 
modem techniques and against the background of modem knowledge of animal 
venoms.”, is still as valid now as it was then.
Pain and oedema are the most consistent and salient feature of O. anatinus 
envenomation. Therefore, the identification and characterisation of components which 
are likely to produce these effects is of paramount interest and was the major objective 
of this study. In the next section, I therefore review current knowledge on the 
mechanisms of pain production by inflammatory mediators and toxins and, in the light 
of this, consider potential modes of action of 0. anatinus venom and how these are 
experimentally addressed in this study.
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Pain-producing and pro-inflammatory effects of inflammatory mediators and 
toxins
Pain is a multicomponent syndrome which encompasses (i) pain directly associated 
with tissue damage and inflammation, (ii) hyperalgesia, a heightened sensitivity to 
noxious stimuli; and (iii) allodynia, the induction of pain by normally innocuous 
stimuli (Woolf et al., 1996). The sensation of pain arises from (noxiously) stimulated 
activity at pain-sensing afferent endings, or nociceptors, which is conducted along 
afferent axons that enter and terminate in the dorsal horn of the spinal cord. These 
terminals form synapses with spinal neurones which give rise to ascending axons that 
project, via the neospinothalamic and paleospinothalamic tracts, to the thalamus which, 
in tum, projects to the primary somatosensory7 cortex (Brown, 1989).
A variety of substances produce pain, hyperalgesia and allodynia. Such 
substances, or algogens, may have an endogenous or exogenous origin. Endogenous 
algogens consist largely of inflammatory mediators that act primarily on nociceptors. 
Exogenously derived algogens are predominantly toxins which may act directly on 
nociceptors or via the release of inflammatory mediators. Consequently, the following 
discussion deals specifically with the peripheral actions of algogens while central 
mechanisms (at and ascending beyond the level of the spinal cord) which contribute to 
these actions will not be considered.
Mechanisms of inflammatory pain: endogenous algogens
Nociceptors are high-threshold sensory receptors which have slowly-conducting 
unmyelinated (C-) or myelinated (A5-4) parent nerve fibres (Chahl, 1979). They 
generally respond to more than one of the following stimulus modalities: mechanical,
4 It has been demonstrated that a phenotypic switch can occur in myelinated Aß neurones, such that they 
also mediate inflammatory pain signalling (Neumann et al., 1996).
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thermal and chemical. Those responding to all three are termed polymodal nociceptors 
and make up a high proportion of C-fibre nociceptors.
Algogenic inflammatory mediators in many cases have been shown to either 
generate action potentials in or to sensitise polymodal nociceptors (Chahl, 1979). 
Nociceptor activation may arise from changes in nociceptor membrane ion channel 
activity either, directly, by the action of algogens on receptor-gated ion channels or, 
indirectly, via intracellular second messengers (Rang et al., 1991). An algogen can 
sensitise5 nociceptors to the actions of other algogens in several ways: by summation of 
subthreshold depolarisations; increasing membrane resistance by, for example, 
blocking K+ channels; by inducing phosphorylation of intracellular enzymes or ion 
channels; and by directly modifying the ion channels which underlie the action 
potential such that their threshold for activation is lowered or inactivation kinetics 
altered (Bevan, 1996).
Following infection or tissue injury, inflammatory responses are generally 
initiated and mediated by cytokines6 which are released from phagocytic cells of the 
immune system (Rang et al., 1991). This ultimately leads to the liberation of algogenic 
inflammatory mediators by the action of enzymes (i) or secretion from specialised 
inflammatory cells (ii). In addition, algogenic neurogenic factors may be released from 
sensory neurones (iii) or from sympathetic neurones (iv). Adenosine triphosphate 
(ATP) (v) may also be released from lysed cells following tissue damage. Additionally, 
the proton (vi) concentration may be elevated by the increase in anaerobic glycolysis 
which accompanies inflammation (Kress and Reeh, 1996) and the active transport of 
lactic acid into the interstitial space by leucocytes (McCarty et al., 1966).
5 Sensitisation, in this context, refers to an enhancement of the response or lowering the threshold for firing 
of nociceptors
6 Cytokines are a group of low molecular weight proteins which may either stimulate or inhibit the 
proliferation of immune cells or their secretion of antibodies or additional cytokines (Kuby, 1992)
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Both ATP and protons are algogenic. The release of each of these algogenic mediators 
and their interaction with sensory nerve terminals is summarised in Fig. 1.1 and 
described in the following sections. It has been the subject of several recent reviews, 
including those of Rang et al. (1991), Kress and Reeh (1996) and Senba and Kashiba 
(1996).
(i) Enzymatic release of algogenic inflammatory mediators
The two major enzymatic products which play key roles in the pain and hyperalgesia 
that accompanies tissue damage and inflammation are the eicosanoids7 (leukotrienes, 
diHETE (dihydroxyeicosatetraenoic acid) and prostaglandins) and bradykinin.
Eicosanoids appear to play a major role in nociceptor sensitisation and either act 
directly on nociceptive neurones or stimulate the release of other, directly acting, 
eicosanoids. Leukotrienes D4 (LTD4) and B4 (LTB4), released during inflammation via 
the lipoxygenase metabolic pathway, stimulate the synthesis and release of 
prostaglandins (PGs) and (18R, 15S)-diHETE from polymorphonuclear leukocytes 
(Rang et al., 1991; Levine et al, 1986; see Fig. 1.1). The prostaglandins PGE2 and 
PGI2 sensitise nociceptive neurones to heat (Mizumura et al., 1993), mechanical 
stimulation (Mizumura et al., 1987) and to other algogens, for example, bradykinin 
(Mizumura et al., 1991). In sensory neurones in vitro which express nociceptor 
properties, PGE2 both increases the magnitude and decreases the activation threshold of 
the tetrodotoxin-resistant Na+ current (TTX-R INa) (Gold et al., 1996b). TTX-R INa is 
likely to determine the action potential threshold in nociceptors as these neurones have 
a resting potential at which TTX-sensitive channels (but not TTX-R INa) are inactivated 
(Caffrey et al., 1992; Gold et al., 1996b) and this mechanism may thus underlie 
nociceptor sensitisation by PGE2 in vivo (Gold et al., 1996b). diHETE also produces
7 Eicosanoids are unsaturated fatty acid derivatives of arachidonic acid
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FIG 1.1. Schematic summary of the release of inflammatory mediators and 
their interactions with sensory nerve terminals. Abbreviations: LTD4, leuko-
triene D4; LTB4, leukotriene B4; PGs, prostaglandins; PMNs, polymorpho­
nuclear cells; NGF, nerve growth factor; 5-HT, 5-hydroxytryptamine; SP, 
substance P; CGRP, calcitonin gene-related peptide; ASIC, acid-sensitive ion 
channel; di-HETE, di-hydroxyeicosatetraenoic acid. NA, noradrenaline. 
Modified from Rang et al. (1991) and Senba and Kashiba (1996).
thermal and mechanical sensitisation of nociceptive neurones (White et al., 1990). 
From these findings it appears that the role of eicosanoids is one of sensitisation rather 
than nociceptor activation per se.
Algogenic kinins, such as bradykinin and kallidin, are also released during 
inflammation through the action of kallikrein, a proteolytic enzyme. Kallikrein releases 
kinins from high-molecular weight kininogens which are present in circulating plasma 
and interstitial fluid (Kress and Reeh, 1996). Bradykinin is a potent producer of pain 
and hyperalgesia when injected intradermally (Manning et al., 1991) and both 
polymodal C-fibre and A5 nociceptors respond to bradykinin (Lang et a l, 1990), 
probably through B2 receptors (Steranka et al, 1988). However, both B1 and B2 
receptor antagonists reduce the hyperalgesia induced by Complete Freund’s Adjuvant 
(CFA) and cytokines, suggesting the involvement of both receptors (Davis and Perkins, 
1994; Perkins et al., 1995). In cultured seasory neurones, bradykinin activates 
phospholipase C, thereby elevating EP3 and DAG levels. DAG in turn activates protein 
kinase C (PKC), resulting in both Na+ channel activation and Ca2+ influx (Burgess et 
al., 1989). Aside from its direct effect on nociceptive neurones, bradykinin may act 
indirectly by degranulating mast cells (Cross et al., 1997) thereby releasing histamine 
and 5-hydroxytryptamine (5-HT), both of which may activate nociceptive terminals 
(see below).
(ii) Release of algo gens from inflammatory cells
Cytokines trigger the migration of various inflammatory cells through blood vessels 
into tissue spaces (Kuby, 1992). These cells include platelets, mast cells, 
polymorphonuclear lymphocytes and macrophages, which all have the potential to 
release algogenic mediators (Senba and Kashiba,, 1996). Fibroblasts also appear to play
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an important role as they synthesise and secrete nerve growth factor (NGF), a potent 
algogen, in response to cytokines (Yoshida and Gage, 1992).
Platelets, which accumulate in tissue spaces during inflammation, release 5-HT 
upon activation by collagen and platelet-activating factor (PAF, a mast cell-derived 
secondary mediator) (Kress and Reeh, 1996). 5-HT has been demonstrated both to 
activate and sensitise nociceptors (Rang et al., 1991). 5-HT3 receptor antagonists block 
hyperalgesia associated with carrageenan-induced inflammation or the injection of a 
combination of inflammatory mediators (Escalier et al., 1989; Kress and Reeh, 1996). 
This suggests that 5-HT3, which represents the only ion channel among 5-HT receptors 
(Kress and Reeh, 1996), is a common target for inflammatory mediators. However, 5- 
HTj and 5-HT2 receptors have also been implicated in the sensitising and excitatory 
effects of 5-HT (Rueff and Dray, 1993). Also, 5-HT has been shown to increase the 
magnitude of TTX-resistant Na+ currents in sensory neurones in vitro (Gold et al., 
1996b; Cardenas et al., 1997), by a mechanism which involves 5-HT4-like receptors 
(Cardenas et al., 1997). While it is clear from these findings that each of the four 5-HT 
receptor subtypes plays a role in the nociceptive effects of 5-HT and other mediators, 
the precise contribution of each subtype remains unclear.
Histamine, in addition to 5-HT in many species, may be released from mast cells 
following stimulation by the antigen-bound reaginic antibody, immunoglobulin E (IgE) 
or peptides such as substance P (see following section) (Fig. 1.1). Histamine 
predominantly produces itch when injected subcutaneously (Keele and Armstrong, 
1964) but not pain unless associated with tissue damage (Magerl et al., 1990; Kress and 
Reeh, 1996). This is reflected in its weak activation of only about 15 % of cutaneous 
nociceptors (Kress and Reeh, 1996). Sensory neurones express Hi receptors whose 
activation by histamine leads to the release of Ca2+ from intracellular stores via IP3 
(Tani et al., 1990) but it is not known whether this occurs at the sensory terminal in
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vivo. Histamine may act principally in synergy with other mediators to potentiate their 
algogenic effects. For example, it has been demonstrated that histamine in 
combination with bradykinin, 5-HT and PGE2, has a more than additive influence on 
the algogenic effects of acidic pH (Steen et al., 1995; Steen et al., 1996; Vyklicky et 
al., 1998).
Cytokines, including interleukins (IL), tumour necrosis factor (TNF) and 
interferons, are released by phagocytic macrophages and other antigen-presenting cells, 
which accumulate at the site of tissue injury (Rang et al., 1991). Cytokines of the IL-6 
family may have a direct action on nociceptors as gpl30, the receptor through which 
EL-6 members act, is expressed by primary sensory neurones (Banner and Patterson, 
1993). However, the possibility that IL-6 may activate or sensitise these neurones has 
not been investigated. Interestingly, EL-6 itself is also expressed in sensory neurones 
following nerve injury (Murphy et al., 1995), suggesting a possible autocrine function.
Another cytokine, IL-lß, which is released from macrophages, promotes the 
secretion of nerve growth factor (NGF) from fibroblasts (Yoshida and Gage, 1992, see 
Fig 1.1). Aside from its role during development, recent evidence suggests that NGF 
plays a key role in hyperalgesia. For example, the inflammatory hyperalgesia produced 
by injecting complete Freund’s adjuvant (CFA) into rats is blocked by the prior 
systemic administration of anti-NGF serum (Woolf et al., 1994). In addition, NGF 
itself produces lasting hyperalgesia when injected into human subjects (Petty et a l, 
1994; Dyck et al., 1997) and experimental animals (Lewin et al., 1993b). This activity 
appears to involve central sensitisation (following retrograde transport of NGF) as well 
as release of mediators from inflammatory cells and sympathetic neurones (Lewin et 
al., 1994; Woolf et al., 1996). NGF has also been shown to sensitise visceral A8- and 
C-fibre afferents (Dmitrieva and McMahon, 1996), suggesting a direct action on 
nociceptors. In addition, the up-regulation of preprotachykinin A (the substance P
precursor) expression in sensory ganglion neurones during CFA-induced inflammation 
was prevented by treatment with anti-NGF antibodies (Leslie et a l , 1995). This 
suggests that NGF mediates changes in sensory neuronal gene expression during 
inflammation and it is conceivable that this effect contributes to the longevity of NGF- 
induced hyperalgesia. NGF has been identified in O. anatinus venom in the present 
study and its hyperalgesic properties are discussed at length in Chapter 6.
(iii) Neurogenic mediators released from sensory neurones: the axon reflex
Nociceptor activation produces a cutaneous flare response, the “axon reflex”, which is 
dependent on intact afferent innervation (Meyer et al, 1996). This is likely to result from 
the vasodilatory and plasma extravasating effects of substance P and calcitonin gene- 
related peptide (CGRP) both of which are released from peripheral sensory terminals 
(Lynn, 1996). As mentioned above, substance P also degranulates mast cells and this may 
further contribute to the flare response.
In addition to effects on the vasculature and mast cells, it is possible that activated 
nociceptive terminals release chemicals which activate neighbouring nociceptors. This 
idea of “spreading sensitisation” was originally suggested by T. Lewis in 1942 but was 
considered unlikely following the finding that spreading sensitisation to heat does not 
occur, despite the presence of a reflexive flare response (Meyer et a l, 1996). However, it 
is possible that neurogenic spreading sensitisation to mechanical and chemical stimuli may 
still occur and could, like the “efferent” effect of sensory neurones on the vasculature, also 
involve neuropeptide release. Interestingly, several recent studies have demonstrated that 
cultured sensory neurones express “autoreceptors” for substance P (i.e. neurokinin or NK- 
1 receptors) and the application of substance P or the NK-1 agonist, Sar-SP, to these 
neurones, produces an inward current and elevates intracellular calcium (Hu et a l, 1997; 
Brechenmacher et al, 1998; Li and Zhao, 1998). Unfortunately, these authors only
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considered the possible presynaptic role of these receptors in the dorsal horn of the spinal 
cord. However, the distribution of expressed substance P autoreceptors may also extend to 
peripheral terminals of nociceptive neurones and, if so, would provide a possible 
mechanism for spreading sensitisation.
(iv) Neuro genic factors released from sympathetic neurones
The pain associated with some chronic pain states, such as causalgia and reflex 
sympathetic dystrophy, is alleviated following sympathectomy suggesting the involvement 
of sympathetic post-ganglionic neurones (McMahon, 1991). Stimulation of sympathetic 
efferents has been shown to increase firing in C-fibres (Rang et al., 1991) and 
noradrenaline increases heat hyperalgesia produced by capsaicin (Drummond, 1995). 
However, it is unlikely that the effect is simply due to a direct action of noradrenaline 
released from sympathetic fibres as high noradrenaline concentrations do not activate C- 
fibers (Lang et al., 1990; Rang et al., 1991). However, prostacyclin (PGI2) induces 
hyperalgesia with a similar time-course to noradrenaline, suggesting that PGL may 
mediate sympathetic neurogenic hyperalgesia (Taiwo and Levine, 1988; Fig. 1.1). Clearly, 
more work needs to be done to clarify the involvement of sympathetic post-ganglionic 
neurones in pain and hyperalgesia.
(v) Adenosine triphosphate (ATP)
ATP is present in all cells at millimolar concentrations and large amounts are therefore 
likely to be released following physical cell damage (Rang et al., 1991). ATP induces 
pain in humans when applied to a blister base (Keele and Armstrong, 1964). This may 
be due to a direct effect on nociceptors, as ATP activates a cation channel in sensory 
neurones in vitro (Krishtal et al., 1988), an effect which is blocked by P2-receptor 
antagonists (Rang etal., 1991).
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(vi) Protons
Inflammatory exudates are acidic (McCarty et al., 1966) and acidic solutions (buffered 
at pH 6.2) produce pain when injected subcutaneously or applied to a blister base 
(Keele and Armstrong, 1964). Acidic pH directly activates polymodal nociceptors and 
potentiates the effects of other inflammatory mediators, including bradykinin, 5-HT, 
histamine, and PGE2 (Steen et al., 1995). Recent evidence suggests this facilitatory 
action is mediated through capsaicin receptors (Vyklicky et al., 1998; see next section). 
In sensory neurones, acidic pH evokes both transient and sustained inward cation- 
selective currents (Bevan, 1996) possibly via an acid-sensitive ion channel (ASIC) 
recently found to be expressed in these neurones (Waldmann et al., 1997). The 
sustained current is markedly potentiated in the presence of an inflammatory mediator 
“cocktail” (containing bradykinin, 5-HT, PGE2 and histamine), further supporting the 
notion that a synergy exists between these mediators and acidic pH (Kress et al., 1997).
General comments
It is clear that a given inflammatory mediator is unlikely to act alone on nociceptive 
neurones following tissue injury. In many of the aforementioned examples, 
combinations of mediators act synergistically to produce a suprathreshold response. 
An interaction between inflammatory mediators and physicochemical stimuli, such as 
low pH, is also very likely. A sustained potentiation of the painful effects of tissue 
acidosis is seen when inflammatory mediators are combined with low pH (Steen et al., 
1996). This could explain a major anomaly between the marked desensitisation 
observed following prolonged administration of individual algogenic mediators and the 
longevity of inflammatory pain (Kumazawa et al., 1987; Lang et al., 1990; Vyklicky et 
al., 1998), i.e. prolonged algetic responses may result from a combination of
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inflammatory mediators and tissue acidosis, rather than from the effects of individual
components.
Toxins which produce pain: exogenous algogens 
Snake and arthropod venoms
In general, there are four8 ways by which several of the aforementioned mechanisms 
and pathways underlying inflammatory pain can be triggered following envenomation.
(i) Venom components may liberate algogens from endogenous precursors. For 
example phospholipases A2, which are present in almost all snake (Iwanaga and 
Suzuki, 1979), as well as bee (O’Conner and Peck, 1979), wasp (Edery et a l, 1979) 
and scorpion (Ramanaiah et al., 1990) venoms, cleave the C2 acyl chain of 
phosphatidylcholine, thereby generating arachidonic acid and lysophosphatidylcholine. 
Arachidonic acid is converted to prostaglandins through the action of cyclooxygenases. 
As described above, prostaglandins sensitise nociceptors whereas lysophosphatidyi- 
choline is a mast cell degranulator (Moreno et a l, 1992) and may be converted to 
platelet-activating factor (PAF) (Teixeira et a l, 1994). Certain snake venoms also 
contain kallekrein-like enzymes which liberate bradykinin from high molecular weight 
kininogens (Iwanaga and Suzuki, 1979).
(ii) Venoms may elicit an antigenic response, leading to the release of 
inflammatory algogens. For example, IL-6, which may have a direct effect on 
nociceptive neurones, is released following Bothrops ssp. and Crotalid snake 
envenomation and scorpion sting in humans (Sofer et a l, 1996; Barraviera et al, 
1995). An investigation into the behavioural hyperalgesia induced by Bothrops 
jararaca venom in rats has also demonstrated the involvement of eicosanoids and PAF
8 pain which is secondary to necrotic and myotoxic effects of venoms is not considered here.
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(Teixeira et al, 1994).
Several insect venoms contain peptides which release histamine and 5-HT from 
mast cells and in this way may contribute to their painful effects. Examples include 
melittin from Apis mellifera venom (Jasani et al., 1979) and mastoparans from Vespid 
wasp venoms (Ho and Hwang, 1991).
(iii) Venoms may contain factors which potentiate the activity of exogenous or 
endogenous algogens. For example, peptides which potentiate the activity of 
bradykinin are present in snake (e.g. Bothrops jararacussu, Ferriera et a l, 1992), spider 
{e.g. Scaptocosa raptoria, Ferreira et a l, 1996) and scorpion (e.g. Buthus occitanus, 
Meki et al., 1995) venoms. These bradykinin-potentiating peptides act by inhibiting 
angiotensin-converting enzyme (ACE) which is the major enzyme responsible for the 
breakdown of bradykinin in the vasculature and other tissues (Campbell, 1995).
(iv) Venoms may themselves contain algogens which act directly on nociceptive 
neurones. For example, Vespid wasp venoms contain kinins which are structurally and 
pharmacologically similar to bradykinin (Edery et al., 1978) and may therefore 
contribute to the painful effects of envenomation. In addition, NGF is present in the 
venom of snakes from several genera (Kostiza and Meier, 1996) and may act similarly 
(see above).
It is possible that many venoms which produce pain do so by directly activating 
or modifying the gating and kinetics of ion channels on nociceptive terminals. For 
example, versutoxin, from the venom of the Australian funnel-web spider, Hadronyche 
versuta, removes TTX-sensitive Na+ channel inactivation in DRG neurones (Nicholson 
et al., 1994) and similar effects are produced by scorpion (Centruroides sculpturatus 
and Leiurus quinqestriatus) neurotoxins (Wang and Strichartz, 1983). It is conceivable 
that such effects on Na+ channel inactivation contribute to the pain which is a major
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presenting symptom following envenomation by these species (Sutherland, 1983; 
Rimsza et al., 1980).
These examples demonstrate that activation of a number of potentially algogenic 
pathways by animal venoms does occur and has been found largely to involve the 
release or potentiation of endogenous inflammatory mediators. However, with the 
exception of the study by Teixeira et al. (1994) described above, no systematic 
behavioural or electrophysiological studies on the mechanisms of venom or venom- 
derived-toxin-induced pain and hyperalgesia have been carried out. This is despite the 
fact that numerous venoms produce pain (Chahl and Kirk, 1979) and this is often a 
major presenting symptom following envenomation.
In contrast to the situation with animal toxins, the nociceptive properties of the 
plant-derived neurotoxin, capsaicin, have been studied extensively.
Capsaicin
Capsaicin (8-methyl-ALvanillyl-6-nonenamide) is the pungent component of capsicum 
peppers which gives rise to a sensation of warmth and burning. It produces burning 
pain and mechanical hyperalgesia when injected intradermally (Simone et a l, 1989) 
and selectively activates C-fibre polymodal nociceptive, thermoceptive and Aö-fibres 
(Bevan and Szolcsanyi, 1990). Prolonged application is selectively excitotoxic for C- 
fibres in vivo (Jansco et al., 1977) and in vitro (Wood et al, 1988). Capsaicin 
depolarises sensory neurones by activating a non-selective cation current (Baccaglini 
and Hogan, 1983; Bevan and Forbes, 1988) and also, probably secondarily, increases 
cGMP, DAG, IP3 and arachidonic acid in these neurones (Wood et al., 1989; Burgess 
et al., 1989).
The selectivity of capsaicin for thermo- and nociceptive neurones suggests that 
capsaicin receptors may form part of an important activation pathway in pain
transduction and has prompted several theories on their normal function. Similarities 
between the currents evoked by low pH and capsaicin initially led to speculation that 
capsaicin receptors normally transduce proton-mediated activity (Bevan and Geppetti, 
1994; Liu and Simon, 1994). However, the finding that protons did not activate 
capsaicin-activated channels in outside-out patches of sensory neurones makes this 
suggestion untenable (Oh et al., 1996). Several recent advances have suggested more 
plausible hypotheses. The capsaicin receptor, VR1 (vanilloid receptor 1) has recently 
been identified, cloned and expressed in oocytes (Caterina et al., 1997). Capsaicin 
activates an inward current only in VR1-expressing oocytes and this is potentiated by 
low pH (6.3). Transfected cells also exhibit noxious heat-activated inward currents 
(Caterina et al., 1997). Thus, the normal role of VR1, which is predominantly 
expressed by small to medium diameter sensory neurones (putative nociceptors), may 
be to transduce noxious heat signals and mediate nociceptor potentiation by the low pH 
which accompanies inflammation. This is further supported by the recent findings of 
Vyklicky et al. (1998) which suggest that the facilitatory action of low pH on the 
activity of inflammatory mediators occurs through capsaicin receptors.
Possible bases for the algogenic effects ofO. anatinus venom
O. anatinus venom may produce lasting pain through any of the aforementioned 
mechanisms. Like other venoms, OaW may contain or cause the release of 
inflammatory mediators. However, the longevity and severity of the symptoms 
associated with envenomation are not consistent with the acute activity of some 
mediators, such as histamine, 5-HT and bradykinin, whose effects are moderate and 
short-lived by comparison (Keele and Armstrong, 1964). Thus while these mediators 
may contribute to acute effects, others such as NGF, which produces lasting 
hyperalgesia (Lewin et al., 1993b) and alters gene expression (Leslie et al., 1995), are
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more likely to contribute to the long-term effects. In fact, a single subcutaneous dose 
of NGF in human subjects produces localised hyperalgesia persisting for up to 7 weeks 
(Petty et al., 1994; Dyck et al., 1997), a time-course similar to that reported following 
O. anatinus envenomation. It is also possible that OdW has a selective, direct effect on 
nociceptive neurones, in an analogous manner to capsaicin.
Objectives of this study
The studies described in this thesis were ultimately aimed at identifying and 
characterising components from 0. anatinus venom which contribute to the painful and 
pro-inflammatory effects of envenomation. The formulation of experiments to meet 
this objective presented a number of difficulties. Firstly, pain is a subjective 
experience and as such is difficult to measure experimentally. Behavioural testing, e.g. 
measuring the limb withdrawal latencies of experimental animals in response to 
noxious mechanical or thermal stimuli, may be used as an index of pain. However, this 
technique relies on the assumption that animals behave in such a way in response to 
pain as humans subjectively experience it and is therefore, by definition, 
anthropomorphic. Anthropomorphism does not present the same problem in other 
types of animal experimentation, e.g. in physiological experiments, because animal and 
human parameters in these cases can be objectively compared and the validity of an 
animal model may thus be reasonably assessed. However, a reflexive response to a 
noxious stimulus provides no information on the subjective sensation of pain likely to 
be experienced by the animal. Although it could equally be argued that data obtained 
from humans presents a similar problem (pain is still subjective), human subjects have 
the advantage of being able to communicate the sensations experienced in a complex 
manner. This allows a more valid comparison of reported sensations with our own and 
those of other subjects. Pain may be measured in this way, following administration of
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an algogen to human subjects, using subjective rating scales (Keele and Armstrong, 
1964). However, this presents a number of additional problems. For example, apart 
from obvious ethical implications for severely painful stimuli, the amount of detailed 
mechanistic information which may be obtained is very limited.
An alternative to the behavioural approach is to assay for the venom-induced 
release of inflammatory mediators which are implicated in the induction of pain. 
Concomitantly, the possibility of a direct effect of venom components may be 
addressed by measuring the activity of pain-sensing neurones. Both types of 
experiment were employed in this study, with a particular emphasis on the latter.
Because very little was known about the characteristics of venom constituents at 
the commencement of this work, an initial part of this study involved the purification 
and characterisation (at the amino acid sequence level) of the major venom proteins 
and peptides (Chapter 3). One peptide, a C-type natriuretic peptide, was extensively 
characterised and demonstrated to release histamine from purified rat peritoneal mast 
cells and to produce some pro-inflammatory effects which are characteristic of O. 
anatinus venom (Chapter 4). However, an exhaustive analysis of the release of 
inflammatory mediators by venom components and their contribution to the painful 
effects of envenomation was not undertaken. Rather, the possibility of a direct effect 
on sensory neurones was investigated using sensory ganglion neuronal cell bodies in 
vitro, which express properties and chemical sensitivities similar to polymodal 
nociceptors in vivo (Chapter 5). 0. anatinus venom did indeed directly activate inward 
currents in these neurones and this activity was associated with an NGF-like protein 
which was characterised further (Chapter 6).
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CHAPTER 2
GENERAL METHODS
The general methods used in the following experimental chapters are described here. 
Specific variations and methods confined to a single chapter are detailed in the Methods 
section of that chapter.
Collection and handling of O. anatinus venom
The majority of material used in this study was obtained from excised crural glands, 
which were a gift from Dr Russell Jones (University of Newcastle, School of Biological 
Sciences). Animals (3), trapped in August from Barrington Tops (NSW), were 
sacrificed by pentobarbitone overdose. A ligature was tied at the distal end of the main 
duct to prevent the loss of material and each crural gland-duct complex was dissected 
free and placed in frozen CO2. Crural glands were subsequently stored at -70 °C and 
thawed at 4 °C when required.
Material was obtained from the glands using a similar method to that described 
by Temple-Smith (1973). An incision was made in the duct just above the ligature and 
material was collected by holding the crural gland and allowing the duct to hang 
vertically into a 1.5 ml polypropylene tube placed on wet ice. Material spontaneously 
leaked from the incision but additional material could be obtained by gently applying 
pressure to the crural gland. The collected venom was stored neat in aliquots at -70 °C. 
Lyophilisation has been reported to produce substantial losses in material and activity 
(Temple-Smith, 1973) and was therefore avoided.
Additional material was collected by Dr Melody Serena (Australian Platypus 
Conservancy, Whittlesea, VIC) from animals which were captured and released during
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routine field surveys. This was accomplished by holding the spur at right angles to the 
hind-limb and aspirating droplets of venom, which appeared on the tip of each spur, 
using a capillary-tipped Gilson micropipette. The animals were released with no 
apparent ill effects and the material was placed on ice in the field and stored long-term 
at -20 °C. This had been determined to be the most effective, rapid and innocuous 
method of obtaining material from live animals during previous field trips with Dr 
David Goldney (Charles Sturt University, Bathurst, NSW) (de Plater, Hons Thesis, 
ANU 1993). Attempts to collect material using latex stretched over a collection 
reservoir (analogous to the method used for the collection of snake venoms), the 
injection of oxytocin (commonly used on field trips to facilitate lactation in females), or 
mild trans-cutaneous electrical stimulation, proved to be unsuccessful.
High-performance liquid chromatography (HPLC)
Prior to each HPLC step, a thawed aliquot of O. anatinus venom was suspended in the 
eluting buffer for isocratic separations and eluent A (see next section) for gradient 
separations. This invariably resulted in the formation of a white precipitate which was 
removed by centrifugation. The precipitation appeared to be more pronounced in Tris- 
(pH 8.5) or HEPES- (pH 7.5) buffered solutions and less pronounced in ammonium 
acetate- (pH 5.0) and, particularly, MES- (pH 6.1, with sorbitol-see below) buffered 
solutions.
Reversed phase HPLC (RP-HPLC)
For the reversed phase separation of peptides of less than 10 kDa, venom was suspended 
in 0.1 M ammonium acetate, pH 5.0, clarified by centrifugation and subjected to 
ultrafiltration using a 10 kDa nominal molecular weight filter (Centricon 10, Amicon or 
Ultrafree 10 k NMWL, PTGC, Waters). The filtrate was recovered and fractionated by 
reversed phase HPLC (RP-HPLC) using a C2/C18 column of dimensions 2.1 mm x 10
cm (pRPC SC2.1/10, Pharmacia) or 3.2 mm x 3 cm (pRPC PC 3.2/3, Pharmacia) 
connected to a SMART (Pharmacia) HPLC system. Eluent A consisted of 0.1 % 
trifluroacetic acid (TFA) in H20  and eluent B consisted of 0.1 % TFA in CH3CN. 
Peptides were eluted using a linear gradient of 5-60 % B over 20 min at a flow rate of 
250 ml min'1. The eluate was monitored continuously using a pPeak detector 
(Pharmacia) at wavelengths of 214, 255 and 280 nm unless indicated otherwise.
In some experiments, whole O. anatinus venom or fractions from other HPLC 
steps were subjected to RP-HPLC. The conditions were as described above except that 
the material was suspended in 0.1% TFA, 5% CH3CN and not subjected to 
ultrafiltration. Detection was at 214, 255 and 280 nm unless indicated otherwise.
Ion-exchange HPLC
Whole venom was fractionated by cation-exchange HPLC using a MonoS PC 1.6/5 (1.6 
x 50 mm, Pharmacia) column connected to the SMART System and eluted with a 0-1 M 
NaCl gradient in 50 mM HEPES, pH 7.5. In some experiments 20 mM MES, pH 6.1, 
was used. Fractions were further purified by RP-HPLC as described above, following 
titration to approximately pH 3 with 3 M TFA. Material not binding to the cation- 
exchange column was fractionated by anion-exchange HPLC using a MonoQ PC 1.6/5 
(1.5 x 50 mm, Pharmacia) column with a linear gradient of 0 - 0.5 M NaCl in 20 mM 
bis-Tris, pH 6.5.
Gel permeation HPLC (HP-GPC)
HP-GPC on the SMART System was carried out using a Superose-12 (Pharmacia) 
agarose-based column of dimensions 3.2 mm x 300 mm. The column was equilibrated 
with several volumes of 50 mM ammonium acetate (pH 5.0) prior to each run. The 
sample was injected in a minimal volume (< 50 pi) and eluted using a flow rate of 40 pi 
min'1. In some experiments, MES buffer (mM, 135 NaCl, 3 KC1, 0.6 MgCl2, 2.5 CaCl2,
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1.2 NaHCCb, 10 glucose, 10 MES, titrated to pH 6.1 with HC1, osmolarity adjusted to 
320 mOsm using sorbitol) was used. The eluate was monitored continuously at 280 nm.
Chromat ofo casing
Chromatofocusing was carried out using a MonoP HR 5/20 column (Pharmacia). This 
column, designed for use with FPLC (Pharmacia) systems, was adapted for use with the 
SMART System using a long column adaptor and incorporating several reservoir fill 
commands in the gradient program (the volumes required exceed the capacity of the 
SMART buffer reservoir cylinders). The column was equilibrated in 0.025 M 
triethylamine which was adjusted to pH 11.0 with HC1 (buffer A). The eluant consisted 
of 1 part Pharmolytes 10.5 - 8.0 (Pharmacia, undiluted) to 45 parts MilliQ H20  (buffer 
B). Both the equilibrating and eluting buffers contained 55 mM sorbitol to facilitate 
analyte solubility. Following sample injection, the equilibrating buffer was run through 
the column at a flow rate of 0.5 ml min'1 for 20 min. The eluting buffer (i.e. 100% B) 
was then run through the column for 100 min at a flow rate of 0.5 ml min'1. The pH of 
the eluate was monitored by measuring the pH of collected fractions at regular intervals. 
Ampholytes were largely removed from chromatofocusing fractions by ultrafiltration 
(Ultrafree 10 k NMWL, PTGC, Waters) and HP-GPC.
Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE)
Vertical slab sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) 
was carried out under non-reducing conditions using Novex 10-20 % gradient pre-cast 
gels in a Novex Xcell Mini-Cell (Novel Experimental Technology, San Diego, CA, 
USA) and a V-Tris(hydroxymethyl)aminomethane-V-Tris(hydroxymethyl)methylglycine 
(Tris-Tricine) (Schägger and von Jagow, 1987) or Tris-Glycine (Laemmli, 1970) buffer 
system. Samples were denatured by heating in sample buffer (0.16 M Tris-HCl, pH 
8.45, 4 % (w/v) SDS, 20% (v/v) glycerol + tracking dyes) at 100 °C for 10 min prior to
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application. Gels were run at a constant voltage of 125 V (current: 80 mA/gel start, 40 
mA/gel end) for approximately 90 min. Proteins were visualised using 0.1 % 
Coomassie blue R250 in 10 % propan-2-ol, 10 % acetic acid. Silver staining was 
carried out according to a protocol based on Blum et al., 1987. Gels were fixed by 
incubation in 50 % ethanol, 12 % acetic acid for 15 min followed by 30 % ethanol for 
15 min. The fixing solution was decanted and the gel incubated for 1 min in 0.8 mM 
sodium thiosulphate. The gel was washed 3 times for 30 s in MilliQ FBO and incubated 
in 14 mM AgNÜ3 , 0.075 % formaldehyde. The gel was again washed in TfO and 
developed using 0.57 M NaCÜ3 , 0.16 mM sodium thiosulphate and 0.05 % 
formaldehyde. Staining was stopped by replacing the developing solution with 30 % 
ethanol, 12 % acetic acid.
Amino acid analysis
Venom and peptide concentrations were determined by quantitative amino acid analysis. 
Lyophilised samples were subjected to gas-phase hydrolysis under nitrogen at 110 °C 
for 20 h, using 6 N HC1 with 0.1 % phenol. Analyses were performed using a Hewlett- 
Packard AminoQuant Series II (Hewlett-Packard) amino acid analyser. Amino acids 
were subjected to pre-column derivitisation with orr/io-phthalaldehyde (OPA with 3- 
mercaptopropionic acid in 0.4 M sodium borate, pH 10.4, Hewlett-Packard) and 9- 
fluorenylmethyl chloroformate (FMOC) and derivitised amino acids were detected using 
an HP 1046 (Hewlett-Packard) fluorescence detector. Quantitative analyses were 
performed in triplicate using a three-level calibration for each amino acid.
Mass spectrometry
Peptide molecular masses were determined using a VG Analytical TOFSPEC (Time-of- 
Flight, Matrix-Assisted Laser Desorption and Ionisation, TOF-MALDI) instrument (VG 
Analytical Division, Fisons Instruments, Manchester, U.K.) and a saturated solution of
a-cyano-4-hydroxycinnamic acid (in 40% CH3CN/0.1% trifluoroacetic acid) as matrix. 
Masses were determined at threshold laser energy using bovine insulin (Sigma, [M+H]+ 
= 5734.5) and gramicidin S (Sigma, [M+H]+ = 1142.5) as internal reference standards. 
Fast Atom Bombardment (FAB) and atmospheric pressure ion-spray (APSI) mass 
spectrometry was performed by Carl Braybrook (Research School of Chemistry, ANU) 
using VG Analytical ZAB SEQ and QUATTRO instruments, respectively. Samples 
were prepared in a-thioglycerol for FAB and in 1 % formic acid/H20  for APSI.
N-terminal amino acid sequencing
Purified peptides and proteins were reduced and S-pyridylethylated by incubation in 6  M 
guanidine-HCl, 0.5 M Tris-HCl, pH 7.9, 1 mM EDTA and 10 mM DL-dithiothreitol for 
1 h at 37 °C. 20 mM 4-vinylpyridine (Sigma) was added and the solution incubated at 
room temperature for 2 h. Pyridylethylated peptides were desalted by RP-HPLC and 
passively adsorbed onto polyvinylidene difluoride (PVDF) membranes (Problott™, 
Applied Biosystems Division, Perkin-Elmer Corp.), treated with Biobrene™ (Applied 
Biosystems Division, Perkin-Elmer Corp.) and subjected to automated Edman 
degradation using Applied Biosystems 494 Procise HT and cLC pulsed liquid protein 
sequenators (Applied Biosystems Division, Perkin-Elmer Corp.).
Endoproteolytic cleavage of proteins and peptides for Edman sequencing 
In-solution cleavage
RP-HPLC-purified, reduced and S-pyridylethylated (4-vinylpyridine, Sigma) peptides 
and proteins were lyophilised and resuspended in 100 mM Tris-HCl, 10 mM CaCB, pH 
7.6, containing 2 % (w/w, enzyme:substrate) endoproteinase Arg-C (sequencing grade, 
Boehringer Manheim Biochemica, with 50 mM EDTA and 50 mM dithiothreitol) or 0.1 
M NH4HCO3 containing 1 % (w/w) Chymotrypsin (sequencing grade, Boehringer
Manheim Biochemica). Arg-C digests were incubated for 3 h at 37 °C and
chymotryptic digests at room temperature for 2  h and the resulting cleavage products 
were purified by RP-HPLC and analysed by MALDI-TOF mass spectrometry as 
described above. In some experiments, endoproteinase Asp-N (sequencing grade, 
Boehringer Manheim Biochemica) was used at a concentration of 2 % (w/w) for 1 h at 
37 °C in 50 mM sodium phosphate, pH 8.0.
In-gel tryptic cleavage
The following method, which was based on Jeno et al. (1995) and Heilman et al. (1995) 
was used for the in situ reduction, alkylation, and enzymatic digestion of proteins in-gel.
Gel pieces, containing Coomassie-stained bands, were excised and destained 
with two 250 (Ltl washes of 40% n-propanol for 5 min followed by two extractions with 
250 pi of 0.2 M NH4HCO3 / 50 % acetonitrile for 15 min at 30 °C. Residual bicarbonate 
and acetonitrile were evaporated in a vacuum centrifuge. Reduction was carried out 
prior to enzymatic digestion in a total volume of 50 pi containing 50 mM Tris-HCl, pH 
8.0, 0.1% SDS, 1 mM EDTA, 10 mM DTT for 45 min at 60 °C. After cooling to room 
temperature, alkylation was achieved by adding 4-vinylpyridine to a final concentration 
of 50 mM followed by incubation for 15 min at room temperature. The gel piece was 
washed several times with 0.2 M NH4HCO3 / 50 % acetonitrile and dried in a vacuum 
centrifuge.
Digestion was initiated by adding 5 pi of 0.2 M NH4HCO3 followed by 0.5 pg of 
porcine trypsin (“modified trypsin sequencing grade” from Promega Corp., Madison, 
WI), dissolved in 1 mM HC1 at a concentration of 0.1 mg ml'1. The gel piece was then 
fully reswollen by repeated additions of 5-10 pi aliquots of 0.2 M NH4HCO3 and the 
mixture incubated overnight at 30 °C. To terminate the digestion, a 1/10 volume of 10 
% TFA was added and the supernatant collected. The resulting peptides were extracted
from the gel pieces by two treatments for at least 40 min each with 100 jil of 0.1% TFA, 
60 % acetonitrile at 30 °C. The extracts were combined and the organic phase volume 
was reduced using a vacuum centrifuge, and the peptides were purified by RP-HPLC as 
described above.
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CHAPTER 3
GENERAL COMPOSITION AND CHARACTERISATION OF O. ANATINUS 
VENOM CONSTITUENTS
Introduction
It has been demonstrated previously that 0. anatinus venom (OaW) contains at least 
seven proteins, which were classified as pre- (Mr9 < 70 kDa) or post-albumins (Mr 70- 
80 kDa), or larger (Mr > 90 kDa) proteins (Temple-Smith, 1973). However, no specific 
information, such as individual molecular weight estimates or amino acid sequence 
data were obtained for any of these proteins. In addition, no attempt was made to 
identify and characterise smaller peptides or other non-protein components in OaW. 
Compositional differences between OaW obtained from excised crural glands and that 
obtained from live animals has also not been investigated. The work presented in this 
chapter was aimed at providing Mr estimates and amino acid sequence data for the 
major OaW proteins and polypeptides as well as resolving any variation between OaW 
collected by different methods and at different times of year.
Although the results reported by Temple-Smith (1973) suggested that seasonal 
variation occurs in the relative expression of the three classes of protein identified in 
OaW, variation of expression of individual components was not clearly established. In 
addition, seasonal variation was not distinguished from variation due to other factors. 
Snake venom composition, for example, may vary at the intraspecies level, between 
individual specimens, due to geographical variation and, in individual specimens, due 
to seasonal variation, diet, habitat, and age (Chippaux et al., 1991). Fortunately, the
9 Mr, relative molecular mass
OaV used in this study (supplied by Dr Melody Serena), was obtained at the same 
locale, from animals which were at least 3 years of age and from several individuals at 
each collection time. This allowed seasonal variation to be distinguished from 
variation due to most of the aforementioned factors.
In snake venom research and antivenom production, pooled material is invariably 
used which yields an average venom quality and may be considered a statistically 
representative “standard” (Kalapothakis and Chavez-Olortegui, 1997). The definition 
of a “standard” OaV composition and the characterisation of individual components 
may be useful for ascertaining OaV variation and for future reference. Such a standard 
has been prepared in this study by pooling OaV from several individual specimens.
The characterisation of individual components, particularly at the amino acid 
sequence level, may be employed to obtain an indication of function based on 
aomology with previously characterised proteins. Obtaining amino acid sequence 
‘tags” for individual OaV components will facilitate the future cloning and expression 
of OaV proteins from an OaV cDNA library, which may become necessary due to the 
difficulty of obtaining viable quantities of material.
This study describes the general compositional characteristics of pooled OaV 
samples derived from live animals and excised glands as well as individual and 
seasonal variation in the expression of OaV proteins. Purification strategies for the 
major venom polypeptides have been devised and are described along with the partial 
or full amino acid sequences where these have been obtained.
Methods
HPLC purification and SDS-PAGE analysis of OaV components
Reversed phase, ion exchange, and gel permeation HPLC were carried out using the 
SMART HPLC System as described in Chapter 2 (General Methods). Material was
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obtained from excised crural glands (OaVA, collected in August and pooled) or 
directly from live animals (OaVB, collected in January, June, September and October 
and pooled, but also analysed individually) and was analysed by SDS-PAGE using both 
the Tris-Tricine and Tris-Glycine buffer systems, as described in Chapter 2.
N-terminal Edman sequencing
Purified OaV peptides and proteins were subjected to direct N-terminal Edman 
sequencing following passive adsorption onto Biobrene-treated PVDF or TFA- 
activated glass-fibre disc. Some OaV components were subjected to in-gel or in­
solution proteolytic digestion, followed by RP-HPLC (using a Sephasil C18 column, 
Pharmacia) of the resulting peptide fragments which were adsorbed onto PVDF and 
submitted to Edman sequencing (see Chapter 2).
Database search protocols and algorithms
Amino acid sequences were analysed for similarity to known proteins using both the 
Baylor College of Medicine (BCM) Search Launcher (URL: http://dot.imgen. 
bcm.tmc.edu:9331/seq-search/protein-search.html) and the Australian National 
Genome Information Service (ANGIS, http://www.angis.org.au). Both BLAST (Basic 
Local Alignment Search Tool, Altschul et a l, 1990)/BEAUTY (BLAST Enhanced 
Alignment Utility, Worley et al., 1995) and FastA (Pearson and Lipman, 1988) search 
algorithms were used. The following databases were searched: dbEST (Expressed 
Sequence Tags), a database of cDNA sequences which have been reverse-transcribed 
from mRNA; SWISS-PROT (annotated database maintained by the Dept. Medical 
Biochemistry at the University of Geneva); and NR (non-redundant), a protein 
sequence database collated from other databases (GenPept, TREMBL, SWISS-PROT 
and PIR) and screened to remove redundancies.
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Gross similarities between proteins, recognised by a particular reference 
sequence, were determined using PROSITE, a database of biologically significant sites, 
patterns and profiles in proteins (ExPASy, Appel et al., 1994). The family and 
superfamily to which a given partially sequenced OaW protein was likely to belong 
could be established in this way.
When an OaW protein appeared to be related to a particular class or family, the 
peptide fragments were aligned individually to members of the family (which were 
aligned together) using the Clustal W multiple sequence alignment program (Ver. 1.7), 
part of the BCM Search Launcher (URL: http://dot.imgen.bcm.tmc.edu:9331/multi- 
align/multi-align.html).
Results
General features of O. anatinus venom
OaW was obtained both from live animals and excised crural glands as a 
translucent, highly viscous liquid which became turbid upon dilution. The protein 
concentration of the main OaW stock obtained from excised glands (OaWA) was found 
to be 39.481 ± 2.656 mg ml'1 (mean ± S.D., triplicate analysis) by quantitative amino 
acid analysis and had a pH of 6.4. Most of the protein components of OaW were 
identified by SDS-PAGE either using Tris-Glycine (Fig. 3.1 A) or Tris-Tricine gels 
(Fig. 3.IB). Tris-Tricine SDS-PAGE gave a superior separation of venom proteins, 
particularly in the low molecular weight range and was used routinely for subsequent 
analyses. Separate analysis of pooled material obtained from excised crural glands 
(OaWA) and directly from live animals (OaVB) enabled the detection of 11 
components, with relative molecular masses ranging from 4-216 kDa (Fig 3.IB). Most 
components were observed to be present in material from both sources. Differences in 
the apparent relative concentration of individual components in OaW A and OaW B may
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FIG 3.1. A. Tris-Glycine SDS-PAGE analysis of O. anatinus venom 
obtained from excised crural glands (OaVA) and directly from the 
spurs of live animals (OaVB). For each source OciV from different 
animals was pooled. B. Tris-Tricine SDS-PAGE analysis of OaVA 
annotated with the names of identified components (see Table 1). C. 
Tris-Tricine SDS-PAGE analysis of OaV samples collected at different 
times of year, grouped according to the month of collection.
be attributed to a seasonal bias because most of the OaVB material was collected in
January and pooled with OaV collected at other times of the year, whereas the entire 
OaVA pool was obtained in August.
Fractionation by HPLC led to the detection of 19 OaV components; more than by 
SDS-PAGE, largely due to isoforms co-migrating on SDS-PAGE. These components 
are described in Table 3.1. Several proteins have been characterised at the amino acid 
sequence level and their sequences compared with those in the SWISS-PROT, NR and 
EST databases (BCM and ANGIS). Possible homologies are summarised in Table 3.1. 
Discrete components have been named according to their molecular weight or 
according to sequence homologies where these have been established.
In addition to the analysis of pooled samples {OaVA and OaVB) OaV samples 
collected from different individuals at different times of the year were analysed by 
SDS-PAGE (Fig. 3.1C). OaV obtained outside the breeding season, where crural 
glands are in the regression, quiescent (December, January) or elaboration phases 
(June), respectively, was constitutively similar to that obtained during the breeding 
season (September, October, i.e. the extrusion-phase, see Chapter 1). However, the 
relative amounts of some components differed depending on the month collected. The 
proteins p28, OVL-50, p66 and p i68 appeared to be maximally expressed during 
December and January, and (except OVL-50) June, whereas GDILP and p i23 
predominated during September and October. The expression of other components 
either showed no dependence on the month of collection or were expressed irregularly 
between individuals in a given month (p35). There were no obvious consistent 
differences between the six OaV samples collected from individual specimens in 
January. Similarly, no obvious differences were apparent between the three samples 
obtained from individuals in September, although some proteins could not be
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Table 3.1. Summary of the major characteristics of OciV components
Component Mol. Wt. AA sequence similarities Comments (activity, etc.) Month of
name (*Da) max.
(**kDa) relative
expression
1132 material 1131.9* no A280, no AAs detected 
following hydrolysis
N. D.
ovCNP-39A 4207.9* C-type natriuretic rat uterus relaxation N. T. A.
ovCNP-39B 4208.3* peptide; A and B have elevates cGMP in aortic
identical AA sequences myocytes
mast cell histamine 
release
GLP-1 5108.8* some homology with N. T. A.
GLP-2 5116.1* granulins/epithelins N. T. A.
GLP-3 4952.9* N. T. A.
pl2/NGF 13327.5* Nerve growth factor involved in activation of N. T. A.
(NGF) inward currents in sensory
neurones
Kunitz - like 15** some homology with major protein, basic N. D.
protein (KLP) kunitz - type protease 
inhibitor family
OVL-15 15** lipocalin homology shares some homology 
with OVL-50
N. D.
p23 2 3 ** possible homology with 
insulin - like growth 
factor binding proteins 
(ILGFBPs)
N. T. A.
p28 28** Jan,Jun
p35 35** Sep
OVL-50 50** lipocalin homology shares some homology 
with OVL-15, acidic.
Jan
GDI-like 55** possible homology with major protein, acidic Sep
protein members of the GDP -
(GDELP) dissociation inhibitor 
(GDI) family
p6 6 6 6 ** Dec - Jan
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Table 3.1. (cont.)
Component
name
Mol. Wt. AA sequence similarities 
(*Da)
(**kDa)
Comments Month of 
max 
relative 
expression
pl23 123** possibly related to 
GDILP
Sep - Oct
pl68 168** Jan, Jun
p205 205** N. T. A.
p216 216** N. D.
N. D. not determined 
N. T. A. no trend apparent
Note: Protease activity as detected by Zymogram SDS-PAGE was associated with 3 proteins of Mr 109 
kDa, 95 kDa and 84 kDa. These were not detected by protein staining, presumably due to low 
abundance, and are not included in this table. Hyaluronidase activity was associated with a high Mr GP- 
HPLC fraction containing p i23 but it is unclear whether this protein is responsible for the activity (de 
Plater et al., 1995),
visualised in the middle September sample (i.e. fifth lane from right of gel) as less 
material was available for analysis.
Most OaV components could be separated effectively by RP-HPLC (jiRPC, 
C2C18 PC3.2/3). Fig. 3.2. A shows a typical RP-HPLC separation of complete OaV A  
annotated with the names of the major components identified. RP-HPLC was not 
employed routinely for the fractionation of venom proteins (>15 kDa) as extensive 
“ghosting” was observed on subsequent blank chromatographic runs, particularly from 
the high molecular weight p55/pl23 material. In addition, the relatively high 
concentration of organic solvent required to elute the high molecular weight material 
increases the risk of protein denaturation and loss of activity. However, RP-HPLC was 
routinely employed for the separation of low molecular weight components from the 
venom. The C2/C18 column (PC 3.1/10), eluted with a linear CH3CN gradient, gave 
very good resolution of OaV peptides. Fig. 3.2B shows an example of the RP-HPLC
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FIG.3.2. A. Reversed phase HPLC fractionation of whole O. anatinus venom. 
pRPC C2/C18 (PC3.2/3) column was used, Eluent A consisted of 0.1 % TFA /
H90  and B consisted of 0.1 % TFA / CH3CN.). B. Reversed phase HPLC
fractionation of a 10 kDa cutoff ultrafiltrate. A |iRPC C2/C18 (PC 3.1/10) was 
used with the same elution conditions described for A. The chromatogram is
annotated with the names of the major components identified (see Table 1).
fractionation of a 10 kDa cut-off (nominal molecular weight) ultrafiltrate. The major 
OaW peptides could be purified to homogeneity using this two-step procedure.
1132 Da material
The major A214 peak resulting from RP-HPLC fractionation of the 10 kDa ultrafiltrate 
(Fig. 3.2B) was subjected to electrospray mass spectrometry. This component had a 
molecular mass of 1131.9. A minor component with a mass of 1114.9 was also present 
in this fraction. The material was subjected to Edman sequencing following adsorption 
to both PVDF and glass-fibre disc. However, no amino acids were detected. Acid 
hydrolysis and amino acid analysis also yielded no amino acids, although a large single 
peak which had apparently been derivatised by orr/zo-pthalaldehyde (OPA) was 
observed. The material also gave no absorbance at 280 nm (Fig. 3.2B). These results 
suggest that the 1132 material is not a peptide.
C-type natriuretic peptide (ovCNP-39)
ovCNP-39 (OaW C-type natriuretic peptide) was extensively studied and details of its 
purification and characterisation are described in Chapter 4.
Granulin - like peptides (GLP-1, 2, 3)
Three peptides, purified by RP-HPLC (labelled GLP-1, 2, 3 in Fig. 3.2B) were 
subjected to TOF-MALDI mass spectrometry, yielding molecular masses of 5108.8, 
5116.1, and 4952.9, respectively. The three peptides were reduced, pyridylethylated 
and subjected to proteolytic digestion using endoproteinase Arg-C (GLP-1, 2 and 3, Fig 
3.3A-C) and Chymotrypsin (GLP-3 only, Fig. 3.3D) and the resulting fragments 
analysed by Edman sequencing.
The two higher molecular weight species had very similar A214/A280/A255 
absorbance ratios as did their Arg-C fragments, which also had comparable retention
FIG 3.3. Reversed phase HPLC purification of proteolytic fragments generated from 
Endoproteinase Arg-C digestion of granulin - like peptides (GLPs) 1 (A), 2 (B) and 3 (C). 
GLP-3 was also subjected to chyotryptic digestion and the resulting fragments purified by 
HPLC as shown in D. Insets show absorbance monitored at 280 nm and 255 nm as 
indicated. Fragments were labelled according to their order of elution and subjected to N- 
terminal sequencing, the results of which are shown in Fig. 3.4.
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times. In contrast, the lower molecular mass species (4952.9) had relatively little 
absorbance at 280 nm and 255 nm (Fig. 3.2B) and gave a very different profile 
following Arg-C digestion (Fig. 3.3). These differences were reflected in the 
elucidated amino acid sequences (Fig. 3.4A). All three peptides were 42 residues in 
length and characterised by the presence of 6 cysteine residues at conserved positions 
between peptides. However, GLP (granulin-like peptide, see below)-1 and -2 appeared 
to have identical amino acid sequences, whereas GLP-3 is somewhat different. 33 % of 
the amino acid sequence of GLP-1/2 and 3 are identical. GLP-1/2 contains two Tyr and 
two Trp residues, compared to one Tyr in GLP-3 and this is probably responsible for 
the greater relative absorbance of GLP-1/2 at 280 nm. The calculated mass of GLP-1/2 
is 5109.7 and that of GLP-3 is 4953.6 (assuming all Cys residues participate in 
disulphide bridges), and these are, with the exception of GLP-2, in close agreement 
with the observed masses.
A database search did not reveal any obvious similarity between these and known 
peptides, although some weak similarity exists with granulins, a family of cysteine-rich 
polypeptides of around 6 kDa. A single precursor, acogranulin, that has tandem 
granulin domains can potentially generate seven different forms of granulin (designated 
A-G, Fig. 3.4B) which are characterised by the following 12-cysteine motif, CX5. 
6CX5CCX8CCX6XCCXDX2HCCPX4CX5-6C (Bhandari et al., 1993). Thus, the OdW 
peptides contain half the number of cysteine residues as other granulins but the spacing 
between them is conserved and the CC motif near the carboxy-terminus which is 
common to all granulins, is also conserved. The OaV peptides have therefore been 
given the tentative name, granulin-like peptides or GLPs (Fig. 3.4B). GLP-1, 2 and 3 
all share 19 % sequence identity with rat granulin A.
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FIG. 3.4. A. The elucidated amino acid sequences of GLP-1 and 2 determined from 
direct N-terminal sequencing and from proteolytic fragments (Arg-C). Note that the 
sequences are identical B. The elucidated sequence of GLP-3, showing overlap of 
Arg-C and chymotryptic fragments (see Fig. 3.3) used to determine the sequence. 
N-term refers to sequence obtained directly from the N-terminus; ArgCA 1 and 2 are 
two sequences obtained from the single peak A (Fig. 3.3C). C. Sequence 
alignments showing overlap between GLP-1/2, GLP-3 and rat and carp granulins 
and the locust brain granulin, PMP-D1.
Nerve growth factor (pll/NGF)
pl2/NGF (nerve growth factor) was extensively studied and its purification and 
characterisation is not dealt with here but described in detail in Chapter 6.
Kunitz-type protease inhibitor-like protein (KLP)
Whole venom was fractionated by cation-exchange HPLC using a MonoS column and 
a linear 0-1 M NaCl gradient in 20 mM HEPES buffer, pH 7.5. The major component 
retained by the column was a 15 kDa protein which eluted at a high NaCl concentration 
(peak labelled KLP, Fig. 3.5A). The fraction was desalted by ultrafiltration (10 kDa 
NMWL). Dilution of the fraction was required prior to ultrafiltration as the material 
tended to precipitate as it became more concentrated. The protein was further purified 
by RP-HPLC on a C2/C18 (PC 3.2/3) column and eluted with CH3CN in 0.1 % TFA 
(Fig. 3.5B). The protein was thus purified to homogeneity as judged by SDS-PAGE 
(Fig. 3.5A, inset). It was reduced, pyridylethylated and subjected to chymotryptic and 
endoproteinase Arg-C digestion (Fig. 3.6A and B, respectively) and some of the 
resulting peptide fragments were subjected to Edman sequencing. The intact protein 
was also subjected to direct N-terminal Edman sequencing. The resulting amino acid 
sequences are given in Fig. 3.6. Fragments of this protein were found to be 
homologous with members of the pancreatic trypsin inhibitor, or Kunitz, family and the 
protein has therefore been designated Kunitz-type protease inhibitor-like protein 
(KLP). When the fragments are aligned in such a way as to maximise amino acid 
overlap with members of the Kunitz family (Fig. 3.7), KLP conforms to the consensus 
pattern of FX3GCX6FX6C (Laskowski and Kato, 1980; Salier, 1990; Ikeo et al., 1992). 
In addition, the active-site domain of Kunitz-type inhibitors, consisting of a GXCK 
motif (Kondo et al., 1982; Salier, 1990; Ikeo et al., 1992), is conserved in KLP 
(residues 25-28, Fig. 3.7). Bovine plasma trypsin inhibitor (BPTI) and cow colostrum
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Fig. 3.5. Purification of the 15 kDa KLP from whole O. anatinus venom 
using A. cation - exchange (MonoS, 0-1 M NaCl gradient in 50 mM 
HEPES, pH 7.5) and B. Reversed phase HPLC (jiRPC C2/C18, PC 
3.2/3, 0-100 % CH3CN in 0.1 % TFA). The inset in A. shows the Tris- 
Tricine SDS-PAGE analysis of purified KLP.
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FIG. 3.6. Reversed phase HPLC purification of proteolytic fragments of KLP 
generated from chymotryptic (A) and endoproteinase Arg-C (B) digestion. 
Several peptide fragments were subjected to Edman sequencing and the 
resulting amino acid sequences are given in C. The protein was subjected to 
direct N-terminal sequencing, the results of which are also shown in C.
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trypsin inhibitor (CCTI) are considered prototype members of the Kunitz family 
although there are many other members. The amino acid sequences of several of these 
are compared in Fig. 3.7.
15 kDa OaV lipocalin (OVL15)
Gel permeation HPLC (Superose 12) of OaV A revealed a 15 kDa protein (Fig 3.8 A) 
which differed from KLP in that it eluted differently on RP-HPLC (Fig. 3.8B) and was 
not retained by the MonoS column. The peptide was subjected to N-terminal Edman 
amino acid sequencing and 25 residues of sequence were obtained. The protein 
appears to be a member of the lipocalin family (Fig. 3.9), a group of proteins which 
play a role in the binding and transport of small hydrophobic molecules such as 
steroids, retinoids and lipids. Members of this family share a common tertiary structure 
and three conserved stretches of sequence (Flower et al., 1991; Flower et al., 1993). 
The first of these is common to all lipocalins and is considered a “signature” pattem. 
The stretch is [DENG] -X-[DEN QGSTARK] -X0,2-[DEN QARK]-[LIVF Y) -XXX-G-X- 
W-[FYWLRH]-X-[LIVMTA], where any of the residues enclosed in [] may be present 
at that position. The N-terminal sequence of the 15 kDa protein (designated OVL15 
for Omithorhynchus venom lipocalin, 15 kDa) conforms to this signature pattem and 
has a number of additional residues in common with core lipocalins (Fig. 3.9). The N- 
terminal sequence of OVL-15 shares 56 % identity with the overlapping 25 N-terminal 
residues of the other OaV lipocalin, OVL-50 (see below).
p23
A 23 kDa protein, designated p23, was purified from OaV  using a combination of 
cation exchange (MonoS, Fig. 3.10A) and RP-HPLC (C2/C18, PC3.1/10) (Fig. 3.10B). 
A broad elution profile from Mono S was obtained, p23 being present in several 
fractions. It was purified to near-homogeneity as judged by SDS-PAGE (Fig 3 .IOC)
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FIG. 3.8. Purification of the 15 kDa OVL-15 from whole O. anatinus 
venom using A. Gel permeation HPLC (Superose 12, 50 mM MES pH 
6.1) and B. Reversed phase HPLC (mRPC C2/C18, 3.2/3.0, 0-100% 
CH3CN in 0.1% TFA). Note the difference in retention time between 
KLP (dotted line) and OVL-15 (solid line). The inset in A shows the 
Tris-Glycine SDS-PAGE analysis of purified OVL-15. Lane 1, OaV;
Lane 2, OVL-15 ex GP-HPLC; Lane 3, OVL-15 ex RP-HPLC.
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FIG. 3.9. Comparison of the elucidated N-terminal amino acid sequence of OVL-15 
with those of OVL-50 and members of the lipocalin family. Abbreviations are as 
follows. E-RABP, epididymal-retinoic acid binding protein precursor; apoD, 
apolipoprotein D; a-l-microgl., a -1-microglobulin.
and reduced, pyridylethylated and subjected to N-terminal amino acid sequencing. Ten 
residues of sequence were obtained (Fig. 3.10D). The sequence shows some similarity 
to members of the insulin-like growth factor binding protein (IGFBP) family, e.g. 40 % 
identity with mouse connective tissue growth factor (FISP-12). However, as only 10 
residues of sequence were obtained, the significance of this overlap is difficult to 
determine. In addition, the consensus sequence for this protein family, 
GC[GS]CCX2CAX6C, (Bradham et al, 1991; Joliot et al., 1992) would occur 
downstream from the elucidated sequence and, therefore, could not be used to confirm 
the structural relationship between p23 and members of the IGFBP family.
50 kDa OaV lipocalin (OVL-50)
A 50 kDa protein was partially purified from the venom by anion-exchange HPLC on 
MonoS, in 20 mM bis-Tris, pH 6.5, using a linear gradient of 0 - 0.5 M NaCl (Fig. 
3.11 A, fraction D). This material was analysed by SDS-PAGE and the band, running 
at an apparent Mr of 50 kDa, was excised and divided in half. Half was subjected to 
direct N-terminal Edman sequencing and half to in-gel tryptic digestion. RP-HPLC 
analysis of the resulting tryptic fragments is shown in Fig. 3.12. Twelve A2 14 peaks 
were subjected to Edman sequencing and the resulting sequences are also shown in Fig. 
3.12. The protein, like OVL-15, appears to be a member of the lipocalin family from 
its N-terminal sequence (see alignment in Fig. 3.9) and has thus been named OVL-50. 
However, no consistent homologies were observed between the other OVL-50 tryptic 
fragment sequences and known proteins.
55 kDa guanosine diphosphate dissociation inhibitor-like protein (GDILP)
The 55 kDa protein, which was the most abundant protein in most OaV samples, was 
excised from an SDS-PAGE gel (see Fig. 3.1) and subjected to direct N-terminal 
Edman sequencing and in-gel tryptic digestion. The resulting tryptic fragments were
FIG 3.10. Purification of p23 from 0. anatinus venom by A. Cation - exchange HPLC 
(MonoS, 0 - 1 M NaCl gradient in 50 mM HEPES, pH 7.4) and B. Reversed phase HPLC 
ftiRPC C2/C18, PC 3.2/10, 0 - 100% CH3CH in 0.1 % TFA). Note that p23 was present 
in each of cation - exchange fractions I, II and II. C. SDS-PAGE analysis of purified 
p23, ex RP-HPLC, corresponding to cation exchange HPLC fractions as indicated. Std, 
molecular weight protein standards D. N-terminal amino acid sequence of p23 and its 
comparison with those of members of the insulin-like growth factor binding protein family 
(precursor forms). Numbers at the end of each sequence correspond to the position 
number of the final amino acid residue of that sequence. Abbreviations are CTGF, 
connective tissue growth factor; CE10, CEF-10; and CYR6, cyr61.
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FIG. 3.11. A. Anion - exchange HPLC (MonoQ, 20 mM bis-Tris, pH 6.5, 
0 - 0.5 M NaCl gradient) partial purification of the 50 kDa protein, OVL- 
50 from a MonoS flow-through fraction (see fig. 3.10). B. SDS-PAGE 
analysis of MonoQ fractions. MSA, MonoS flow - through fraction. Std,
molecular weight protein standards.
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FIG 3.12. Reversed phase HPLC purification of proteolytic fragments of OVL-50 
generated from in-gel tryptic digestion. Several peptide fragments were subjected 
to Edman sequencing and the resulting amino acid sequences are shown below the 
chromatogram as is the elucidated N-terminal sequence. A comparison of this 
sequence with those of OVL-15 and other lipocalins is shown in Fig. 3.9.
purified by RP-HPLC using a Sephasil C18 column (Fig. 3.13). The purified peptides 
were subjected to Edman sequencing and the sequences obtained are shown in Fig 
3.13. No conclusive homology to known proteins is apparent, although there is limited 
similarity to members of the guanosine diphosphate dissociation inhibitor (GDI) 
superfamily, including Rab-GDI and the choroideremia gene product, CHM 
alternatively known as Rab-escort protein (REP) (Waldherr et al., 1993; Wu et al., 
1996). Sequence alignments between these GDI family members and the 55 kDa 
protein from OaV are shown in Fig. 3.14. Members of the superfamily show several 
highly conserved regions, including the DVX3GTGX2EX2L motif (Sequence 
Conserved Region, SCR, 1A) beginning at residue 6  (Wu et al., 1996). The 55 kDa 
protein, tentatively named GDILP (GDI-like protein) possesses the conserved DV diad 
at residue 6  (see Fig. 3.14.) (Wu et al., 1996). N-terminal sequence beyond residue 10 
was not obtained and therefore it was not possible to determine whether the remainder 
of the SCR1A motif was conserved. No other sequences were obtained within other 
SCR sites to confirm the GDI homology.
pl23
A protein band corresponding to 123 kDa from OaV (pl23) was excised from an SDS- 
PAGE gel and subjected to in-gel tryptic digestion. The resulting peptide fragments 
were purified as described for GDILP (Fig. 3.15). Two resulting peptide fragments 
were subjected to Edman sequencing and the sequences obtained are given in Fig. 3.15. 
Peptide A(l) shares 67 % identity with peptide C from GDILP while peptide B was 
truncated but otherwise identical to peptide D from GDILP. Peptide A(2) did not show 
any overlap with peptides from GDILP and database searching revealed no obvious 
homologies.
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FIG 3.13. Reversed phase HPLC purification of proteolytic fragments of the 55 kDa 
protein, GDILP, generated from in-gel tryptic digestion. The inset shows the re­
purification of fractions underlying the horizontal bar, using a shallower gradient. 
Several peptide fragments were subjected to Edman sequencing and the resulting 
amino acid sequences are shown below the chromatogram. 9 residues of N-terminal 
amino acid sequence were also elucidated and this is shown below the proteolytic
fragment sequences.
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FIG 3.15. Reversed phase HPLC purification of proteolytic fragments of the 
123 kDa protein (pl23), from O. anatinus venom, generated from in-gel tryptic 
digestion. Several peptide fragments were subjected to Edman sequencing 
and the resulting amino acid sequences are shown below the chromatogram. 
Peak A gave rise to both a major (1) and minor (2) sequence.
Discussion
A total of 19 components were identified in OciV. Several of these were purified and 
either fully or partially sequenced and in some cases demonstrated to belong or be 
related to specific protein/polypeptide families. Some proteins exhibited a difference in 
their relative level of expression at different times of the year, while the remainder 
showed no apparent trend.
Temple-Smith (1973) found that high molecular weight proteins varied 
irregularly depending on the time of year, whereas “postalbumins” predominated in 
material taken from extrusion-phase glands, and “prealbumin” proteins predominated 
in material taken from regressing and quiescent crural glands. A direct comparison 
between this and data obtained in the present study is difficult as the former only 
classified proteins into molecular weight ranges. However, a comparison of the 
relative proportions of proteins from the electrophoretic analysis of Temple-Smith 
(1973) with that of the present study suggests that the major “post-albumin” component 
is actually the 55 kDa GDILP. This being the case, the increased expression of GDILP 
in September is consistent with the increase in “post-albumins” observed by Temple- 
Smith. However, p66, another “post-albumin”, appeared to be maximally expressed in 
December and January when crural glands are in regression. Among the high 
molecular weight proteins, p i23 expression predominates in extrusion-phase material 
while pl68 predominates in regression- and elaboration-phase material (see Fig. 3.1C).
As the SDS-PAGE comparisons of relative OaV protein expression were 
qualitative, only major trends were easily discernible. In addition, material from only 1 
elaboration-phase, 4 extrusion-phase and 6 regression-phase individuals were 
compared and a more exhaustive study may reveal more inter-individual variation 
within a given collection time. Nevertheless, the results do suggest a seasonal variation 
in some venom components and this is consistent with observed seasonal changes in
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the secretory activity of crural glands (Temple-Smith, 1973). As the crural gland 
actively secretes material only during the breeding season, material taken outside this 
time has presumably undergone a period of storage. The selective reduction in the 
apparent concentrations of p i23 and GDELP outside the breeding season suggests that 
these proteins may be susceptible substrates for proteolytic enzymes in OaV (Temple- 
Smith, 1973; de Plater, Hons thesis, ANU, 1993).
Apart from the C-type natriuretic peptide and pl2/NGF, none of the components 
of OaV could be unequivocally identified based on their amino acid sequences. 
However, in several cases, homology was found between OaV components and 
particular protein families or superfamilies. For the OäV lipocalins (OVL-15 and 
OVL-50) and Kunitz-type protease inhibitor-like protein (KLP), “signature” domains 
which are universally conserved between members of these families were found in the 
corresponding OaV proteins. Thus, it is possible to speculate upon their function based 
on the activities of other family members with which they share homology. Each of the 
major components identified in OaV and characterised are discussed in the following 
sections.
Non-peptide/protein material
OaV contains large quantities of a low molecular weight material (mol. wt. 1131.9), 
designated 1132 material, which was refractory to Edman sequencing and did not yield 
amino acids following acid hydrolysis. These results suggest the 1132 material may 
not be a peptide. Although approximately 90 % of the dry weight of most venoms 
consists of protein material, many non-protein components, including metal ions, 
inorganic anions, lipids, nucleosides, carbohydrates and amines, are also present 
(Bieber, 1979). The molecular weight of the 1132 material and its reaction with OPA 
suggests it may be peptide-like, although refractory to Edman sequencing and resistant
to acid hydrolysis. Acylpolyamines may behave in such a way. These compounds, 
which block and modulate several types of ion channel, are found both endogenously 
and in arthropod venoms (Williams, 1997). Whether or not the 1132 material is a 
polyamine may be established by NMR and further mass spectrometric analyses.
OaV peptides
Three related, 42 residue peptides have been purified from OaV and sequenced. They 
have been tentatively designated GLP (granulin-like peptide) -1,2 and 3. Although the 
homology between GLPs and granulins is limited, the positions of each of the 6 GLP 
cysteine residues align with cysteine residues of granulins. This suggests they may 
share a similar pattem of disulphide connectivity and topology, although granulins 
contain twice as many cysteines in total as GLPs. Like GLP, several forms of granulin 
have been identified, where a single precursor, acogranulin, which has tandem granulin 
domains, gives rise to the multiple forms. The GLPs are also similar in size to 
granulins, typically around 6 kDa. Granulins play a role in the regulation of epithelial 
proliferation (Bhandari et al., 1993) and their presence in leukocytes and inflammatory 
exudates suggests possible roles in inflammation and wound repair (Bhandari et al., 
1992). Other members of the granulin family include an equine neutrophil 
antimicrobial peptide, eNAP-1 (Couto et al., 1992) and a locust brain peptide (PMP- 
Dl) of unknown function (Nakakura et al., 1992), the sequences of which are given in 
Fig. 3.4C. Although granulin-like peptides have not been previously described in a 
venom, granulins contain a subdomain comparable to the N-terminal subdomain of 
small alpha-toxins from scorpion venoms, which slow Na+ channel inactivation (Hrabal 
et al., 1996; Lin and Nussinov, 1995).
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Kunitz-type protease inhibitor-like protein (KLP)
A 15 kDa basic protein has been purified from the venom and partially structurally 
characterised. It is a member of the Kunitz-type protease inhibitor family, and has 
therefore been named KLP (Kunitz-type protease inhibitor-like protein). A number of 
snake venom basic protease inhibitors, which include the dendrotoxins, a group of 
neuronal K+ channel blockers, are also members of the Kunitz family and share 
homology with KLP (Harvey, 1997). Another member of this family is tissue factor 
pathway inhibitor (TFPI), an endogenous anticoagulant which acts by inhibiting 
activated factor X and producing a feedback inhibition of the factor Vlla/tissue factor 
complex (Broze, 1995), whose sequence is compared with that of KLP in Fig. 3.7. 
Other homologous members of the Kunitz family include domains found in 
Alzheimer’s amyloid beta-protein (Ikeo et al., 1992) and calcicludine, a blocker of 
high-threshold Ca2+ channels from Dendroaspis angusticeps venom (Schweitz et al., 
1994). ß-bungarotoxins from Bungarus multicinctus venom also have a Kunitz-like 
structure but lack a reactive-site Lys or Arg (see above) and therefore have no protease 
inhibitor activity (Kondo et al., 1982). Whether KLP functions as a protease inhibitor 
in OaW, or has evolved a specific function is unknown at this stage, although 
preliminary results (de Plater, unpublished) suggest that KLP, unlike BPTI (the 
“prototype” Kunitz-type protease inhibitor), does not inhibit trypsin. This is intriguing 
as the active site domain, consisting of a GXCK motif is conserved in KLP (residues 
25-28).
Lipocalins
Two lipocalins, a 50 kDa (OVL-50) and a 15 kDa (OVL-15) form (OVL: 
Omithorhynchus venom lipocalin), have been identified in OaW and partially 
sequenced. Both OVL-50 and OVL-15 clearly contain the lipocalin “signature” pattem
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and share a relatively high degree of homology with core members of the lipocalin 
family. Lipocalins are generally involved in the binding and transport of small 
hydrophobic molecules. Examples include epididymal retinoic acid binding protein (E- 
RABP), an androgen-dependent protein found in the lumen of the epididymis which is 
required for sperm maturation (Newcomer, 1993); apolipoprotein D (apoD), which is 
implicated in the transport of several small hydrophobic molecules including sterols 
and steroid hormones and which may play a key role in cholesterol homeostasis 
(Suresh et al., 1998); and a -1-microglobulin whose function is unclear, but 
interestingly, is derived from the same precursor protein as bikunin, a Kunitz-type 
protease inhibitor (Chan and Salier, 1993). Lipocalins have not been previously 
identified in a venom and speculation on the role of the OVL proteins is difficult 
although at least two lipocalins, human NGAL (Neutrophil gelatinase-associated 
lipocalin) and mouse 24p3 are acute-phase proteins10 which may play important roles 
in inflammation (Liu and Nilsen-Hamilton, 1995; Cowland and Borregaard, 1997).
Other proteins
It was not possible to establish the significance of the N-terminal sequence similarity 
between the 23 kDa protein and members of the insulin-like growth factor binding 
protein (IGFBP) family, as only 10 residues were obtained and the consensus sequence 
for this family lies downstream from the elucidated sequence. Members of the IGFBP 
family include the mouse protein, cyr61 and its chicken homologue, CEF-10 which are 
growth factor-inducible immediate-early gene products thought to act cooperatively 
with growth factor activities (Bradham et al., 1991; Kireeva et al., 1998). Connective 
tissue growth factor (CTGF), a mitogenic peptide that binds heparin and is secreted by
10 Acute-phase proteins are hepatocyte-derived serum proteins produced during the early stages of an 
inflammatory response (Kuby, 1992)
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fibroblasts after activation with transforming growth factor beta (TGF-ß) (Grotendorst, 
1997), is also a member of the IGFBP family. No members of this family appear to 
have been found previously in a venom.
The most abundant protein in the majority of OdW samples was a 55 kDa protein 
which was partially sequenced. Although only limited sequence data were obtained, 
the protein appears to show some homology to members of the GDP-dissociation 
inhibitor (GDI) superfamily, including Rab-GDI, which plays an important role in the 
recycling of GTPases (Rab proteins) involved in vesicular membrane transport (Wu et 
al., 1996). The significance of the similarity between the 55 kDa protein, which has 
tentatively been designated GDILP (GDI-like protein), and GDI proteins is difficult to 
determine as the N-terminal region contained the only elucidated sequence which fell 
within a conserved GDI region. A 123 kDa OaW protein, p i23, shares some homology 
with GDILP, suggesting that the two proteins are related and that p i23 may in fact be a 
precursor of GDILP.
General comments
Structural similarity in proteins may reflect evolution from a common ancestral protein 
with a divergence of function. For example, snake venom cardiotoxins and crotamine 
share homology with phospholipases A and ribonuclease respectively and probably 
share a common ancestral protein, although their activities and functions have clearly 
diverged (Strydom, 1979). In addition, animal toxins with unrelated biological 
functions very often possess a similar architecture. This may occur because certain 
motifs, for example the snake toxin fold11, undergo a “natural engineering”, which may 
be associated with an accelerated rate of evolution (Ohno et al., 1998). In contrast, the
11 the snake toxin fold is a common motif shared by phospholipases A2 from Viperid and three-fingered 
toxins from Elapid and Hydrophiid snake venoms
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core structure of the protein, which may not be subject to the same evolutionary 
pressure, is conserved. Therefore speculation on the function of OaV proteins, based 
on their amino acid sequence homology must be viewed with due caution.
It is clear that many of the proteins and peptides in OaV, with the exception of 
NGF and ovCNP-39, are unique and although often showed some similarity to other 
proteins, these proteins have not previously been identified in a venom. The 
elucidation of both N-terminal and internal stretches of amino acids will facilitate the 
future cloning and expression of OaV proteins and this may confirm the suspected 
homologies outlined here and provide viable quantities of individual components for 
biological activity screening.
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CHAPTER 4
THE C-TYPE NATRIURETIC PEPTIDE FROM O. ANATINUS VENOM: 
STRUCTURE, PHARMACOLOGY AND PATHOPHYSIOLOGICAL 
PROPERTIES
Introduction
When administered systemically to experimental animals, O. anatinus venom (OaV) 
produces hypotension, peripheral vasodilatation (Kellaway and LeMessurier, 1935) and 
gives rise to a sustained, tonic relaxation of the rat uterus in vitro (de Plater, Hons 
Thesis, ANU 1993). The latter activity is associated with a 4.2 kDa peptide which has 
been demonstrated to be a C-type natriuretic peptide (ovCNP-39) (de Plater et al., 
1995). This chapter describes the purification and structural characterisation of 
ovCNP-39 and addresses the possibility that it may contribute to the pathophysiological 
effects of O. anatinus venom (OaV).
In mammals, three classes of natriuretic peptides have been described: atrial 
natriuretic peptide (ANP), which is predominantly produced by the cardiac atria (de 
Bold et al., 1981); brain natriuretic peptide (BNP), originally isolated from porcine 
brain (Sudoh et al., 1988) but predominantly produced by the cardiac ventricles; and C- 
type natriuretic peptide (CNP), the distribution of which includes the brain and 
endothelium (Sudoh et al., 1990; Suga et al., 1993). All forms incorporate a 17-residue 
intra-molecular disulphide loop, with ANP and BNP characteristically having both C- 
and N- terminal sequence extensions beyond the loop, while CNP extends only N- 
terminally. Two principal post-translational cleavage products of a common CNP 
precursor have been identified in eutherian mammals: CNP-22 (Sudoh et a l, 1990) and 
the less abundant N-terminally extended CNP-53 (Minamino et al., 1990).
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Although the normal physiological role of the natriuretic peptides, in particular 
CNP, is unclear, their natriuretic, diuretic and vasorelaxant properties suggest that they 
play a role in the control of blood pressure and fluid/salt homeostasis (Nakao et al, 
1992). Natriuretic peptides produce their vasorelaxant/hypotensive effects by elevating 
intracellular cyclic guanosine 3’,5’- monophosphate (cGMP) in vascular smooth 
muscle cells. This occurs via the activation of two classes of receptor, ANPa and 
ANPb, both of which function as particulate guanylate cyclases (Chang et a l, 1993, 
Koller et al, 1991). CNP acts via ANPb (Koller et al, 1991) whereas ANP and BNP 
act via ANPa receptors (Schulz et al, 1989; Lowe et al, 1989). A third class of 
receptor, ANPc, has no guanylate cyclase domain and is believed to be important for 
the metabolic clearance of ANP (Almeida et al, 1989).
CNP has been shown to stimulate cGMP production in uterine tissue and ANPb 
receptors, which are selective for CNP, have been identified in the rat uterus (Dos Reis 
et al, 1995). To confirm that ovCNP-39 is truly responsible for the uterus relaxing 
effect of OaW, the potency of both isoforms of ex vivo material were compared with 
that of synthetic ovCNP-39. In addition, the relative potencies of synthetic ovCNP-39, 
CNP-22 and ANP in relaxing the rat uterus have been investigated. This is of 
particular interest since ANP is regarded as a potent inhibitor of rat uterine contractions 
(Bek et a l, 1988; Potvin and Varma, 1990).
ovCNP-39 may, via guanylate cyclase activation in vascular smooth muscle, 
contribute to the hypotension and vasodilatation which accompanies OaW 
administration. The ability of this peptide to elevate cGMP in vascular smooth muscle 
cells has therefore been investigated. The possibility that ovCNP-39 can cause plasma 
extravasation (oedema) and mast cell degranulation has also been addressed. Such an 
action would be consistent with the properties of ANP and CNP-22 which are known 
both to participate in fluid and electrolyte homeostasis (Flynn et a l, 1983; Morita et al,
1992) and to induce mast cell degranulation (Opgenorth, et al., 1990; Yoshida et al., 
1996). The amino acid sequences of natriuretic peptides indicate that they are members 
of the polybasic, amphiphilic group of peptides which include mastoparan, substance P 
and kinins (Aridor et al., 1993). These peptides degranulate mast cells in a receptor- 
independent fashion by interacting directly with the heterotrimeric G protein, Gi3 
(Aridor et al., 1993). The possibility that ovCNP-39 induces histamine release from 
mast cells in a similar, receptor-independent manner has been investigated using 
ovCNP-39 peptide fragments.
Methods
Peptide purification
Whole OaW was diluted in 0.1 M ammonium acetate, pH 5.0 and subjected to 
ultrafiltration using a 10 kDa nominal molecular weight filter (Centricon 10, Amicon). 
The filtrate was recovered and fractionated by reversed phase HPLC (RP-HPLC) using 
a C2/C18 column (jxRPC SC2.1/10, Pharmacia). Eluent A consisted of 0.1 % 
trifluoracetic acid (TFA) in H2O and eluent B consisted of 0.1 % TFA in CH3CN. 
Peptides were eluted using a linear gradient of 0-60 % B over 20 min at a flow rate of 
250 |il min'1.
Capillary electrophoresis
O. anatinus venom and synthetic peptides were analysed by capillary electrophoresis, 
using a Beckman P/ACE™ 2000 system. Peaks were monitored by UV detector at a 
wavelength of 214 nm. 20 p.1 of a 1:10 dilution of whole venom was used and synthetic 
ovCNP-39 was employed as an external retention-time standard. Separation was achieved 
over 20 min at a field strength of 500 V cm' 1 using 20 mM sodium citrate/20 mM MES (2- 
[Wmorpholinojethanesulphonic acid), pH 6.0, and a 27 cm eCAP™ neutral capillary
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(Beckman). Peak areas were obtained by integration and a ratio of a given peak area to 
the total area above baseline was used to determine the relative concentration of ovCNP- 
39.
Isolated rat uterus preparation
The effect of OaW fractions on the isolated rat uterus was examined. This preparation 
was initially used to screen the venom for bradykinin-like activity but as described 
above it was found that OaW relaxed, rather than contracted, the rat uterus. The 
preparation was quite sensitive to OaW and therefore its use as a bioassay was retained.
A method based on Li and Rand (1989) and Martinez-Mir et al. (1990) was used. 
Diethylstilboestrol (DES, 5 mg kg'1) was administered intraperitoneally to female 
Wistar rats (300-500 g) 24 hours before each was anaesthetised with 4% halothane in 
O2, killed by decapitation and exsanguinated. Spontaneous contractions were often 
observed in uteri from rats not treated with DES, making it difficult to measure changes 
in baseline tension and DES treatment was therefore used routinely. Uteri from DES- 
treated rats had much less spontaneous activity at room temperature and this may be 
related to the fact that oestrogen has an inhibitory effect on prostaglandin-induced 
contractions in this preparation (Perusquia and Kubli-Garfia, 1992). An abdominal 
incision was made and the intestine pulled to one side exposing the uterine horns which 
were trimmed of both mesentery and fat and divided into segments 1 cm in length. 
Each segment was suspended in an organ bath by tying a loop at each end with a 
surgical thread and looping one end over a rigid wire at the bottom of the bath and 
tying the other end to an isotonic strain gauge linked via a MacLab™ digital/analog 
interface to a Macintosh computer. A resting tension of 1 g was applied and 30 min 
allowed for equilibration. The bath solution contained (mM) 164.0 NaCl, 5.6 KC1, 0.6 
CaCl2, 2.7 glucose and 6 NaHCCb and was bubbled with 95% 0 2 / 5% C 02. Stable
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tonic contractions were obtained by adding 50 mM KC1 and tension was monitored 
continuously. Relaxation was expressed as a percentage of the KCl-induced 
contraction. All experiments were conducted at room temperature (20 - 23 °C).
Synthesis of peptides
CNP-22 (human, porcine and rat forms are identical), ovCNP-39, ovCNP-39(l-17) and 
ovCNP-39( 18-39) were synthesised using an Applied Biosystems 470A solid phase 
peptide synthesizer using FMOC/NMP chemistry. Disulphide bridges were formed by 
potassium ferricyanide oxidation12. All peptides were purified by preparative RP- 
HPLC (BioRad Model 700 Gradient Module) using a Dynamax C8 column (300A, 
21.4 mm x 25 cm, Ranin Associates) and analyzed by amino acid analysis and TOF- 
MALDI mass spectrometry to confirm authenticity. Rat a-ANP(l-28) was purchased 
from Auspep (Melbourne, Australia). The sequences of the peptides used are given in 
Table 4.1.
Table 4.1. Amino acid sequences of natriuretic peptides and fragments
ovCNP-39 LLHDHPNPRKYKPANKKGLSKGCFGLKLDRIGSTSGLGC
CNP-22* GLSKGCFGLKLDRIGSMSGLGC
OvCNP-39(l-17) LLHDHPNPRKYKPANKK
ovCNP-39( 18-39) GLSKGCFGLKLDRIGSTSGLGC
rat a-ANP ( 1 - 2 8 )  SLRRSSCFGGRIDRIGAQSGLGCNSFRY
Amino acid difference between ovCNP-39 and CNP-22 is indicated in boldface 
* identical for human, rat and pig
Preparation of rat aortic smooth muscle cell cultures
Smooth muscle cells were prepared using a method based on that described by Mar-
12 Ferricyanide oxidation was carried according to the protocol described in the Applied Biosystems Inc. 
manual, Strtegies in Peptide Synthesis - Introduction to cleavage, pp. 58-59
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sault et al. (1991) and Schweitz et al. (1992). Segments of descending thoracic aortae 
were excised from male Wistar rats (6-10 weeks old) and placed in Ca2+- and Mg2+-free 
phosphate-buffered saline (PBS) containing 0.1 % collagenase (Type I, Sigma) for 2 h 
at 37 °C. Connective tissue was carefully removed under a dissecting microscope and 
each aortic segment was opened longitudinally and the intimal surface removed by 
gentle scraping with a pasteur pipette. The denuded pieces of tissue were then 
transferred to a sterile centrifuge tube containing Ca2+- and Mg2+-free PBS and 0.02% 
elastase (Type IV from Porcine pancreas, Sigma) and incubated at 37 °C for 30 min. 
Myocytes were mechanically dissociated by trituration using a pasteur pipette. Intact 
pieces of tissue were transferred to a fresh solution of elastase, re-incubated at 37 °C for 
a further 30 min and triturated again. The resulting supernatants were pooled and the 
dissociated cells recovered by centrifugation at 125 g  (1000 rpm) for 5 min and 
resuspended in Medium 199 (GDBCO), supplemented with 20 % fetal bovine serum 
(GEBCO), 200 units ml'1 penicillin and 50 jag ml*1 streptomycin. The cell suspension 
was evenly distributed into the collagen-coated wells of a 24-well tissue culture plate. 
Plates were incubated at 37 °C in 95% Ü2/5% CO2. Cells were passaged every 5 days 
by washing confluent layers once with Ca2+ and Mg2+ free PBS and then incubating the 
cells with the same solution but containing 0.1 % trypsin, at 37 °C for 10 min. The 
resulting suspension was distributed into new collagen-treated tissue culture plates as 
described above. Experiments were conducted using cells from passage number 5 as 
these have previously been shown to predominantly express ANPb receptors (Suga et 
al., 1992).
Although removal of the intima should result in a pure smooth muscle cell 
culture (Chamley-Campbell et al., 1979), it was not possible to determine whether this 
was accomplished without resorting to electron microscopy. Under phase-contrast 
microscopy, the morphology of individual vascular smooth muscle cells is difficult to
discern in confluent cultures and, even if this could be accomplished, they are 
morphologically similar to fibroblasts (Ross, 1971). Therefore, to confirm that the 
cultures contained predominantly smooth muscle cells, an FITC-conjugated antibody 
against smooth muscle a-actin, was used. This antigen is specifically found in smooth 
muscle cells (Skalli et al., 1986). Confluent cell layers were dissociated according to 
the passaging method described above and the resulting cell pellet resuspended in PBS 
and placed on ice. Methanol (cooled in liquid N2) was added drop-wise to a final 
concentration of 90 % (v/v) as the tube was vortexed gently. The cells were incubated 
for 30 min at -20 °C and collected by centrifugation, the supernatant was removed and 
the cells rinsed once with PBS and once with PBS containing 0.1% sodium azide and 
0.1% BSA (PBA), suspended in 0.1% Triton/PBA, incubated on ice for 3 min and 
washed with PBA. The cells were resuspended in PBA containing 0.5 % (v/v) anti-a- 
smooth muscle actin (FITC conjugate, Molecular Probes, Inc.) and incubated for 1 h at 
4 °C. Fluorescence-activated cell sorting (FACS) analysis revealed that 87 % of cells 
were immunoreactive to anti-smooth muscle a-actin, thereby confirming that the 
culture contained predominantly smooth muscle cells.
Cells were counted in confluent layers by fluorescent staining of nucleic acids
TMusing the CyQuant Cell Proliferation Assay Kit (Molecular Probes, Inc.). A standard 
curve was generated by dissociating cells with trypsin followed by haemocytometer 
counting. Cells, at defined concentrations, were incubated with the CyQuant™- 
GR/Lysis buffer following freeze-thawing and were vortexed. Cells were aliquoted 
into the wells of a 24-well tissue culture plate and the fluorescence of each well 
measured using a fluorescence microtitre plate reader with excitation and emission 
wavelengths set at 480 nm and 520 nm, respectively. A standard curve of fluorescence 
versus number of cells was constructed. For determining cell concentrations in 
confluent layers, media was removed from the wells by gently inverting each plate.
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Plates were then frozen at -70 °C, thawed and the CyQUANT-GR/Lysis buffer added to 
each well. Fluorescence was read after 5 min, as described above and the number of 
cells determined from the standard curve.
cGMP measurements
Incubations were performed according to Schweitz et al. (1992). Cells were pre­
incubated in 1 ml Earle's salt solution (mM: 140 NaCl, 5 KC1, 1.8 CaCl2, 0.8 MgS04, 5 
glucose, 50 HEPES, pH 7.4), containing 0.3 mM of the phosphodiesterase inhibitor, 
isobutylmethylxanthine (Sigma), for 10 min at 37 °C. Peptides were added and the 
plate was incubated for a further 10 min at 37 °C. The incubation solution was then 
replaced with 200 pi of a 2:1 ethanol/5 mM EDTA solution and the plate incubated at 4 
°C for 2 h. The contents of each well was transferred to an Eppendorf tube and dried in 
vacuo. The extracts were then resuspended in 200 pi 0.05 M Tris, 4 mM EDTA, pH 
7.4, and cGMP concentrations determined by competitive radioimmunoassay using a 
cGMP pH] assay kit (Amersham). [3H]cGMP was added to each assay tube, followed 
by 0.05 M Tris, pH 7.5 and 4 mM EDTA. 0.5-8 pmol cGMP standards (to construct a 
standard curve) and vascular smooth cell extracts were then added to the tubes, 
followed by antiserum. The tubes were incubated in the refrigerator for 1.5 h to allow 
the antibody to bind. The antibody-cGMP complex was then precipitated using a 60 % 
saturated (NH4)2SC)4 solution and incubating the tubes in an ice-bath for 5 min 
followed by centrifugation. The supernatant was carefully decanted and the pellet 
resuspended in MilliQ H20. The samples were mixed thoroughly with liquid scintillant 
(PCS, Amersham) and counted in a Packard Tri-Carb 460 scintillation counter. Co, 
cpm in the absence of unlabelled cGMP, was determined by subtracting the blank 
counts per minute (cpm) from the cpm tubes containing only the antibody and pH] 
cGMP. Cx, or cpm bound in the presence of standard or cGMP from smooth muscle
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cell extracts, was determined from the cpm for tubes containing these. CJCX was 
calculated and plotted against pmol cGMP standard to generate the standard curve. 
The pmol cGMP from the vascular smooth muscle cell extracts was determined using 
the corresponding CJCX values and this standard curve.
Isolation and purification of peritoneal mast cells
Mast cells were obtained from male Wistar rats (300-500 g). Each animal was 
anaesthetised with halothane, decapitated and an incision made in the abdominal 
cavity. The peritoneum was washed using 8 ml phosphate buffered saline containing 
10 U ml"1 heparin. Cells were collected by centrifugation at 4 °C for 10 min at 500 g 
(2500 rpm) and the resulting crude cell pellet (containing 5-10 % mast cells) was 
resuspended in 3 ml HEPES buffer containing (in mM): NaCl, 137; KC1, 2.7; CaCl2, 
0.3; MgCl2, 1.0; NaH2P04, 0.4; glucose, 5.6; HEPES, 10, pH 7.4 and 0.1% bovine 
serum albumin, and layered over 2ml 30% Ficoll (in HEPES buffer/BSA). Following 
centrifugation at 4 °C for 10 min at 180 g (900 rpm) the Ficoll layer was diluted in 8 ml 
HEPES buffer (without BSA) and the mast cells collected by centrifugation at 500 g 
(2500 rpm) and resuspended in HEPES buffer (without BSA) at a concentration of 105 
cells ml'1. Mast cell purity was greater than 80% as determined by cell morphology 
and haemocytometer counting. Mast cells from several rats were pooled for each day’s 
experiments.
Assay of mast cell histamine release
Mast cells were aliquoted into tubes containing peptides in 50 jil HEPES buffer 
(without BSA) to give a final cell concentration of 5xl04 per ml. The tubes were 
vortexed briefly and incubated at 37 °C for 15 min after which they were placed on ice 
and centrifuged at 4 °C for 10 min at 500 g (2500 rpm). The supernatant was removed
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and placed in sample tubes. Histamine released into the supernatant was assayed by 
HPLC (LC1090, Hewlett Packard) using pre-column derivitisation with ortho- 
pthalaldehyde (OPA with 3-mercaptopropionic acid in 0.4 M sodium borate, pH 10.4, 
Hewlett-Packard): 1 pi supernatant was mixed with 7 pi sodium borate (pH 10.4,
Hewlett Packard) and 3 pi OPA reagent using the auto-sampling facility of the 
AminoQuant Sysem. This was injected onto an ODS-Hypersil C18 (5 pm, 20 x 2.1 
mm, Hewlett-Packard) guard column, which provided good separation in a short time 
with sensitivity in the pmol pi'1 range. Buffer A consisted of 0.1 M sodium acetate, 1.3 
mM triethylamine (Pierce, HPLC grade) and 0.4 % (v/v) tetrahydrofuran, titrated to pH 
7.2 with acetic acid and Buffer B consisted of acetonitrile:methanol:buffer A (10:10:5). 
Three histamine-OPA adducts (Ronnberg et al., 1984) were eluted using a 5 min linear 
gradient of 0-100% B at a flow rate of 450 pi min'1 and detected using an HP 1046 
(Hewlett-Packard) fluorescence detector with excitation and emission wavelengths of 
330 nm and 450 nm, respectively. The adduct giving rise to the largest peak was used 
for quantitation as this was unaffected by peptide and other material in the supernatant.
Measurement of oedema
The ability of peptides to produce oedema was determined using the rat hind paw. 
Female Wistar rats (300-500 g) were anaesthetised with sodium pentobarbitone (60 mg 
kg-1 i.p., with supplementary doses to maintain anaesthesia). Synthetic peptides, 
dissolved in 50 pi phosphate buffered saline (PBS), were introduced into one hind paw 
by way of subplantar injection. The PBS vehicle was injected into the opposite paw as 
a control. Three animals were used for each peptide concentration (a total of 18 rats). 
Increases in paw volume occurring as a result of oedema were measured 
plethysmographically using the method of Van Arman et al. (1965). An apparatus was 
constructed consisting of a halved 50 ml syringe barrel, half-filled with mercury and
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attached to a blood pressure transducer (Gould Statham P23ID) via a tube filled with 
H2O. The blood pressure transducer was connected to a blood pressure 
monitor/amplifier (constructed by JCSMR workshop) which was attached to a 
Macintosh computer via a MacLab™ digital/analog interface and monitored using the 
Chart™ program. The entire apparatus was mounted on a perspex stand and 
experiments were carried out under a fume-hood (to avoid the risk of mercury vapour 
inhalation). A line was marked above the topmost callus pad on each rat hind-paw and 
the paw was immersed to that line. The mercury displaced by the paw immersion 
caused a pressure increase which was transmitted to the blood pressure transducer by 
the H20  impinging upon the transducer diaphragm. Thus increases in paw volume 
resulting from oedema produced an increase in the recorded mercury displacement and 
this was shown in preliminary experiments to be reproducible. Oedema was monitored 
for three hours, after which time the rats were sacrificed by pentobarbitone overdose.
Statistics
Values are expressed as means ± SEM. Dose-response data was fitted by the method 
of least squares using a four-parameter logistic function (Microcal Origin © program, 
Ver. 3.54, Microcal Software Inc.). Data were analysed using the Student’s t-test for 
comparing two EC50 or paw volume means, or one way analysis of variance for 
comparing multiple EC50 values. Differences were considered significant if p<0.05.
Results
Purification of the CNP-like peptide
Material passing through a 10 kDa nominal molecular weight exclusion ultrafiltration 
membrane was subjected to RP-HPLC and the resulting fractions were assayed for 
uterus relaxant activity (Fig. 4.1). Maximum activity was associated with two A2m
Retention volume (ml)
FIG. 4.1. Reversed phase HPLC chromatogram of O. anatinus venom 
10 kDa ultrafiltrate showing rat uterus relaxing activity associated with 
each 100 pi fraction. Maximum activity was associated with the two
peptides designated A and B.
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peaks. MALDI-TOF mass spectrometric analysis of these peaks revealed [M+H]+ 
masses of 4207.9 and 4208.3, respectively. Each peptide was homogeneous by SDS- 
PAGE, RP-HPLC and TOF-MALDI mass spectrometry.
Structure
Both active peptides were subjected to direct N-terminal sequence analysis. In 
addition, fragments generated by digesting the peptides with endoproteinase Arg-C 
(Fig. 4.2) and Chymotrypsin (Fig 4.3) were sequenced. The sequences obtained for 
each peptide were identical, despite the fact that both the N-terminal Arg-C and 
chymotryptic fragments of the isoforms differed in retention times. The elucidated 
primary structure, shown in Fig. 4.4, consisted of 39 residues which gives a calculated 
[M+H]+ mass of 4208.5. The homology between these peptides and members of the C- 
type natriuretic peptide (CNP) family (Fig. 4.5) led to the designation of ovCNP-39 
0Omithorhynchus venom C-type natriuretic peptide). The isoforms, named according 
to their order of RP-HPLC elution, are designated as ovCNP-39 A and ovCNP-39B, 
respectively. The ovCNP-39 sequence is characterised by a non-conservative Met 
Thr substitution at position 34 in comparison to the consensus eutherian form. This 
lies within the highly conserved 17 residue “loop” which is between the two Cys 
residues of natriuretic peptides.
In order to elucidate the basis for the heterogeneity between ovCNP-39A and 
ovCNP-39B, mixtures of the purified peptides and synthetic ovCNP-39 were analysed 
by RP-HPLC. As shown in Fig 4.6, ovCNP-39A co-eluted with the synthetic material 
whereas ovCNP-39B eluted as a separate peak. There was apparently no dynamic 
exchange between the isoforms: upon re-chromatography, each eluted as a single peak 
with a conserved retention time. This was also observed after incubating the peptides in 
6 M guanidine-HCl at 100 °C for 1 h. Chymotryptic mapping of each (disulphide-
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FIG. 4.2. Endoproteinase Arg-C (RC) digestion of active material, peak A (A) 
and peak B (B). The material was reduced, S-pyridylethylated and incubated 
with Endoproteinase Arg-C for 3 hours at 37°C followed by reversed phase 
HPLC analysis. Peak labels correspond to regions of elucidated sequence shown
in Fig. 4.4.
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FIG. 4.3. Chymotryptic (CHY) digestion of active material, peak A (A) and 
peak B (B). The material was reduced, S-pyridylethylated and incubated with 
Endoproteinase Arg-C for 3 hours at room temperature followed by reversed 
phase HPLC analysis. Peak labels correspond to regions of elucidated sequence
shown in Fig. 4.4.
LLHDHPNPRKYKPANKKGLSKGCFGLKLDRIGSTSGLGC
I-------- direct----------- |
I -A/BCHYl- I--A/BCHY2-- |--- A/BCHY3---
I A/BRC1- I------ A/BRC3------ | -A/BRC2--
FIG.4.4. The elucidated amino acid sequence of the A and B material. The full, 39 
- residue sequence was determined from the N-terminus of intact peptides and 
from chymotryptic (CHY) and Arg-C (RC) fragments. The sequences obtained for 
both peptides (A/B) were identical and the level of homology with C-type 
natriuretic peptides led to the designation of ovCNP-39 (Omtihorhynchus venom 
C-type natriuretic peptide, 39 residues).
ovCNP-39 
porcine CNP-53 
human CNP-53 
chick CNP-22 
human BNP 
human ANP
LLHDHPNPRKYKPANKKGLSKGCFGLKLDRIGS 
DLRVDTKSRAAWAR LLHEHPNARKYKGGNKKGL SKGCFGLKLDRIG S M|S 
DLRVDTKSRAAWARjLLQEHPNARKYKGANKKGLSKGCFGLKLDRIGSMS'
iGLdR^CFdvtKLDRIGSMS
SPKMVQG^GCFG F ® D R  
SLRRS^CFGGRMDRI
SGLGC
GLGC
GLGC
GLGC
SGLGC
s g l g c:
KVLRRH
NSFRYR
FIG. 4.5. Comparison of natriuretic peptide sequences. The C-terminal 22 residue
portions of human and porcine CNP-53 are identical and correspond to CNP-22. 
Within this region, ovCNP-39 is characterised by a Met —> Thr substitution at
position 34. ANP = atrial natriuretic peptide; BNP = brain natriuretic peptide.
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FIG. 4.6. HPLC co-elution analysis of synthetic ovCNP-39 (A), ovCNP-39A (B) and 
ovCNP-39B (C). Each of these peptides was mixed and injected simultaneously 
with synthetic ovCNP-39. ovCNP-39A (B) co-eluted with the synthetic material 
whereas ovCNP-39B (C) eluted differently. Synthetic ovCNP-39 is therefore similar
to ovCNP-39A and the heterogeneity appears to be associated with the B isoform.
intact) isoform showed that the heterogeneity is associated with the N-terminal 11 
residues (Fig. 4.7) because the N-terminal chymotryptic fragment of synthetic ovCNP- 
39 and ovCNP-39A eluted with comparable retention times, whereas the ovCNP-39B 
N-terminal chymotryptic fragment eluted somewhat later. By FAB mass spectrometry 
each of these N-terminal fragments had a mass of 1389.7 which is identical to the 
calculated mass. Further cleavage at Asp4 with endoproteinase Asp-N proceeded in the 
N-terminal chymotryptic fragment derived from ovCNP-39A but not in that derived 
from ovCNP-39B (Fig. 4.8).
The proportion (w/w) of ovCNP-39 in whole venom was estimated at 0.086 
using relative A2m peak area derived from capillary electrophoresis. As the detection 
was performed at 214 nm, the peak area resulting from each component of the venom is 
proportional to both its molecular mass and concentration, i.e. proportional to the total 
weight of each component. As most components of the venom are of a higher 
molecular weight than ovCNP-39 (see Chapter 3), the mass ratio of 0.086 thus obtained 
would be lower than the molar ratio. Therefore, while the relative mass fraction of 
ovCNP-39 represents 8.6% of venom components, it is likely to represent a 
substantially greater mole fraction.
Rat uterus activity
3 nM purified ovCNP-39A and ovCNP-39B produced a 37 ± 3 % (n = 3) and 41 ± 4 % 
(n = 3) relaxation of the KCl-contracted rat uterus, respectively (Fig. 4.9). This was 
comparable to the effect of 3 nM synthetic ovCNP-39, which produced a 43 ± 2 % (n = 
4) relaxation, but differed significantly (p <0.01) from that of the primary circulating 
form of rat ANP, a-ANP(l-28), of which 3 nM produced only a 13 ± 1 % (n = 4) 
relaxation (Fig. 4.9).
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FIG. 4.7. HPLC analysis of chymotryptic fragments from synthetic ovCNP-39 
(A), ovCNP-39A (B) and ovCNP-39B (C). Disulphide-intact material was 
digested with Chymotrypsin. This resulted in two fragments: the N-terminus, 
which corresponds to CHY1 (see Fig. 4.4) and the C-terminal fragment which 
is made up of the CHY2 and CHY3 fragments (see Fig. 4.4) attached via a 
disulphide linkage. CHY 1 resulting from ovCNP-39B (C) eluted later than
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CHY 1 from both the synthetic peptide (A) or ovCNP-39A (B).
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FIG. 4.8. Reversed phase HPLC analysis of peptides resulting from the 
Endoproteinase Asp-N cleavage of the N-terminal chymotryptic fragments 
derived from ovCNP-39A (A) and ovCNP-39B (B). Note that cleavage at 
Asp4 occurred in the ovCNP-39A fragment but not in the ovCNP-39B
fragment.
Concentration-response curves for the relaxant effect of synthetic natriuretic 
peptides on the rat uterus are shown in Fig. 4.10. Synthetic ovCNP-39 relaxed the 
uterus more potently (EC50 = 4.8 ± 0.2 nM, n = 4) than ovCNP-39( 18-39) (EC50 = 13.5 
± 2.1 nM, n = 4, p < 0.05), CNP-22 (EC50 = 14.1 ± 3.0 nM, n = 4, p < 0.05), and rat oc- 
ANP1-28 (EC5o = 37.1 ± 2.4 nM, n = 4, p < 0.01). Full concentration-response data for 
the ex vivo ovCNP-39 isoforms on the rat uterus were not obtained due to material 
limitations.
Elevation of cGMP in cultured aortic smooth muscle cells
The effect of purified O. anatinus venom natriuretic peptides (ovCNP-39A and B) as 
well as synthetic ovCNP-39, ovCNP-39( 18-39), CNP-22 and rat a-ANP(l-28) on 
cGMP formation in vascular smooth muscle cells (VSMCs) was assayed using cultured 
rat aortic myocytes. All of these peptides have an intact 17-residue disulphide loop 
which is the minimum requirement for natriuretic peptide receptor binding (Furuya et 
al., 1992). The resulting concentration-response curves are presented in Fig. 4.11. 
After a 10 minute incubation with VSMCs at 37 °C, 1 pM ovCNP-39 A induced a 55- 
fold (40.59 ± 6.32 pmol/106 cells, n=3) increase and 1 jjM  ovCNP-39B a 62-fold 
(45.94 ± 2.35 pmol/106 cells, n=3) increase in cGMP levels from resting levels (0.74 ± 
0.07 pmol/106 cells, n=4). Similarly, 1 jiM synthetic ovCNP-39, ovCNP-22 and CNP- 
22 produced 48, 54, and 53-fold increases in cGMP, whereas rat a-ANP(l-28) 
produced only a 4-fold (3.04 ± 0.10 pmol/ 106 cells, n=3) increase. The EC50 values for 
all the natriuretic peptides, other than ANP (for which no Emax was determined), were 
not significantly different (p > 0.1, n=3).
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FIG. 4.9. Responses of the isolated rat uterus to 3 nM ex vivo ovCNP-39A (A), ovCNP- 
39B (B), 3 nM synthetic ovCNP39 (C) and 3 nM rat a-ANP(l-28) (D). The uterus was 
tonically pre-contracted with 50 mM KC1 before the addition of each peptide.
•  cwOP-39 
a  o\OP-39(18<39) 
o OP-22 
a nataAP(1-28)
Ffepüde ccnoertration (ty
FIG. 4.10. Cumulative concentration-response curves for the relaxation of the KC1- 
contracted isolated rat uterus by natriuretic peptides. Peptides were added in increasing 
concentrations and isometric tension monitored continuously. Logistic functions were 
fitted to the data to obtain EC50 estimates.
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FIG. 4.11. The effect of ovCNP-39 and other natriuretic peptides on accumulation 
of cGMP in cultured vascular smooth muscle cells. Thoracic rat aortic smooth 
muscle cells from passage 5 were incubated with peptides for 10 min at 37 °C 
in Earle's salt solution with 0.3 mM isobutylmethylxanthine. ovCNP-39A (A) and 
ovCNP-39B (B) produced a concentration-dependent increase in cGMP which 
was similar to CNP-22 (C), synthetic ovCNP-39 (D) and the synthetic fragment,
ovCNP-39( 18-39) (D) but differed from that of ANP (C).
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Oedemagenic effects
Synthetic ovCNP-39 and CNP-22 both produced oedema following subplantar 
injection into the rat hind paw (Fig. 4.12). 5 nmol (in a volume of 50 jil) of either 
ovCNP-39 or CNP-22, for each the highest concentration tested, led to a significant 
increase in paw volume after 20 min and this was sustained for up to 3 h. Maximal 
increases over contralateral, control paw volume were 37 ± 2 % (n = 3) for ovCNP-39 
and 33 ± 5 % (n = 3) for CNP-22 (Fig. 4.12A). 250 pmol of each peptide (n = 3) 
produced a slight (though not significant) response (Fig. 4.12B), while 5 pmol (n = 3) 
produced a negligible response (Fig. 4.12C).
Mast cell histamine release
o-Pthalaldehyde (OPA) derivitisation of a histamine standard, followed by reversed 
phase HPLC, gave rise to three histamine-OPA adducts (Fig. 4.13A). The histamine- 
OPA fluorophore has been demonstrated previously to produce three peaks upon 
HPLC, which are believed to correspond to different stereoisomers which are readily 
inter-convertible (Ronnberg et al., 1984). The adduct giving rise to the largest peak 
was used for quantitation as this was unaffected by peptide and other material in the 
supernatant.
Fig. 4.13B demonstrates the HPLC analysis of the total histamine released from 
mast cells by sonicating the cell pellet. An example of the HPLC analysis of baseline 
histamine release following a 10 min incubation at 37 °C in the absence of any 
secretogogue, is shown in Fig. 4.13C. An HPLC analysis of histamine release resulting 
from the incubation of mast cells with 0.1 mg ml'1 OaW for 10 min at 37 °C is shown 
in Fig. 4.13D. It can be seen that this concentration of OaW induces substantial release 
of histamine.
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FIG 4.12. Oedemagenic effect of subplantar injections of ovCNP-39 and CNP-22 in the 
rat hind-paw. Peptides (in a 50 pi volume) were injected at concentrations of 10'4 M (A), 
5 x 10'6 M (B) and 10~7 M (C) (filled circles) and the phosphate-buffered saline vehicle 
was injected into the contralateral paw as a control (open circles). Changes in paw 
volume were monitored plethysmographically over 180 min. * p<0.05, ** p<0.005.
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FIG. 4.13. Assay of histamine release from peritoneal mast cells. A. 100 pmol 
histamine standard giving rise to three histamine-OPA adducts, labelled His-OPA- 
A, B and C. Peak A was used for quantitation. B. Total mast cell histamine 
released by sonication. C. Basline histamine release over 10 min at 37 °C. D. Mast 
cell histamine released by incubation with 0.1 mg.ml'1 OaV for 10 min at 37 °C
Retention volume (ml)
FIG. 4.14. Reversed phase HPLC chromatogram of a 10 kDa ultrafiltrate from 
OaV. Each collected fraction (100 pi volume) was lyophilised and incubated with 
peritoneal mast cells for 10 min at 37 °C. The histamine release resulting from each 
fraction is shown in the histogram beneath the chromatogram.
A reversed phase chromatogram of a 10 kDa-cutoff ultrafiltrate of OaW is shown 
in Fig. 4.14 and beneath it are the results of a preliminary screen of fractions for mast 
cell histamine-releasing activity. Fractions containing the ovCNP-39 isoforms, A and 
B, appeared to be most active. This led to the construction of dose-response curves for 
histamine release induced by synthetic13 ovCNP-39, CNP-22 and a-ANP(l-28).
Synthetic ovCNP-39 produced a concentration-dependent release of histamine 
from purified peritoneal mast cells, with an estimated EC50 of 10.0 ±3.8 jiM (n = 4, 
Fig. 4.15). This was slightly (though not significantly) less potent than CNP-22 and rat 
a-ANP(l-28), which produced estimated EC50 values of 4.1 ± 0.5 jjAI (n = 4) and 2.9 
± 0.6 (iM (n = 4), respectively (Fig. 4.15). However, a-ANP(l-28) showed 
significantly greater efficacy than either ovCNP-39 and CNP-22. 30 jiM a-ANP(l-28) 
released 1333.9 ± 87.5 (n = 4) pmol histamine/5xl04 cells, whereas 30 pM ovCNP-39 
and CNP-22 released 889.0 ± 75.5 pmol (p < 0.05, n = 4) and 992.5 ± 109.5 pmol (p < 
0.05, n = 4) / 5xl04 cells, respectively.
In order to investigate the possible existence of natriuretic peptide receptors on 
mast cells, the potency of ovCNP-39 and ovCNP-39( 18-39) were compared with 
ovCNP-39(l-17), which lacks the disulphide loop essential for natriuretic peptide 
receptor binding. Concentration-response curves for the histamine-releasing activities 
of the ovCNP-39 fragments, ovCNP-39(l-17), ovCNP-39( 18-39), and ovCNP-39 itself 
are presented in Fig. 4.16 (see Table 4.1 for sequences). There was no significant 
difference in the potency of these peptides (n = 4). ONP-39(l-17) and ONP-39(18-39) 
had estimated EC50 values of 6.6 ± 0.8 pM and 10.0 ± 1.8 |iM, respectively.
13 The relatively high concentrations of peptide required to elicit histamine release precluded use of the ex 
vivo peptide isoforms for these experiments.
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FIG. 4.15. Mast cell histamine release dose-response curves for natriuretic 
peptides. The ability of ovCNP-39 from OaV and endogenous CNP-22 and rat a- 
ANP(l-28) to release histamine from purified rat peritoneal mast cells was 
assessed over a range of concentrations.
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■ ovCNP-39(1-17)
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FIG. 4.16. Mast cell histamine release dose-response curves for ovCNP-39 
fragments. The potency of intact ovCNP-39 and ovCNP-39 C-terminal (ovCNP- 
39(18-39)) and N-terminal (ovCNP-39(l-17)) fragments in releasing histamine
from purified rat peritoneal mast cells were compared
Discussion
Structure
This chapter describes the characterisation of a 39-residue C-type natriuretic peptide, 
ovCNP-39, from O. anatinus venom which relaxes the rat uterus in vitro. Based on 
amino acid sequence homology, ovCNP-39 appears to be a typical member of the CNP 
class, although it is distinctive in that it comprises 39 residues and, ex vivo, exists as 
two isoforms. The identification of a C-type natriuretic peptide in OaV is particularly 
interesting in that it constitutes a relatively high mole fraction of venom components.
The structure of CNP-22 is highly conserved between mammals to the extent that 
the human, porcine and rat forms are identical (Kojima et al., 1991; Tawaragi et al., 
1990; Tawaragi et al., 1991). CNP-53 shows slightly more heterogeneity (Tawaragi et 
al., 1991) in its N-terminal sequence but as it is the loop structure which participates in 
ANPb receptor activation, amino acid substitutions or extensions at the N-terminus do 
not affect activity (Furuya et al., 1992). The high degree of similarity between ovCNP- 
39 and endogenous CNP-22 (the Met —> Thr substitution, at position 17 of CNP-22, is 
the only difference) indicates the peptide is structurally a member of the C-type 
natriuretic peptide family.
The length of ovCNP-39 suggests that processing of the pro-peptide differs from 
that of CNP-22 and CNP-53. CNPs of varying lengths have also been isolated from the 
heart of several species of elasmobranch fish (Suzuki et al., 1992; Takano et al., 1994). 
These include CNP-38, CNP-39 (sequence is somewhat different from ovCNP-39, 
Suzuki et al., 1992), CNP-21 and CNP-41 (Takano et al., 1994). Retention of the 
typical proteolytic processing signal Lys-Lys, which precedes the C-terminal 22 
residues in both ovCNP-39 and the elasmobranch cardiac forms suggests that the
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proteolytic enzyme(s) which targets this site is either absent or inactive in both the 
platypus crural gland and the elasmobranch heart.
The difference between the two ovCNP-39 isoforms, which exhibited identical 
primary structures but eluted differently on RP-HPLC, was not resolved. The masses 
were identical and no dynamic exchange between the two forms was apparent, even 
under strongly denaturing conditions. This suggests an unusual, stable conformational 
difference between the isoforms, which has not been previously reported in natriuretic 
peptides. The heterogeneity was localised to the N-terminal 11 residues and apparently 
makes the His3-Asp4 bond refractory7 to cleavage by endoproteinase Asp-N in the B 
isoform. This stretch contains two prolines and it is therefore possible that the 
isoforms represent different proline cis-trans conformers, as has been reported in a 
number of peptides (Gesquiere et al, 1989, O’Neal et a l, 1996). Such peptides have 
slow rates of isomerisation and can therefore be resolved on RP-HPLC as two peaks, 
one representing the cis conformer and the other the trans conformer (Gesquiere et a l , 
1989; Henderson and Mello, 1990; Melander et a l, 1982). However, in these cases 
the conformers are in dynamic equilibrium and re-chromatography of either peak 
results in the appearance of two peaks (Gesquiere et al., 1989). In contrast, the ovCNP- 
39A and ovCNP-39B isomers are homogeneous upon rechromatography. It is 
anticipated that this paradox will be resolved in future NMR experiments which are not 
feasible at present due to limited sample availability.
Natriuretic peptides in animal venoms
A recent report describing CNP-like immunoreactivity in Bothrops jararaca (South 
American pit viper) venom (Murayama et al., 1997) is the only other example of a CNP 
in an animal venom, although Dendroaspis angusticeps (Green Mamba snake) venom 
contains an ANP-like peptide in low abundance (Schweitz et al., 1992). Although the
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endogenous function of CNP is unknown, the fact that CNP is released from 
endothelial cells following stimulation with cytokines suggests it may serve as an 
autocrine or paracrine mediator in cytokine-associated disorders (Suga et al., 1993). 
Also, patients with septic shock and chronic renal failure show elevated serum CNP 
levels (Hama et al., 1994). These findings, in addition to its discovery in O. anatinus 
and Bothrops jararaca venom, imply a pathophysiological function, a possibility which 
is dealt with below.
cGMP elevation in vascular smooth muscle cells
The structural and functional similarities between ovCNP-39 and CNP-22 suggest that 
they act at the same receptor. CNP potently stimulates cGMP accumulation in cultured 
VSMCs (Furuya et al., 1990) through the activation of ANPB receptors (Suga et al., 
1992). The lower levels of activity observed with ANP reflects the relatively low 
expression of ANPa receptors in these cells (Suga et al, 1992). The present study 
therefore suggests that ovCNP-39 acts upon ANPB receptors, with a comparable 
affinity to CNP-22. Furuya et al. (1992) demonstrated that only the disulphide-linked 
ring portion of CNP (CNP(6-22)) participates in the stimulation of cGMP accumulation 
in VSMCs. They found that the LKL motif (position 9-11 in CNP-22) was essential for 
this activity whereas substitution of Met for Gin at position 17 did not reduce activity. 
This is consistent with the observation that ovCNP-39 is equipotent with CNP-22, 
despite being extended at the N-terminus and having a Met—»Thr substitution.
An increase in vascular smooth muscle cGMP, resulting from natriuretic peptide 
stimulation, produces vasodilatation (Wright et al., 1996). CNP, while being less 
potent than ANP in eliciting vasodilatation in systemic arteries, produces relaxation in
peripheral veins more potently than ANP through the activation of ANPB receptors 
(Wei et al., 1993), suggesting ovCNP-39 would act similarly. ovCNP-39-mediated
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histamine release from mast cells may also promote vasodilatation and increase 
vascular permeability (Kuby, 1992). Both effects may serve to facilitate diffusion of 
venom components. These findings also indicate the likely contribution of ovCNP-39 
to the hypotension and peripheral vasodilatation which accompanies the administration 
of OaV to experimental animals (Kellaway and LeMessurier, 1935).
Uterus relaxing activity
The uterus relaxing activities of ovCNP-39 and CNP-22 may reflect the ability of these 
peptides to stimulate cGMP production in uterine tissue via ANPB receptors (Dos Reis 
et al., 1995). An increase in smooth muscle cGMP activates cGMP-dependent protein 
kinase (cGK) which is known to phosphorylate a number of proteins involved in 
smooth muscle relaxation (Archer et al., 1994; Cornwell et al., 1991; Komalavilas and 
Lincoln, 1994; Walsh et al., 1995). The greater potency of CNP compared with ANP 
can be explained by the fact that ANPa receptors, through which ANP acts, are 
localised mainly to the non-contractile endometrium. However, ANPB receptors, 
through which CNP acts, are found on both the myometrial smooth muscle and the 
endometrium (Dos Reis et al., 1995). In addition, ANPB mRNA levels are about 100 
times higher than those of ANPa in the rat uterus (Dos Reis et al., 1995). Yet 
surprisingly, ANP is more potent than CNP in stimulating cGMP production in 
segments of whole uterus (Dos Reis et al., 1995). This apparent anomaly remains 
unresolved but it raises the possibility that relaxation of the rat uterus by CNP involves 
second messengers other than cGMP. Alternatively, diethylstilboesterol treatment may 
have modulated the activity of ANP receptors in the present study.
ovCNP-39 was found to relax the rat uterus more potently than either CNP-22 or 
ovCNP-39( 18-39). Since the latter two peptides are equipotent and predominantly 
differ from ovCNP-39 by the absence of an N-terminal extension (Table 4.1), these
results suggest that the N-terminal extension underlies the increased potency of 
ovCNP-39. This is somewhat surprising considering that extensions of, or amino acid 
substitutions at, the N-terminus of CNP-22 do not appear to affect its interaction with 
ANPb receptors in vascular smooth muscle (Furuya et al., 1992) and raises the 
possibility of tissue heterogeneity for this receptor population. Alternatively, the N- 
terminal extension of ovCNP-39 may confer a higher affinity for other natriuretic 
peptide receptors such as ANPa and ANPc. ANPc, which binds all natriuretic peptides 
with high affinity, undergoes endocytosis following binding and fuses with lysosomes 
where the peptide undergoes hydrolysis (Barr et al., 1996). It thus appears to play a 
role in the control of circulating natriuretic peptide concentrations (Brandt et al., 1995). 
However, studies using the specific ANPc agonist, ANP(4-23)-NH2 (cANP), have 
demonstrated that ANPC receptors inhibit adenylate cyclase activity (Anand Strivastava 
et al., 1990) and evoked catecholamine release in PC 12 cells (Trachte et al., 1995), but 
activate phospholipase C in vascular smooth muscle cells (Resink et al., 1988) and 
Ca2+ channels in adrenal glomerulosa cells (Isales et al., 1992). Whether any of these 
processes underlie the responses observed in the present study is unclear but their 
potential involvement could be investigated by studying the effect of cANF on uterine 
motility in the presence and absence of natriuretic peptides.
Oedemagenic and mast cell histamine releasing activities
It has previously been demonstrated that OaV produces a marked paw oedema within 
30 mins of injection, which is attenuated by the 5-HT2 receptor-specific antagonist, 
ketanserin (de Plater, Hons. Thesis, ANU, 1993). This study has shown that both 100 
jiM ovCNP-39 and CNP-22 caused a significant paw oedema within 20 min of 
injection. The rapidity of the responses is consistent with the effects of mast cell 
degranulation rather than those arising from secondary mediators derived from
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arachidonic acid metabolism (Bonta et al., 1979). Therefore, the ability of various 
forms of the natriuretic peptides to degranulate rat peritoneal mast cells (that 
dominantly release histamine rather than 5-HT, which is released by cutaneous mast 
cells) was studied. All natriuretic peptides tested induced significant histamine release 
and were equipotent in this respect. However, the results suggest that ovCNP-39 and 
CNP-22 have a lower efficacy than a-ANP(l-28). The significance of such a 
difference in efficacy is unclear, as the mechanism of non-immunogenic14 histamine 
release remains unresolved (see Cross et al., 1995).
A number of polybasic peptides, including mastoparan (Higashijima et al., 1988), 
substance P (Mousli et al., 1990) and kinins (Bueb et al., 1990), elicit histamine release 
from mast cells. Numerous structure-activity and binding studies suggest that polybasic 
peptides do not interact with conventional peptide receptors on mast cells (reviewed by 
Mousli et al., 1990 and Mousli et al., 1994), but rather produce exocytosis by directly 
activating the G-protein, Gj3 (Aridor et al., 1993). This is supported by the finding that 
a range of polybasic peptides stimulate the GTPase activity of purified Gi-proteins 
reconstituted into phospholipid vesicles (Higashijima et al., 1990). The structural 
requirements for this activity include a minimum length, net positive charge, and an 
amphipathic a-helical structure (Higashijima et al., 1990). These peptides are thought 
to insert into the bilayer such that their positive charges make direct contact with the G- 
protein (Higashijima et al., 1990). Thus, it would be expected that such structural 
requirements would be important in determining histamine-releasing activity. 
However, Cross et al. (1995) demonstrated that mast cell degranulation by peptides is 
not necessarily dependent on the formation of amphipathic a-helices, and suggested 
that cationic secretogogues interact with negatively charged extracellular sites to
14 immunogenic release in this case refers to release of histamine by IgE, attached to an allergen, and 
mediated through the IgE receptor.
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promote subsequent activation of Gß. These may be sialic acid residues, as treatment 
of mast cells with neuraminidase inhibits histamine release by peptides (Emadi-Khiav 
et al., 1995).
Do ovCNP-39 and CNP-22 release histamine from mast cells in a similar, 
receptor-independent manner? This study indicates that the answer to this question is 
yes. Both peptides are polybasic and the results suggest that the N-terminal fragment of 
ovCNP-39, ovCNP-39(l-17) and the C-terminal fragment, ovCNP-39( 18-39) release 
histamine with a similar potency. Interaction of CNP with ANPB receptors minimally 
requires that the disulphide linkage is intact and that the stretch of amino acids, CNP-
22(Leu9-Lys10-Leu11) within the loop is present (Furuya et al., 1992) Neither of these 
requirements are satisfied by the N-terminal fragment, ovCNP-39(l-17), suggesting 
that ANPb receptors are not involved.
Conclusion
This chapter describes the purification and structure of a novel 39-residue C-type 
natriuretic peptide (ovCNP-39) from OaV, which is responsible for the uterus relaxing 
activity of OaV. The myorelaxant, cGMP-elevating, oedema-producing and mast cell 
degranulating activities of the C-type natriuretic peptide, ovCNP-39, from OaV, have 
also been examined. The two ex vivo ovCNP-39 isoforms (which have identical amino 
acid sequences), synthetic ovCNP-39 and endogenous eutherian CNP-22, all produced 
a concentration-dependent relaxation of the rat uterus and cGMP elevation in VSMCs; 
ANP was significantly less potent in both respects. ovCNP-39 and CNP-22 produced 
oedema in the rat paw with a similar potency and their effective concentration range 
was comparable with that required for a-ANP-induced plasma extravasation in rat skin 
(Opgenorth et al., 1990). An initial screen of HPLC fractions from a 10 kDa 
ultrafiltrate of the venom suggested that the two ex vivo isoforms of ovCNP-39 induce
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histamine release from peritoneal mast cells. Further examination of this by 
constructing concentration-response curves for histamine release indicated that 
synthetic ovCNP-39 and fragments corresponding to the N- and C-termini, were 
equipotent with CNP-22 and ANP, although the latter exhibited greater efficacy.
The observation that ovCNP-39 elevates cGMP levels in vascular smooth muscle 
cells also suggests that it may underlie the vasodilatory and hypotensive effects of 
OaV. Furthermore, the oedemagenic and mast cell histamine releasing activities of 
ovCNP-39 suggest that it may contribute to the local effects of envenomation.
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CHAPTER 5
THE ELECTROPHYSIOLOGICAL EFFECTS OF O. ANATINUS VENOM ON 
RAT DORSAL ROOT GANGLION NEURONES
Introduction
The severe pain which accompanies O. anatinus envenomation may arise from the 
action of secondary mediators released from inflammatory cells. Alternatively, it may 
involve a primary, direct effect of a venom component(s) on nociceptive neurones or, 
indeed, a combination of both. The release of inflammatory mediators is likely to be at 
least partially involved. Chapter 4 describes a C-type natriuretic peptide, ovCNP-39, 
from the venom which elicits histamine release from mast cells. However, the 
longevity and severity of envenomation symptoms are not readily explained by such 
acute-phase effects which are moderate and short-lived by comparison (Keele and 
Armstrong, 1964). On the other hand, late-phase mediators, such as eicosanoids, 
cytokines (e.g. EL-lß) and nerve growth factor (NGF) have more prolonged algetic 
effects (Follenfant et al., 1989; Ferriera et al., 1988; Petty et al., 1994) and may 
therefore be important contributors. However, this study addresses the possibility that 
the venom has a direct effect on nociceptors.
Electrophysiological studies of nociceptors in vivo have been hampered by the 
difficulty of gaining access to nociceptive terminals. Traditionally, extracellular 
recordings are made from isolated nociceptive fibres (C- and A8- fibres) which 
innervate a defined receptive field upon which algogenic agents are placed (e.g. Foster 
and Ramage, 1981) or injected into a neighbouring artery (e.g. Chahl and Iggo, 1977). 
The two major problems associated with these techniques are a) the amount of
electrophysiological information that can be obtained is limited as one has little 
electrical control over the fibres from which one is recording, e.g. voltage- and current­
clamping is not possible and it is not possible to exchange intracellular ions; and b) it is 
difficult to determine whether the observed effects are produced or modulated by 
inflammatory mediators released by the algogen. These problems have been 
circumvented to an extent by the identification of a population of dissociated sensory 
neuronal cell bodies which express properties associated with nociceptors in vivo. 
Such properties include substance P-like immunoreactivity and responsiveness to the 
algogenic agents capsaicin, bradykinin and prostaglandin E2 (PGE2) (Baccaglini and 
Hogan, 1983). In addition, slowly conducting A8- and C-fibers, which are 
predominantly nociceptive, have small-medium diameter parent cell bodies (Harper 
and Lawson, 1985). Dorsal root ganglion (DRG) neuronal cell bodies which exhibit 
these properties are thus likely to be nociceptive and have been used to study the 
electrophysiological properties of nociceptors in vitro (Gold et al., 1996a). In these 
neurones, capsaicin has been shown to activate a nonselective cation channel (Oh et al.,
1996) while prostaglandin E2 and other algogenic agents, such as adenosine and 5-HT 
potentiate a tetrodotoxin-insensitive Na+ current (Gold et al., 1996b; Cardenas et al.,
1997) .
Using the whole-cell patch clamp technique, the effects of OaW on small-to- 
medium diameter dorsal root ganglion neurones, many of which are likely to be 
nociceptors, have been investigated.
Methods
Venom preparation
Neat OaN was suspended at a concentration of 1 mg ml'1 in either MES solution (mM: 
135 NaCl, 3 KC1, 0.6 MgCl2, 2.5 CaCl2, 1.2 NaHC03, 10 glucose, 10 MES, titrated to
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pH 6.1 with HCl, osmolarity adjusted to 320 mOsm using sorbitol) or HEPES, pH 7.4, 
solution (as above except HEPES replacing MES).
Cell culture
Male Wistar rats (5-8 weeks old) were anaesthetised with halothane (4% in Cb) and 
decapitated. A single incision was made in dorsal skin, the skin flaps pulled to either 
side and the vertebral column was cut at the cervical and lower lumbar regions. While 
holding the cervical end with forceps, the ribs were cut as closely as possible to the 
spinal vertebrae without damaging them and the column freed from the underlying 
mesentery. The column was placed in HEPES solution (described above), trimmed of 
excess tissue and remaining rib fragments, and dorso-ventrally hemisected. Dorsal root 
ganglia (DRGs) from both thoracic and lumbar regions were removed under a 
dissecting microscope using fine forceps and placed in H-16 Dulbecco’s modified 
Eagle’s medium (DMEM, supplemented with 100 units ml'1 penicillin G and 0.1 mg 
ml'1 streptomycin), containing 2.5 U m l1 collagenase (Sigma, Type I) at 36 °C for 45 
min. DRGs were then washed several times with DMEM and incubated in 5 mg ml'1 
‘dispase’™ (Boehringer Manheim, Grade n, >0.5 U.ml1) at 36 °C for 30 min. DRGs 
were then resuspended in DMEM supplemented with 10 % fetal calf serum and the cell 
bodies were dissociated by trituration with a fire-polished pasteur pipette. DRG 
neurones were distributed into 10 wells of a 24-well tissue culture plate containing 
coverslips coated with collagen and poly-D-lysine (Sigma). Electrophysiological 
recordings were carried out 6-24 hours after plating.
Electrophysiology
Whole cell currents in DRG neurones were measured using an Axopatch ID (Axon 
Instruments). Data were acquired on an IBM-PC compatible computer using pClamp 
software (Ver. 6, Axon Instruments) with a digitisation rate of 20 kHz and a Macintosh
computer using Chart (Ver. 3.2, AD Instruments) software, with a digitisation rate of 2 
Hz. Digitisation was accomplished using a TL-1 DMA interface (Axon Instruments) 
and a Mac Lab™ digital/analog interface (AD Intruments), respectively. Electrodes 
were fabricated from Vitrex Modulohm I/S borosilicate glass using a Sutter Instruments 
(Model P-87) electrode puller. Electrode resistances ranged from 1.5-3 M£L Both 
capacitance and series resistance compensation (set at 80-90%) were used. Patch 
electrodes were filled with (mM) 147 KC1, 2 2Na-ATP, 0.5 2Na-GTP, 11 EGTA, 1 
CaCl2 , 2 MgCL, 10 HEPES, titrated to pH 7.2 with KOH and osmolarity adjusted to 
305 mOsm using sorbitol. The standard HEPES bath solution was as described above 
and the bath was continually perfused at a flow rate of approx. 1-2 ml min'1. In some 
experiments, intracellular Cl* was largely replaced with gluconate, giving a [Cl'ji of 8.4 
mM; alternatively, extracellular Cl' was largely replaced with gluconate to give a [Cl']0 
of 9.2 mM; and to block K(Ca) currents, intracellular K+ was completely replaced with 
TEA. The liquid junction potentials of these solutions were calculated (Barry, 1994) 
using a junction potential calculator program (JPCalcW © 1996 Peter H Barry, Axon 
Instruments).
O. anatinus venom (1 mg ml'1) was applied to individual neurones by pressure 
ejection (5-10 psi) using a Picospritzer (GV Corp.) through flow pipes with internal 
diameters of 100 Jim (GC Microbore DB-17, J & W Scientific). Flow pipes were 
attached to fine plastic tubing which was back-filled with 100-300 j l l I  volumes of test 
solution and a three way tap was used to prevent front-filling with bath solution by 
capillary action. Very small amounts of material could be used in this way. The 
optimum position of flow pipes for superfusing cells was estimated visually by ejecting 
high-salt solution through the flow pipe into the bath filled with H2 O and monitoring 
solution flow under a phase-contrast microscope. Up to 5 flow pipes were glued
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together and each could be moved into optimal position during an experiment, using a 
micromanipulator, to exchange solutions.
Solutions
Capsaicin (Fluka Chemica) solutions were made up freshly on the day of each 
experiment from a 10 mM stock in ethanol (stored at -20 °C), such that the final 
concentration of 1 pM capsaicin contained 0.01% ethanol. Stocks of thapsigargin 
(Research Biochemicals International) and 5-nitro 2-(3-phenylpropylamino) benzoic 
acid (NPPB, Research Biochemicals International) were also made up freshly in DMSO 
on the day of each experiment. These stocks were diluted to give a final concentrations 
of 1 pM thapsigargin and 10 pM NPPB each of which contained 0.02% DMSO.
High-performance liquid chromatography and SDS-PAGE 
See Chapter 2 (General Materials and Methods) for details.
Data analysis and statistics
To compare OaW currents under different experimental conditions, the average current 
was calculated. The inward current (I) resulting from each application was integrated 
with respect to time (t) and divided by the duration (T) of the response, i.e. Response X
= l/T oJ I dt. Leak current was not subtracted. In some experiments, OaW was applied 
twice; once in the absence and once in the presence of a particular inhibitor. The 
second response (Response B) was divided by the first response (Response A) to yield 
a response ratio (A/B). This was compared to the response ratio obtained by two 
applications of OaW, both under normal conditions (i.e. in the absence of inhibitors). 
Results are expressed as means ± S.E.M. and compared using an unpaired Student’s t- 
test. Significant differences were accepted at the p< 0.05 level.
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Results
OaV - activated currents
Of 96 DRG neurones subjected to a 10 s application of 1 mg ml'1 O. anatinus venom at 
pH 6.1, 69 (72%) responded, following an average latency of 23.3 ± 3.0 sec, with an 
inward current characterised by multiple transient events (Fig. 5.1 A). The current had a 
mean peak amplitude of -4.65 ± 0.34 nA which recovered to baseline in 56/69 
neurones. In these cells, the mean duration of the response was 246.7 ± 36.5 s. 27/96 
(28%) neurones were deemed to be unresponsive in that they exhibited effects similar 
to pH 6.1 alone, i.e. either a single transient inward current or no response (Fig. 5.IB).
1 mg ml'1 BSA in MES buffer (pH 6.1) also had the same effect as pH 6.1 alone. OaV 
diluted in standard bath solution (HEPES, pH 7.4) produced either no effect or small, 
transient inward currents (n=5. Fig. 5.1C) which differed markedly from the more 
pronounced currents resulting from OaV (MES) buffered at pH 6.1 (Fig. 5.1 A, B). As 
the response was much more robust and reproducible at pH 6.1 these conditions were 
employed for subsequent experiments.
Correlation with capsaicin sensitivity
There was no correlation between sensitivity to capsaicin and OaV (neurones were 
deemed to be capsaicin-sensitive if they responded to a 10 s application of 1 pM 
capsaicin with a characteristic inward current, Fig 5.IB). Of 6 capsaicin-sensitive 
neurones, 4 responded to OaV and of 4 capsaicin-insensitive neurones, 3 responded to 
OaV. As both capsaicin-sensitive and insensitive neurones responded to the venom 
DRG neuronal subtypes were discriminated, in subsequent experiments, solely on the 
basis of soma diameter (20-40 jim).
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A. OaV, pH 6.1 - RESPONSIVE
pH 6.1 OaV
♦ ♦
0.5 nA
1 min
B. OaV, pH 6.1 - UNRESPONSIVE 
pH 6.1 OaV OaV
I ♦ ♦
1 nA
30 sec
C. OaV, pH 7.4 - RESPONSIVE
1 |iM CAP
0.5 nA
1 min
FIG 5.1. Typical responses of DRG neurones to OaV. A. Effect of MES (pH 6.1) and 
1 mg m l'1 OaV (at pH 6.1), on a responsive DRG neurone. B. A neurone classified 
as unresponsive: this cell was also relatively insensitive to pH 6.1 but responded to a 10 s 
application of 1 pM capsaicin. C. The effect of 1 mg m l'1 OaV made up at pH 7.4
in HEPES buffer. All applications were of 10 s duration.
Ionic basis and Ca2+ - dependence of the current
Current-voltage curves were obtained by applying a voltage ramp from -110 to 60 mV 
at a rate of 65 mV s'1, before and during the response to OaW (Fig. 5.2A). This rate 
was chosen as it was slow enough to remove voltage-dependent Na+ currents by 
inactivation, but rapid enough so that the large transient events produced by OaW did 
not produce disturbances in the resulting ramp current. Subtraction of the curve 
obtained before from that obtained during the OaW response (Fig. 5.2B), yielded a 
linear inward current-voltage relationship in the -100 to -50 mV range (Fig. 5.2C). At 
membrane potentials more positive than -50 mV, voltage-dependent currents were 
activated, both in controls and following the application of OaW. The linear range was 
therefore extrapolated (r-values ranged from 0.967 to 0.999) to give a reversal potential 
for the OaV-activated current of -11.4 ± 2.0 mV (n = 22, Fig 5.2C and Table 5.1). This 
was close both to the calculated (using the Nemst equation) Eci of -6.9 mV and the 
reversal potential for the non-selective cation current (Currie and Scott, 1992; Crawford 
et al., 1997a), suggesting the involvement of chloride and/or nonselective cation 
currents.
Ca2+-dependent non-selective cation and chloride currents are known to occur in 
rat DRG neurones (Currie and Scott, 1992; Currie et al., 1995). Therefore, to establish 
the dependence of the response to OaW on intracellular Ca2+, the Ca2+-ATPase 
inhibitor, thapsigargin, was used to prevent the re-filling of intracellular Ca2+ stores. 
The effect of thapsigargin was investigated by applying OaW twice in the presence of 
thapsigargin (Fig 5.3). As a control, two applications of OaW were made in the 
presence of standard HEPES solution (n = 7) or standard solution containing 0.02% 
DMSO (n = 3). In control neurones, the second application of OaW resulted in a larger 
(p < 0.05, n = 10) response (1/T J I.Ot, see Methods) than the first (Fig 5.3A, B). In
contrast, thaspsigargin (1 pM) significantly (p < 0.01, n = 5) reduced the amplitude of
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A B OaV OaV
t t
0.75 nA I
3 min
C 1 |iM THAPSIGARGIN
OaV OaV OaV
t t inr—T
0.75 nA [
3 min
FIG. 5.3. The effect of thapsigargin on the ratio of the second to the first response to 
OaV. OaV was applied twice to each neurone and the response quantitated using the 
formula 1 /d  J I .3 t -  A. Ratio of response 2 / response 1 under control conditions 
(n = 10) and when 1 pM thapsigargin (n = 5) was included in the bath solution from 
the start of recording. B. and C. show examples of neurones responding to two 
applications of OaV under control conditions (B) and in the presence of thapsigargin (C). 
In these experiments, OaV (1 mg ml'1) was applied for 10 s. * p < 0.05.
the second response compared to the first (Fig 5.3A, C) and this was irreversible upon 
washing out the thapsigargin (Fig 5.3C).
To establish which Ca2+-dependent currents give rise to the OaV response, Erev 
was determined following various ion replacements. Replacing extracellular Cl' with 
gluconate resulted in a significant (p<0.01, n=4) positive shift in Erev which, 
nevertheless, fell well short of the calculated Eci (61.6 mV) (Table 5.1). Replacing 
intracellular Cl' with gluconate shifted Erev in the opposite direction to that expected 
from the calculated Eci (Table 5.1). Any detected contribution from Cf would be 
reduced under these conditions because the linear part of the current-voltage curve used 
to obtain Erev is centered around ECi, i.e. the driving force and, thus, Cf flux would be 
markedly decreased. However, no reduction in the OaV-induced current was apparent. 
Thus these data suggest that the response to OaV is probably dominated by a non- 
selective cation current.
When intracellular Cf was largely replaced with gluconate, neurones responded 
with a sustained current which lacked large transient events and failed to recover to 
baseline (n = 5, Fig. 5.4A). A similar effect was observed upon treatment with the Cf 
channel blocker, 5-nitro 2-(3-phenylpropylamino) benzoic acid (NPPB, 10 jjM, n = 3, 
Fig. 5.4B). Thus Cf may underlie the transient events which characterise the OaV- 
induced inward current.
Replacing intracellular K+ with TEA resulted in a significant (p<0.05, n = 6) 
positive shift in Erev, suggesting that a K+ (possibly Ca2+-dependent) current may also 
be activated by OaV. However, its contribution is likely to be small given the Erev 
observed under normal conditions of -11.4 ± 2.0 mV (Table 5.1) and the calculated Ek 
o f -98 mV.
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FIG 5.4. A. The effect of replacing intracellular Cl" with gluconate on the response 
to OaV (1 mg ml'1, 10 s). B. A representative trace demonstrating the effects of the 
chloride channel blocker NPPB (10 pM, duration indicated by black bar) on the 
response to OaV (lmg ml'1, 10 s).
Table 5.1.
Cl' equilibrium potentials, calculated using the Nemst equation, and observed 
reversal potentials following various ion substitutions. See Methods for solution
compositions.
N E ci Erev (mV)
(mV)
Standard solutions 22 -6.9 -11.4 ±2.0
[Cf]0 replaced with gluconate 4 61.6 5.2 ±1.9**
[Cf]i replaced with gluconate 5 -70.7 -1.1 ±3.5*
[K +]i replaced with T E A 6 0.3 0.0 ±2.8*
* p < 0.05 ** p < 0.01
N-number of experiments; ECi-calculated Cl' equilibrium potential; Erev-mean extrapolated reversal 
potential from N experiments.
Purification and characterisation of the active material
Gel permeation HPLC (HP-GPC) was used to fractionate OaV initially for the purpose 
of identifying factor(s) which give rise to the inward current activity. This approach 
had the advantage that the MES buffer (in which OaV is most active) could be used as 
an eluent and fractions could be assayed directly without prior desalting or 
lyophilisation. HP-GPC of whole venom yielded 11 absorbance (280 nm) peaks, 
identified as GPC-I - GPC-XI (Fig 5.5A). Fraction GPC-V produced the inward 
current in DRG neurones characteristic of whole OaV (Fig 5.6A).
This fraction was demonstrated to be heterogeneous by SDS-PAGE analysis (Fig 
5.5E, Lane 3) and was subjected to further purification. Reversed phase HPLC (RP- 
HPLC) was used because this had previously been demonstrated to provide a good 
separation of low molecular weight OaV proteins (see Chapter 3). RP-HPLC (jiRPC 
C2/C18) fractionation of the active GPC fraction is shown in Fig 5.5B. Activity was 
associated with fraction El from this chromatogram (labelled RP-1III for reversed
GPC-V
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FIG 5.5. Purification of active material from OaV. A. HP-GPC of OaV. Activity 
was associated with GPC-V and this fraction was further purified by RP-HPLC.
B. Activity was associated with fraction RP-1 III. C. RP-1 III was further purified 
by RP-HPLC, giving rise to an active fraction RP-2II which, D. was purified to 
near-homogeneity by a final RP-HPLC step (RP-3II). E. Tris-Glycine SDS-PAGE 
analysis of active fractions. Std = molecular weight standards.
phase I, fraction ED). Again, this fraction was shown to contain several proteins (Fig 
5.5E, Lane 4) and was therefore subjected to further rounds of RP-HPLC. A reduced 
flow-rate (100 jiL min'1) was used in these RP-HPLC steps to improve resolution (Fig 
5.5C, D) and fractions were prepared between steps by dilution in 0.1% TFA/H20  to 
give a final CH3CN concentration of 5 %. Thus, lyophilisation, which tended to 
diminish the recovery of activity, was avoided. A 10 s application of 20 (ig ml*1 of 
fraction RP-3II (resuspended in MES buffer, pH 6.1), resulting from the third round of 
RP-HPLC (Fig 5.5D), produced inward currents characteristic of whole venom (see Fig 
5.6B) and yielded a comparable extrapolated Erev of -5.28 ± 3.85 mV (n = 3). This 
fraction was not completely homogeneous by SDS-PAGE (Fig 5.5E, Lane 6). 
Although it was enriched in p i2, the fraction also contained the 15 kDa protein, KLP, 
which was demonstrated to be inactive (n = 3) following purification by cation- 
exchange and reversed phase HPLC (see Fig. 3.5, Chapter 3 for details of purification).
Attempts were also made to purify the active material from OdW using cation- 
exchange (CIEX) HPLC (Fig. 5.7A). As shown in Fig 5.6C, activity was associated 
with fraction II (CEEX FE, Fig. 5.7A) which exhibited marked heterogeneity by SDS- 
PAGE but also contained p i2 (Fig. 5.7B). However, no activity was observed when 
pl2 from CIEX FE was purified to apparent homogeneity by two subsequent RP-HPLC 
steps (Fig 5.7C, D, E and F). A shift in retention time was observed between the two 
RP-HPLC steps, i.e. pl2 eluted somewhat later in the second step (Fig. 5.7E), raising 
the possibility that loss of activity was accompanied by a change in the conformation or 
association state of p i2. A 15 kDa protein (KLP or OVL-15) was present in fractions 
I-IV from the second RP-HPLC step (Fig. 5.7E, F). These fractions were concentrated 
prior to SDS-PAGE (Fig. 5.7F) and the apparent absence of 15 kDa material from 
fraction I of the previous RP-HPLC step (Fig. 5.7C, D, Lane 3) reflects it relatively low 
abundance in this fraction.
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FIG. 5.7. Purification of p 12 by cation-exchange and reversed phase HPLC.
Std VI V IV III II I
A. Cation-exchange HPLC of OaV. Activity was associated with fraction II 
(CIEX FII). B. Tris-Glycine SDS-PAGE of cation-exchange fractions.
C. RP-HPLC of CIEX FII. D. Tris-Tricine SDS-PAGE analysis of reversed 
phase fractions I and II from B. E. Further purification of p 12 (I from C) by
RP-HPLC. F. Tris-Tricine SDS-PAGE of RP-HPLC fractions from E. Note
retention-volume shift between pl2 - containing fractions I (C.) and VI (E.)
indicated by the dotted line.
Active, homogeneous material was not recovered using the above purification 
strategies and a combination of anion-exchange HPLC and chromatofocusing was 
therefore used to avoid organic solvents which may have diminished the recovery of 
activity. The flow-through fraction from MonoQ was further fractionated using a 
MonoP chromatofocusing column (see Chapter 3), equilibrated with triethylamine 
buffer, pH 11.0 (Fig. 5.8A). A fraction, eluting at pH 10.1, was desalted by HP-GPC 
(Superose 12, Fig. 5.8B) and analysed by Tris-Tricine SDS-PAGE (Fig. 5.8C). A 10 s 
application of this fraction (80 jig ml'1 in MES, pH 6.1), containing both pl2 and p50, 
was demonstrated to be weakly and inconsistently active (n = 3, Fig. 5.8D).
From the different chromatographic dimensions employed, it is apparent that the 
protein common to each active fraction is p i2. The active fraction RP-313 (Fig. 5.5) 
was subjected to N-terminal amino acid sequence analysis. Both a major and minor 
sequence was obtained. The minor sequence was identical to that of KLP (see chapter 
3), which was the only contaminating protein detectable by SDS-PAGE (Fig 5.5E). 
The major protein sequence exhibited substantial homology with ß-nerve growth factor 
(ß-NGF). The protein was subjected to proteolytic digestion and the majority of the 
sequence determined from the resulting peptide fragments. pl2 shares 90 % identity 
with ß-NGF from mouse salivary glands and 67 % identity with NGF from Naja naja 
venom. Only two of the substitutions are at conserved sites (see Fig 6.5, Chapter 6).
The possibility that NGF from another source could produce the same effect as 
OaV and pl2-containing fractions was investigated using mouse salivary ß-NGF 
(supplied by Prof. Ian Hendry, JCSMR and also obtained from ICN Pharmaceuticals 
Inc.). This material, at a concentration of up to 0.1 mg ml'1, did not elicit OaV-like 
inward currents (Fig. 5.9A, n=5). However, k-252a, which inhibits many of the 
biological activities of NGF (Knusel and Hefti, 1992) by binding to the cytoplasmic 
kinase domain of the high-affinity NGF receptor, trkA (Knight Jr et ai, 1997),
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FIG 5.9. A. Effect of two 10 s applications of mouse NGF (mNGF, 0.1 mg ml'1) 
in MES buffer (pH 6.1), followed by OaV (lmg ml'1). Artefacts (§) in current 
trace are due to applied voltage ramps. B. Effect of k-252a on the response to 
OaV. Ratio of response 2 / response 1 under control conditions (n=10) and in the 
presence of 200 nM k-252a (n=4). *p < 0.05. C. Example of responses to OaV in
the absence and presence of k-252a.
significantly (p<0.05, n = 4) reduced the second response to OaV relative to the first in 
two-application experiments (Fig 5.9B, C). This effect was at least partially reversible 
(Fig 5.9C) which is consistent with the reversibility of the TrkA-k252a interaction 
which has been demonstrated previously in radioligand binding studies (Knight Jr et 
al., 1997).
Discussion
Although many venoms and toxins are considered potent algogens (Chahl and Kirk, 
1975) and behavioural studies have demonstrated hyperalgesic effects of snake venoms 
(Teixeira et al., 1994), this is the first example where the possibility of a direct effect of 
a venom on putative nociceptors has been investigated. OaV was found to produce a 
lasting inward current in these neurones. Such an effect may contribute to the 
intractable pain which accompanies platypus envenomation.
While cultured DRG neurones provide a useful experimental model for 
nociceptive terminals, permitting the accessibility and electrical control not possible in 
terminals, the potential limitations of this model must be acknowledged. Firstly, it is 
assumed that the membrane properties expressed in DRG cell bodies are also expressed 
at the sensory terminals. The fact that capsaicin, bradykinin, protons and PGE2 activate 
cell bodies as well as peripheral terminals (Baccaglini and Hogan, 1983; Gold et al., 
1996b; Bevan, 1996) and substance P and CGRP immunoreactivity is seen in both the 
soma and terminals (Gold et al., 1996a), suggests the assumption is reasonable. 
However, other properties, such as the distribution of ion channels, may differ between 
the sensory terminal and cell body. For example, in central neurones, K+ channel 
subtypes have specific cellular localisations (Hwang et al., 1993). Further work needs 
to be done to determine whether this may be the case in DRG neurones.
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There are also several factors which are believed to affect the cellular properties 
expressed by DRG neurones in culture. The age of the animal from which the DRGs 
are obtained is a critical factor, with properties such as the expression of capsaicin- 
sensitivity (Gold et al., 1996a) and voltage-dependent Na+ channels (Ogata and 
Tatebayashi, 1992) being age-dependent. In the present study, adult animals were used 
to prevent confounding results by age-dependent variations in the expression of 
nociceptor properties. However, the composition of the medium in which the DRG 
neurones are cultured also profoundly influences the expression of nociceptor 
properties. Withdrawal of NGF from the culture medium leads to a progressive loss of 
both proton and capsaicin sensitivity over several days which is reversible when NGF 
is added back to the medium (Bevan and Winter, 1995). Similarly, NGF removal leads 
to the disappearance of TTX-resistant action potentials (Aguayo et al., 1991). NGF 
was not included in the medium used in the present study so NGF-dependent channels 
may have changed within the 24 h of culture. Nevertheless these neurones expressed 
both capsaicin and proton sensitivity and this may be attributed to the brevity of the 
acute NGF-free culture (loss of capsaicin and proton-sensitivity has a half time of 
several days (Bevan, 1996)). Other studies demonstrating the responsiveness of DRG 
neurones to PGE2 and 5-HT, have involved acute culture in the presence of NGF (Gold 
et al., 1996a and b). Thus, it is not clear whether NGF-treated or untreated neurones 
more accurately reflect the properties associated with nociceptive terminals. To what 
extent the absence of NGF in the medium affects the response to OaV was not 
investigated in this study but could be resolved in future experiments by comparing the 
responsiveness of neurones to OaW, cultured with or without NGF.
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Comparison with other algogens
Several inflammatory mediators which are algogenic have been demonstrated to have a 
direct action on nociceptive neurones. However, currents produced by these agents 
appear to be quite different from those evoked by OaV. Capsaicin activates an inward 
current in rat sensory neurones which inactivates rapidly upon removal of capsaicin 
(Petersen et al., 1996). PGE2, adenosine and 5-HT potentiate a TTX-resistant Na+ 
current (Gold et al., 1996b) whereas bradykinin activates a Ca2+ conductance (Burgess 
et al., 1989) which declines within 30 s of its removal. Low pH, which produces pain 
and hyperalgesia in human subjects (Steen and Reeh, 1993) activates both transient and 
sustained (for the duration of low pH) nonselective cation currents in sensory neurones 
(Bevan, 1996). The extended time course and multiple transients which characterise 
the response to OaV have not been observed following treatment with any of the 
above-mentioned algogens, although similar currents have been observed following 
application of glutamate agonists (Crawford et al., 1997a), tachykinins and intracellular 
IP3 (Li and Zhao, 1998).
Little correlation was observed between capsaicin sensitivity and OaV sensitivity. 
This suggests that capsaicin and OaV target different populations of sensory neurones. 
Capsaicin is considered to be a good marker for nociceptive neurones in that it causes 
pain (Torebjörk et al., 1992), activates cutaneous nociceptors in vivo (Martin et al., 
1987) and is selective for small-medium diameter sensory neurones in vitro (Gold et 
al., 1996a). However, it does not activate all nociceptors. 16 % of polymodal, 22 % of 
mechano-heat and 47 % of mechano-cold nociceptors are capsaicin-insensitive (Gold et 
al., 1996a; Martin et al., 1987). By comparison, 67 % of capsaicin-sensitive DRG 
neurones were activated by OaV compared with 75% of capsaicin-insensitive neurones. 
Thus many nociceptive neurones which may not be activated by capsaicin are likely to 
be activated by OaV.
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pH-dependence
The response of DRG neurones to OaW was pH-dependent in that robust and 
reproducible responses were elicited only when the venom was applied at pH 6.1 but 
not at pH 7.4. The physiological basis for this remains unknown. It has been 
demonstrated previously that the proton current elicited by rapidly lowering the 
extracellular pH to 6.1 is markedly potentiated in the presence of inflammatory 
mediators (Kress et al., 1997), suggesting a synergy between these factors. 
Analogously, a component of the capsaicin-activated inward current, which normally 
exhibits marked tachphylaxis, is potentiated by subsequent applications of capsaicin at 
pH 6.3 (Petersen et al., 1996). However, this may occur at the level of the capsaicin 
receptor as lowering the pH to 6.3 markedly potentiated the response of vallinoid 
receptor (VRl)-expressing oocytes to capsaicin (Caterina et al., 1997).
Applying the venom at an acidic pH does have physiological implications. 
Inflammatory exudates are acidic (McCarty et al., 1966) due to both a cellular switch to 
anaerobic glycolysis in inflamed tissue, thereby increasing production of H+ (Kress and 
Reeh, 1996), and the active transport of lactic acid by leucocytes, into the interstitial 
space (McCarty et al, 1966). Thus the direct effect of OaW upon nociceptive neurones 
may be potentiated markedly, in vivo, by tissue acidosis. Since the venom itself has a 
pH of 6.4 (see Chapter 3) this may also potentiate the activation of sensory neurones by 
OaW.
Involvement of [Ca2+] ,• and the ionic basis of the current
Thapsigargin prevents the refilling of intracellular Ca2+ stores by inhibiting 
sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) Ca2+ pumps (Verkhratsky and 
Shmigol, 1996). Thus, its ability to inhibit inward currents induced by a second or 
subsequent application of OaW suggests that the current is Ca2+-dependent and that the
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Ca2+ is derived from intracellular stores. It has been demonstrated previously that up to 
10 min incubation with thapsigargin is required before Ca2+ from internal stores is 
depleted by resting leakage (Shmigol et ai, 1995a). Thus, inward currents resulting 
from the first OaV application may result from the discharge of Ca2+ from stores not 
depleted by slow resting leakage during the relatively brief pre-incubation with 
thapsigargin.
These results should be interpreted with caution as it has been demonstrated that 
thapsigargin in the jiM range also blocks high-voltage and, to a lesser extent, low- 
voltage activated Ca2+ currents in mouse DRG neurones (Shmigol et a i, 1995a) and 
adrenal glomerulosa cells (Rossier et al., 1993). However, the observation that the 
second response to OaV is reduced compared to the first supports the notion that 
thapsigargin inhibits the OaV current by blocking Ca2+ release from intracellular stores. 
If the inhibition were dependent on the block of plasmalemmal channels, both 
responses should be affected as there would be no requirement for the prior depletion 
of Ca2+.
Whether due to the block of SERCA pumps or plasmalemmal Ca2+ channels, the 
ability of thapsigargin to inhibit the OaV-activated inward implicates its dependence on 
intracellular Ca2+ elevation. The reversal potential measured under standard conditions 
and following ion replacement also indicate the involvement of Ca2+-activated 
nonselective cation currents (Ican) and possibly Ca2+ -dependent Cf currents (Ici(Ca))- 
Ici(Ca) does not appear to play a major role as shifts in Erev when gluconate replaced 
intracellular C f, although significant, fell well short of the calculated ECi. Furthermore, 
NPPB, which has been demonstrated to block Ici(Ca) tail currents in DRG neurones 
(Currie and Scott, 1992), did not block the response to OaV. However, under these 
conditions, the currents were sustained and lacked large transient events suggesting that 
Ici(Ca) may contribute to these events. Blocking K+ currents by replacing intracellular
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K+ with TEA also resulted in a minor but significant shift in the observed Erev, 
suggesting that a K+ conductance, possibly IK(Ca>, is also activated by OaW.
Ca2+-dependent currents, Ici(Ca) and Ican, may be activated both by Ca2+ entering 
the cell through voltage-activated channels and caffeine-induced release of Ca2+ from 
intracellular stores (Currie and Scott, 1992; Crawford et al., 1997a). These currents, 
which are also activated in DRG neurones by glutamate, cGMP (Crawford et al., 
1997a), and the sperm factor oscillin (Currie et al., 1992; Parrington et al., 1996) 
exhibit some of the characteristics of the OaV-mediated response. These include a 
comparable delay to the onset of the response and pronounced transient events 
underlying the observed whole cell currents (Crawford et al., 1997a). These 
similarities support the idea that release of Ca2+ from intracellular stores also gives rise 
to the OaW response.
Two distinct mechanisms mediate Ca2+ release from intracellular stores in 
neurones: inositol (1,4, 5)-trisphosphate (EP3)-induced release and Ca2+-induced release 
(CICR). These mechanisms involve two different types of Ca2+ release channel. The 
Ca2+ release channel implicated in CICR, which is characterised by specific binding of 
the plant alkaloid, ryanodine, is known as the ryanodine receptor (RYR). Several 
subtypes, arising from three distinct genes have been identified, and correspond to the 
skeletal (RYR1), cardiac (RYR2) and brain (RYR3) isoforms (Pozzan et al., 1994; 
Meissner, 1994). The mechanistic basis of OaV-induced release of Ca2+ has yet to be 
investigated. However, similar currents evoked in DRGs by glutamate and cGMP 
appear to be mediated by both IP3R and RYR (Crawford et al., 1997b) and may involve 
CICR (Crawford et al., 1997a). In addition, caffeine, which also evokes similar 
currents (Currie and Scott, 1992), specifically lowers the threshold of CICR channels 
for Ca2+ ions enabling CICR at resting Ca2+ concentrations (Sitsapesan and Williams, 
1990). The possible involvement of the RYR and CICR in the resonse to OaW may be
96
addressed in future experiments by investigating the relative abilities of ryanodine and 
heparin (an inhibitor of the IP3 receptor) to inhibit the OtfV-activated currents.
CICR gives rise to elevations in intracellular Ca2+ only in those DRG neurones 
which are caffeine-sensitive (Shmigol et al., 1995b). Interestingly, this represents 
around 70 % of DRG neurones (Shmigol et al., 1995b), which is equivalent to the 
number responding to OaV in this study.
Purification of pl2fNGF from OaV and its involvement in inward current activity 
SDS-PAGE analysis revealed that the protein, pl2, was common to each 
chromatographic fraction that elicited inward currents in DRG neurones and this was 
found to share substantial amino acid sequence homology with NGF. NGF produces 
hyperalgesia when injected into human subjects (Petty et al., 1994) and experimental 
animals (Lewin et al., 1993). It appears to act directly on sensory neurones but also 
releases autacoids from inflammatory cells and sympathetic neurones (Woolf et al., 
1996). Interestingly, acute administration of NGF to chick DRG neurones produces 
transient increases in intracellular calcium (Yamashita and Kawana, 1991); it rapidly 
prolongs the duration of the Ca2+-dependent component of the action potential in 
mouse DRG neurones (Shen and Crain, 1994) and sensitises visceral A5- and C-fibre 
afferents (Dmitrieva and McMahon, 1996). NGF also evokes increases in cytosolic 
free Ca2+ in TrkA-expressing C6-2B glioma cells (De Bemardi et al., 1996). Despite 
these effects, mouse salivary ß-NGF did not evoke the inward currents characteristic of 
OaV or pl2-containing fractions.
There could be a number of reasons for the lack of activity of mouse NGF. 
Firstly, pl2 may differ structurally from NGF or, secondly, a co-factor, present in the 
venom, may be required for activity. Regarding the first possibility, two peptide 
fragments, comprising residues 74-85 and the C-terminal 13 residues, have not been
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recovered from the digests (see Chapter 6 for details) and may differ in sequence from 
the mouse form. NGF binds to two distinct receptors, one with high affinity, a tyrosine 
kinase receptor, TrkA, and one with low affinity, p75, which is a member of tumour- 
necrosis-factor-receptor superfamily (Smith et al., 1990). Binding of NGF with p75 
occurs via three positively charged residues, Lys-32, Lys-34 and Lys-95 (Ibanez, 1994). 
The corresponding Lys residues are present in p i2, suggesting that its binding to p75 
would be commensurate with NGF. Mutations to these residues do not appear to affect 
TrkA activation (Ibanez et al., 1992). However, deletion of residues 112-118 in the C- 
terminus, prevents TrkA-mediated biological activities of NGF (Drinkwater et al., 
1993) and both His-75 and His-84 have been found to be important for the interaction 
of NGF with TrkA (Woo and Neet, 1996). As the corresponding sites containing these 
residues have not been sequenced in pl2 they may differ and, accordingly, interaction 
with TrkA and biological activity may also differ. Either of the substitutions at 
conserved sites (e.g. Asn-25 or Lys-61) in p i2, could also affect its biological activity 
although the corresponding residues in mouse NGF do not appear to be involved in the 
interaction with TrkA.
It is possible that the discrepancy between the ability of pl2-containing fractions 
and mouse NGF to elicit inward currents could be due to the involvement of a co­
factor. As pl2 could not be purified to homogeneity, co-purified proteins or other 
factors could act synergistically with pl2 to produce or to elevate the response. For 
example, larger inward currents were observed in fractions containing both pl2 and 
KLP, compared with those containing pl2 and other proteins and, therefore, a synergy 
between p 12 and KLP may exist. KLP shares homology with members of Kunitz-type 
protease inhibitor-like family of proteins (see Chapter 3), which includes the ß-amyloid 
protein implicated in Alzheimer disease. NGF potentiates the neurotoxicity of this
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protein in hippocampal neuones (Yanker et al., 1990) and it appears to contribute to the 
trophic effects of NGF in PC12 cells (Majocha et al., 1994).
There are additional instances of synergistic effects between NGF and other 
factors. For example, the cytokines IL-lß and IL-6 increase NGF-mediated tyrosine 
phosphorylation and process outgrowth in olfactory neuroepithelial cells (Vawter et al., 
1996), laminin increases the trophic effects of NGF in sympathetic neurones from adult 
rats (Cowen et al., 1997), and retinoic acid is required for the NGF induction of transin 
gene expression in PC 12 cells (Cosgaya, 1997). It is therefore possible that a synergy 
exists between pl2 and another protein or undetermined factor in the venom and that it 
is the absence of this factor which underlies the lack of inward current activity of 
mouse NGF. Clearly, it would be of use to screen all chromatographic fractions (not 
containing p i2) in order to determine whether there is a factor which can confer this 
activity on mouse NGF.
The ability of the TrkA inhibitor, k-252a to attenuate the response to the venom 
(Fig. 5.9B) suggests the involvement of TrkA receptors. TrkA kinase activity leads to 
the phosphorylation of phospholipase Cy (Kim et al., 1991) and subsequent 
phosphatidylinositol hydrolysis to produce IP3 and HVinduced release Ca2+ from 
intracellular stores (Berridge, 1993). Indeed, in C6-2B glioma cells expressing TrkA, 
k-252a blocked the NGF-evoked rise in intracellular Ca2+ (De Bemardi et al., 1996).
Only 45 % of DRG neurones from adult rats express TrkA and this expression is 
largely confined to small-diameter neurones (Bennett et al., 1996). This is consistent 
with the proportion of cells (72 %) responding to OaV, given that small-medium 
diameter neurones were specifically targeted. However, it is possible that OaV acts via 
a receptor other than TrkA, whose activity is also inhibited by k-252a. For example, k- 
252a is a potent inhibitor of protein kinase C (Gschwendt et al., 1996) and the OaV 
activity may involve a pathway which utilises this enzyme. The requirement of TrkA
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for the response may be clarified in future experiments using specific antibodies to 
TrkA which prevent it from binding NGF.
Conclusion
A direct effect of OaV on nociceptive neurones may be largely responsible for the 
intractable pain which accompanies platypus envenomation. The possibility of a 
venom or venom component having a direct action on nociceptive neurones apparently 
has not been investigated previously, despite the fact that numerous venoms and toxins 
are algogenic (Chahl and Kirk, 1975). This is probably due to the difficulty of 
unambiguously defining a direct as opposed to an indirect action of nociceptors in in 
vivo and in situ15 preparations. The use of DRG neurones which express nociceptor 
properties largely circumvents this problem but relies on the assumption that the 
nociceptive DRG cell soma expresses the same properties as its terminal. The fact that 
other pain-producing substances generate inward currents in these neurones suggests 
that a direct action of OaV on these neurones is also likely to produce pain.
The magnitude of the OtfV-mediated inward currents and the fact that they far 
outlast the duration of the application, suggests that OaV may also be more potent in 
this respect than other algogens. Upon envenomation, nociceptive endings would 
almost certainly be exposed to higher concentrations of OaV than used in this study 
(the venom was diluted around 40-fold to achieve the standard concentration used for 
this study) and for a longer time (i.e. greater than 10 sec). The conditions used to elicit 
the inward currents in this study are therefore, if anything, conservative in comparison 
to what might be expected following envenomation. Thus it is probable that if the 
effect of OaV on DRG neuronal cell bodies truly reflects its activity at the nociceptive
15For example, the method of Steen and Reeh (1992) which utilises a superfused skin-saphenous nerve 
preparation, removed intact from the rat, that allows the application of chemicals to the corium side of 
identified receptive fields
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terminal, this direct action would contribute substantially to the painful effects which
accompany envenomation.
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CHAPTER 6
THE NERVE GROWTH FACTOR (NGF) FROM O. ANATINUS VENOM
Introduction
Nerve growth factor (NGF) was originally described as a diffusible agent derived from 
mouse sarcoma cells which elicited neurite outgrowth in embryonic chick neurones 
(Levi-Montalcini and Hamburger, 1953). Attempts to purify the active factor proved to 
be difficult due to the continued presence of contaminating nucleic acids and this led to 
the use of crude snake venom (from Agkistrodon piscivorus) as a source of 
phosphodiesterase. It was found, serendipitously, that the snake venom actually 
produced more neurite proliferation than the sarcoma sample and this observation 
ultimately led to the purification and identification of nerve growth factor (NGF) from 
snake venoms (Cohen and Levi-Montalcini, 1956; Cohen, 1959). Subsequently, NGF 
was found to be abundant in male mouse submaxillary glands (Cohen, 1960) and NGF 
from this source has been extensively studied due to its abundance and relative ease of 
purification.
NGF was the first neurotrophic factor to be discovered and, in many ways, is 
considered the prototype neurotrophin16 although three other mammalian neurotrophic 
factors have been identified: brain-derived neurotrophic factor (BDNF), neurotrophin-3 
(NT-3) and neurotrophin-4 (NT-4) (Kullander et al., 1997). In the developing 
peripheral nervous system, NGF plays an important role in the survival and 
maintenance of sympathetic neurones and a subpopulation of sensory neurones, which
16 Neurotrophins are factors which promote the survival, differentiation, and maintenance of neurones
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includes nociceptive neurones. Centrally it supports the survival and growth of basal 
forebrain cholinergic neurones in the brain (Crowley et a l , 1994).
NGF from mouse submaxillary glands exists as a high molecular weight complex 
of 140 kDa, with a sedimentation coefficient of 7S (Varon et al, 1968). 7S NGF 
consists of 5 subunits, with a stochiometry of 2 a, 2 y and 1 ß. The ß-subunit (ß-NGF, 
Mr approx. 13.2 kDa) is the most extensively studied subunit and is responsible for the 
nerve growth-promoting activity of NGF. It is generally isolated as a non-covalently 
linked dimer, the 2.5S complex, but both the monomeric and dimeric forms are active 
(Stach and Shooter, 1974). The y-subunit is a member of the kallikrein family of 
trypsin-like serine proteases and appears to play a key role in the processing of the ß- 
NGF precursor at the C-terminus (Fahnestock, 1991). The sequence of the ex-subunit 
shows significant homology with the y-subunit and also appears to be a kallekrein 
although it lacks enzymatic activity and its function is unknown (Fahnestock, 1991). 
All snake venom NGFs are homologous with mouse ß-NGF and, with the exception of 
that from Crotalus adamanteus venom, which associates with a y-subunit (Perez-Polo 
et a l, 1978), are not found associated with other subunits. It has also been 
demonstrated that neither the mouse a- or y- subunits bind to Naja naja venom NGF 
(Server et al, 1976).
Kostiza and Meier (1996) have classified snake venom NGFs into the following 
four classes (Type I-IV) on the basis of structural characteristics. Type I NGFs are 
dimeric forms similar to mouse ß-NGF which have a subunit molecular weight of 
aroung 13, 000. Examples of species whose venom contains Type I NGFs include the 
cottonmouth moccasin (.Agkistrodon piscivorus), South American pit viper (Bothrops 
jararaca) and Taiwan cobra (Naja naja atra). Type II NGFs have a higher molecular 
weight and contain 10-20 % carbohydrate and may or may not exist as dimers. Type II
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NGFs are found in the venoms of the common lancehead (Bothrops atrox), Malayan pit 
viper (Agkistrodon rhodostoma), Southern European sand viper (Vipera ammodytes) 
and Russell’s viper (Vipera russellii). Type in NGFs have a homodimeric structure 
linked by disulphide bonds and are found in the venoms of the Formosan banded krait 
(Bungarus multicinctus) and puff adder (Bins arietans). Type IV NGF refers to that 
found in diamondback rattlesnake (Crotalus adamanteus) venom which associates with 
a y-subunit as described above. Snake venom and mammalian NGFs share about 64 % 
sequence homology and NGF from Naja naja and Vipera russelli venoms show a 
similar neurotrophic activity to mouse NGF (Koyama et al., 1992; Kozista and Meier, 
1996).
The probable contribution of OaV NGF to the OßV-induced inward current 
activity in dorsal root ganglion neurones has been described in Chapter 5. The fact that 
mouse NGF did not produce inward currents raised the possibility that OaV NGF, 
whose primary structure elucidation is the subject of this chapter, may have a novel 
structure.
Methods
NGF Bioassay
A neuronal survival assay was used to assay the NGF activity of OaV. Dissociated 
neuronal cultures from dorsal root ganglia (DRG) of 8-day old chick embryos, prepared 
by Prof. Ian Hendry and Katarina Haydon (Division of Neuroscience, John Curtin 
School of Medical Research), were used. DRGs were dissected from the embryos and 
incubated at 37 °C in Ca2+/Mg2+-free phosphate buffered saline (PBS) containing 0.1 %
trypsin for 20 min. DRGs were transferred into Dulbecco’s modified Eagle’s medium 
(DMEM) containing 2 % foetal calf serum, dissociated by trituration using a fire- 
polished Pasteur pipette and plated in the polyomithine and laminin-coated wells of a
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96-well culture plate. The wells contained 10-fold serial dilutions of ß-NGF or OaV. 
Neuronal survival was quantified after 48 h by counting the number of bright-phase, 
spherical neurones occupying 4 microscope (phase-contrast) fields in each well. In the 
absence of NGF, very few neurones survive for 48 h under these conditions.
N-terminal Edman sequencing
Purified OaV NGF was reduced, S-pyridylethylated (see Chapter 2) and subjected to 
direct N-terminal Edman sequencing following passive adsorption onto PVDF. The 
protein was also subjected to in situ digestion in excised Coomassie-stained gel pieces 
(see Chapter 2) using endoproteinase Lys-C (lysyl endoproteinase from Achromobacter 
lyticus, Wako), or in-solution digestion with Chymotrypsin and endoproteinase Arg-C 
(both sequencing grade, Boehringer Manheim Biochemica). The resulting peptide 
fragments were purified by RP-HPLC (using a Sephasil C18 column, Pharmacia or a 
Brownlee Aquapore OD-300 column, Perkin-Elmer), adsorbed onto PVDF and 
submitted to Edman sequencing (see Chapter 2).
Database search protocols and algorithms
NGF sequences were obtained from the National Library of Medicine Genbank Protein 
Sequence database (URL: http://www.ncbi.nlm.nih.gov/PubMed/) and were aligned as 
a family using the Clustal W multiple sequence alignment program (Ver. 1.7), part of 
the BCM Search Launcher (URL: http://dot.imgen.bcm.tmc.edu:9331/multialign/multi- 
align.html).
Results
A preliminary investigation of the neurotrophic effects of OaV revealed that whole 
OaV promoted the survival of chick sensory ganglion neurones in a dose-dependent 
manner. Fig. 6.1 shows the effects of increasing OaV and mouse ß-NGF
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Fig. 6.1. Concentration-response of 8 day old chick dorsal root ganglion 
neurones to O. anatinus venom (OaV, open circles) and mouse ß-NGF (closed 
circles). The number of surviving neurones at each concentration was 
determined after 48 hr by counting the number of bright- phase cells in 4 
microscope fields. Each point represents the mean of duplicate experiments.
Fig. 6.2. Electrospray mass spectrum of purified O.anatinus NGF. The 
molecular weight of the protein was determined to be 13327.5 (major peak, A)
concentrations on neuronal survival. Each curve is based on an experiment performed 
in duplicate. Under these conditions, the absence of neurotrophic support results in the 
death of neurones over a 48 hour period. The activity of OaV thus suggested the 
presence of a neuronal growth factor and NGF was subsequently identified as the factor 
associated with OaV-elicited inward currents (Chapter 5). The lower potency of OaV 
compared to purified ß-NGF reflects the fact that NGF only constitutes a proportion of 
total OaV protein. However, the assay may also be affected by cytotoxic or other 
factors in OaV, as is often the case with NGF-containing snake venom fractions 
(Kostiza and Meier, 1996).
The NGF from OaV was purified to near-homogeneity using a combination of 
HP-GPC and RP-HPLC, as described in Chapter 5 (see Fig 5.5). It had an apparent 
relative molecular mass of 12 kDa as determined by SDS-PAGE under non-reducing 
conditions and analysis by electrospray mass spectrometry revealed a molecular weight 
of 13,327.5 (Fig. 6.2). This is comparable to Type I snake venom and mouse ß-NGFs 
which have molecular weights of around 13,200 (Fahnestock, 1991; Koyama et al., 
1992; Kostiza and Meier, 1996).
OaV NGF was subjected to in-solution proteolytic digestion using Chymotrypsin 
and endoproteinase Arg-C and in situ digestion in gel pieces using endoproteinase Lys- 
C. The resulting fragments were purified by RP-HPLC (pRPC C2/C18, 3.1/10 column 
for chymotryptic and Arg-C fragments; Brownlee Aquapore OD-300 column for Lys-C 
fragments) as shown in Fig. 6.3. Peptide fragments were subjected to N-terminal 
Edman analysis and a large proportion of the protein was mapped from the resulting 
sequences. The elucidated sequence is shown in Fig. 6.4. Two regions of the protein, 
corresponding to residues 74-85 and 106 to the C-terminus, could not be determined 
from peptide fragments and their sequences remain unresolved. Both regions 
(indicated by dashes in Fig. 6.4 and Xs in Fig. 6.5) are likely to be present given the
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FIG 6.3. Reversed phase HPLC purification of proteolytic fragments generated from 
chymotryptic (A), endoproteinase Arg-C (B) and endoproteinase Lys-C (C) digestion of 
purified NGF. Lys-C digestion was performed “in-gel” and the fragment purified using 
an Brownlee Aquapore OD-300 column (Perkin-Elmer) while the other two digests were 
performed in solution and the fragments purified using a mRPC C2/C18 SC3.1/10 
column (Pharmacia). In all cases, eluent A consisted of 0.1% TF A/FLO and eluent B 
consisted of 0.1% TFA/CH3CN. Fragments were labelled according to the proteolytic 
enzyme and fraction number, and were subjected to N- terminal sequencing, the results of
which are shown in Fig. 6.4.
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similarity in mass between OaV NGF and NGFs from other species. However it is 
possible that, if glycosylated (like Type II NGFs), carbohydrate moieties contribute to 
the observed mass, i.e. a reduced mass resulting from “missing” sequence elements 
may be compensated for by carbohydrate.
A comparison of NGF sequences from OaV and from other species, including 
from the venom of Viperid {Vipera russelli) and Elapid {Naja naja atra) snakes, is 
given in Fig. 6.5. In the 94 residues of sequence elucidated, OaV NGF exhibits 90% 
identity with mouse NGF and 67% identity with Naja naja atra venom NGF. One 
highly conserved site, corresponding to residue 25, is substituted in OaV NGF. 
Residue 61, which is conserved except in chicken NGF, is also substituted in OaV 
NGF. Residues 56-97 of O. anatinus NGF have been previously elucidated from 
genomic DNA sequencing (Kullander et al., 1997) and are identical to the sequence 
obtained here for the OaV NGF (Fig. 6.5).
Discussion
OaV produces a dose-dependent, NGF-like increase in the survival of sensory ganglion 
neurones in vitro. Subsequently, it has been shown to contain an NGF-like protein, 
which has been purified and most of its amino acid sequence determined. It was found 
to share a greater degree of homology with mammalian NGFs than with snake venom 
NGFs.
Structure
By electrospray mass spectrometry, OaV NGF was found to have a molecular weight of 
13,327.5, indicating its similarity to mouse ß-NGF and Type I snake venom NGFs. No 
evidence of glycosylation {i.e. like type II snake venom NGFs) was apparent from the 
Edman sequencing results, although further analyses may prove otherwise. Vipera 
russelli russelli NGF (a Type II NGF) is N-glycosylated at Asn within the signal
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sequence, Asn-X-Thr(Ser) (Koyama et al., 1992), which is not present in OaV NGF 
(V.r.russelli NGF Asn21 corresponds to OaW NGF Asp-23).
OaW NGF migrates as an approximately 12 kDa protein on SDS-PAGE under 
non-reducing conditions. It thus does not appear to be a disulphide-linked dimer and 
therefore differs from Type LH NGFs such as those from Bungarus multicinctus and 
Bins arientans venoms.
Unlike Crotalus adamanteus venom from which a yß-like subunit complex was 
recovered (Perez-Polo et al., 1978), no other NGF subunits have been recovered from 
OaW. This suggests OaW NGF is not a Type IV NGF (Kostiza and Meier, 1996).
Pro-inflammatory and algo genic effects of NGF
Aside from its role during development, it has been clearly established that NGF affects 
non-neuronal cells, especially those derived from haematopoetic stem cells (Kostiza 
and Meier, 1996). NGF potently elicits histamine release17 from mast cells (Pearce and 
Thomson, 1986) and this activity appears to be mediated specifically through high 
affinity TrkA receptors (Horigome et al., 1993). Histamine increases vascular 
permeability and thus may facilitate the diffusion of venom components. NGF also 
increased the number of mast cells at the site of injection (Aloe and Levi-Montalcini, 
1977) and administration of anti-NGF antibodies decreased the number of free and 
tissue-adherent mast cells in rodents (Aloe, 1988), suggesting a possible role in mast 
cell hyperplasia. NGF induces the differentiation of neutrophils, macrophages, 
eosinophils and basophils from progenitor cells (Matsuda et al., 1988a and b), has a 
chemotactic effect on polymorphonuclear leukocytes (Gee et al., 1983) and promotes 
basophil degranulation (Kostiza and Meier, 1996). These cytokine-like effects may
17 However, only components from a 10 kDa ultrafiltrate were assayed for histamine-releasing activity in this 
study (see Chapter 4) and the histamine-releasing activity of OaW NGF was not investigated
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contribute to the pro-inflammatory effects of OaW.
The potential therapeutic efficacy of NGF in preventing the onset of symptoms of 
neurodegenerative diseases has prompted experimental studies on the effects of 
systemic NGF administration and there is a remarkable similarity between the observed 
effects of NGF and OaW. For example, the subcutaneous or intravenous injection of 
recombinant NGF into healthy human subjects resulted in pain and hyperalgesia which 
lasted up to 7 weeks (Petty et al., 1994; Dyck et al., 1997). Mechanical and heat 
hyperalgesia have also been described in experimental animals following NGF 
administration (Lewin et al., 1993) and similarities between NGF-induced hyperalgesia 
and that associated with tissue injury have led to the suggestion that expression of NGF 
in inflamed tissue may be a critical link between tissue injury and hyperalgesia (Lewin 
and Mendell, 1993).
The mechanism of NGF-induced hyperalgesia is complex and appears to involve 
a sympathetic component, mast cell degranulation and an effect on sensory neurones 
(Woolf et al., 1996). Sympathectomy abolishes the mechanical hyperalgesia and 
markedly reduces the thermal hyperalgesia induced by NGF in rats (Andreev et al., 
1995; Woolf et al., 1996), suggesting that NGF-induced hyperalgesia requires the 
activation of sympathetic post-ganglionic neurones. However, depletion of mast cell 
granules and the administration of 5-HT receptor antagonists abolishes early (< 3 h) 
NGF-induced heat hyperalgesia (Lewin et al., 1994), suggesting that mast cell 
degranulation also plays a role in the acute phase at least. In addition, the NMDA 
receptor antagonist, MK-801 blocks the late phase (> 7h) thermal hyperalgesia 
produced by NGF, suggesting a central mechanism (Lewin et al., 1994) which may 
follow the retrograde transport of NGF in sensory neurones (Woolf et al., 1996). 
Subsequent upregulation of both neuropeptide (Lindsay and Harmer, 1989; Donnerer et 
al., 1992; Leslie et al., 1995) and Na+ channel expression (Toledo-Aral et al., 1995)
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and, perhaps, hyperinnervation of peripheral tissue (Albers et al., 1994; Leslie et al., 
1995) may also contribute to the NGF-induced hyperalgesia.
ß-NGF, like OaW (Kellaway and LeMessurier, 1935), also produces a dose- 
dependent hypotensive effect in rats following intravascular administration (Yan et al., 
1991). Prior depletion of histamine from mast cells using compound 48/80 and 
treatment with the antihistamine, chlorpheniramine, rendered the animals refractory to 
NGF, suggesting the effect is mediated primarily through histamine release from mast 
cells (Yan et al., 1991). Thus, in addition to ovCNP-39, NGF may contribute to the 
hypotensive effects of OaW.
What is the function of NGF in O. anatinus venom?
The role of NGF in OaW may be related to its role in snake venom and mouse 
submaxillary glands. Several, largely speculative, theories have been proposed. It has 
been suggested that both venom and submaxillary glands may function simply to 
remove excess NGF from the circulation (Hogue-Angeletti and Bradshaw, 1979). It is 
also possible that the glands secrete NGF, like other sympathetic target organs, to 
regulate sympathetic innervation during development (Hogue-Angeletti and Bradshaw, 
1979). However, this raises the question as to why other organs receiving extensive 
sympathetic input do not produce quantities of NGF anywhere near as large as those 
found in venom and submaxillary glands.
Interestingly, the NGF content of murine submaxillary glands is sexually 
dimorphic. NGF is found in far greater abundance in the submaxillary gland of the 
male mouse compared to the female (Thoenen and Barde, 1980). A parallel situation 
exists in O. anatinus, where the NGF-secreting crural gland is found only in the male. 
In the mouse, testosterone modulates NGF synthesis (Thoenen and Barde, 1980) and it 
may also be a key regulator of crural gland secretory activity, given that phasic
hypertrophy of the crural and secondary sex glands coincide (Temple-Smith, 1973). 
Intriguingly, intraspecific fighting between male mice following social isolation 
produces a massive release of NGF from the salivary glands into the bloodstream (Aloe 
et al., 1986). The observed adrenal hypertrophy following NGF administration 
suggests that the adrenal gland is a primary target for this systemic NGF release (Aloe 
et al., 1986). The crural venom apparatus is believed to play a key role in the 
resolution of similar aggressive behavioural encounters between male O. anatinus (see 
Chapter 1) and it is conceivable that an associated release of NGF into the bloodstream 
also occurs. Perhaps associated adrenal gland hypertrophy following an aggressive 
encounter would have the advantage of increasing adrenaline-mediated “fight-or-flight”
I o
reactions during subsequent encounters. Unfortunately, a sex difference in snake 
venom NGF concentrations has not been investigated (Kostiza and Meier, 1996) 
making any speculation on a similar function in snakes difficult.
NGF may potentiate or contribute to the toxic effects of venom and saliva. 
Crude mouse submaxillary gland extracts are lethal when injected intraperitoneally into 
adult mice at relatively low protein concentrations (Liuzzi and Angeletti, 1968). 
Extracts from male mouse submaxillary glands are much more potent in this regard 
than those from female mice (Liuzzi and Angeletti, 1968), suggesting that NGF is 
responsible for, or contributes to, the lethal effects. Submaxillary gland extracts from 
the venomous shrews (Blarina brevicauda, Solenodon paradoxus and Neomys sp.) 
produce dyspnoea, hypotension, convulsions and death following administration to 
experimental animals (Dufton, 1992). In humans, shrew bites result in oedema, a 
burning sensation and “shooting” pains which may persist for days (Dufton, 1992). 
The parallels between these effects and those of OaV and NGF, in addition to the 
presence of NGF in other rodent submaxillary glands (NGF is also abundant in the
18 such reactions include a decrease in visceral organ activity and stimulation of heart and skeletal muscles.
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submaxillary gland of the African rat, Mastomys natalensis, Fahnestock, 1991), raise 
the possibility that NGF is also a component of venomous shrew saliva.
NGF may also contribute to pain and hyperalgesia associated with both OaW and 
snake envenomation. Kostiza and Meier (1996) have estimated that 50 pg of NGF 
could be injected from an elapid snake bite. For a 75 kg human, this equates to around 
0.7 pg kg'1. Such a dose would be more than sufficient to produce long-lasting (> 12 
days) hyperalgesia in humans following subcutaneous injection, which has been 
described following NGF doses as low as 0.03 pg kg'1 (Petty et al., 1994). However, 
reports of lasting hyperalgesia following snake envenomation are not apparent in the 
literature, although at least one patient receiving a Naja naja bite was believed to have 
presented with prolonged (several months) hyperalgesia (John Klein, 
http:Wwww.cobra.org, pers. comm.). Clinical studies of snake bite symptoms and 
management are necessarily dominated by the early resolution of life-threatening 
effects, e.g. neurotoxicity and coagulopathy. Where prolonged pain has been reported, 
it is commonly associated with myonecrotic and haemorrhagic effects (e.g. Clement 
and Pietrusko, 1978). Another complicating factor is the administration of antivenom 
which may contain anti-NGF antibodies, thus diminishing any NGF-induced 
hyperalgesia in envenomed patients. Notwithstanding these considerations, reports of 
severe pain following envenomation by snakes whose venom contain NGF, are 
common. For example, venom from members of the Bothrops and Crotalidae genera, 
as well as from Bungarus caeruleus and Naja naja naja, all contain NGF and produce 
marked pain (Ribeiro and Jorge, 1997; Teixeira et al., 1994; Plowman et al., 1995; 
Guisto, 1995; Theakston et al., 1990).
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Conclusion
The presence of NGF in OaW is of great interest, not only because it is present in snake 
venoms but also because many parallels exist between the activities of OaW and NGF 
from other mammals. In particular, the ability of NGF to produce pain and long-lasting 
hyperalgesia is an exceptional feature which may underlie similar effects observed 
following O. anatinus envenomation. OaW NGF also appears to contribute to the 
inward current activity of OaW in DRG neurones and this activity may contribute to the 
algogenic effects of OaW. OaW NGF is structurally very similar to both mouse and 
Type I snake venom NGFs, suggesting a similarity in biological activity. The much 
higher degree of sequence homology shared between OaW and mouse NGFs compared 
to snake venom NGFs, is consistent with the other mammalian characteristics of O. 
anatinus.
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CHAPTER 7
GENERAL DISCUSSION AND FUTURE DIRECTIONS
General discussion
Pain and oedema are the most consistent features of O. anatinus envenomation and the 
major objective of this study was to identify and characterise components and 
mechanisms likely to contribute to these effects. Initially, the major components of O. 
anatinus venom (OaV) were characterised at the protein sequence level to ascertain any 
homology with known polypeptides which have pro-inflammatory effects. Two 
components, ovCNP-39 and NGF, were subsequently characterised in detail, and the 
possibility that OaV may directly activate nociceptive neurones was investigated.
Overall, 19 separate components have been detected in OaV by a combination of 
SDS-PAGE and reversed phase HPLC. Several of these exhibited a difference in their 
level of relative expression depending on the season in which the venom was collected, 
while the remainder showed no apparent trend. This supports prior evidence of 
seasonal variation in venom composition and is consistent with seasonal changes in 
crural gland histology (Temple-Smith, 1973). Although some OaV components were 
demonstrated to be related to specific protein/polypeptide families, no intuitively 
obvious functions were suggested by their amino acid sequences except in the case of 
the C-type natriuretic peptide (ovCNP-39) and pi 2/nerve growth factor (NGF).
The peptide, ovCNP-39, which constitutes a relatively high mole fraction of 
venom components, was found to release histamine from mast cells and to produce 
oedema. ovCNP-39 had a comparable potency to eutherian CNP with regard to cGMP 
elevation in cultured vascular smooth muscle cells. Thus, ovCNP-39 may contribute to
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the vasodilatory and hypotensive effects of OaW both through the release of histamine, 
which is a potent vasodilator and through cGMP elevation in vascular smooth muscle.
The longevity and severity of the hyperalgesic effects of OaW are, however, not 
reconcilable with the acute activity of mediators such as histamine (Keele and 
Armstrong, 1964). Hence, the possibility of a direct effect of OaW on sensory neurones 
was investigated using sensory ganglion neuronal cell bodies in vitro, which express 
properties and chemical sensitivities similar to polymodal nociceptors in vivo (Gold et 
al., 1996a). OaW was found to produce a lasting inward current in these neurones and 
this appears to be the first example of a direct electrophysiological effect of a venom on 
nociceptive neurones. Following envenomation, nociceptive endings would almost 
certainly be exposed to higher concentrations of OaW for a longer time (i.e. greater than 
10 sec) and the conditions used to elicit the inward currents in this study are therefore 
probably conservative in comparison to what might be expected under normal 
circumstances. It is thus likely that a direct effect on nociceptive neurones contributes 
substantially to the painful effects of envenomation.
The inward current activity was associated with OaW NGF which shares 90 % 
identity with mouse ß-NGF in the 94 residues of partial sequence obtained in this 
study. However mouse ß-NGF does not activate an inward current in the same 
preparation which suggests a possible synergy between OaW NGF and another 
component in the venom, although no consistently co-purified component was detected 
by SDS-PAGE.
Interestingly, the biological activities of NGF and OaW are remarkably similar. 
A single subcutaneous dose of recombinant human NGF in human subjects produces 
localised hyperalgesia persisting for up to 7 weeks (Petty et a l, 1994), a time-course 
similar to that which follows O. anatinus envenomation (Fenner et al., 1992). NGF
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also produces hypotension (Yan et ai, 1991) and may, in addition to ovCNP-39, 
contribute to the hypotensive effect of OaW in experimental animals.
Like OaW, venoms from several snake genera also contain natriuretic peptides, 
NGF and Kunitz-type protease inhibitors (some of which have ion channel blocking 
activities). In these respects, OaW may be considered to resemble snake venoms. 
However, it may also be regarded as akin to mammalian exocrine secretions, such as 
the mouse submaxillary gland secretion, given that OaW NGF shares 90 % homology 
with mouse submaxillary ß-NGF and only around 67 % with snake venom NGFs. 
Curiously, no case reports of lasting hyperalgesia following snake envenomation are 
apparent in the literature, despite the known hyperalgesic effects of NGF. This may be 
related to structural differences between snake venom and human NGFs, such that 
snake venom NGF is recognised as foreign and destroyed by the human immune 
system. On the other hand, OaW NGF is structurally much more similar to mammalian 
NGFs and may therefore escape immunological targeting. Presumably, the absence of 
immunological reactions to OaW components following intraspecific envenomation 
would also be important for maintaining its efficacy in O. anatinus and preventing the 
development of resistance to subsequent envenomations. However, if an 
immunological reaction did occur following intraspecific envenomation, it may have 
the advantage of promoting autoimmune-mediated crural gland regression in the 
victim.
This study has described several ways in which OaW may produce noxious, pro- 
inflammatory effects and therefore lends support to its putative involvement in 
intraspecific conflicts between reproductively active male O. anatinus. OaW may thus 
facilitate the maintenance of home range boundaries and allow dominant males to 
monopolise breeding females. This role alone appears to set OaW apart from snake and 
other animal venoms wherein the primary role lies in food procurement and self-
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defence (not intraspecific) and further suggests its similarity to mammalian exocrine 
gland secretions. Notable examples include the mouse submaxillary gland, which 
releases large amounts of NGF during intraspecific fighting between male mice and, 
shrew submaxillary glands, which produce a toxic secretion of unknown function but 
with similar properties to OaV.
Suggestions for future experiments
The design of experiments aimed at elucidating the factors and mechanisms which 
underlie the pain-producing and hyperalgesic effects of OaV, presents a number of 
difficulties. Pain and hyperalgesia are subjective sensations and this makes them 
difficult to measure experimentally. In addition, pain is a complex phenomenon and 
many factors may contribute to its induction and perceived severity. For example, the 
mechanisms underlying NGF-induced hyperalgesia appear to involve both sympathetic 
and sensory neurones as well as non-neuronal inflammatory cells (Lewin et al., 1994; 
Woolf et al., 1996) and therefore the mechanisms of OaV-induced hyperalgesia may be 
equally complex, if for no other reason than the fact that OaV contains NGF.
As discussed previously, these effects may be characterised by measuring the 
limb withdrawal latencies of experimental animals as an index of pain and 
hyperalgesia, and various inhibitors and antagonists could be administered systemically 
to probe postulated mechanisms. However, apart from potential ethical implications, 
the amount of detailed mechanistic information which may be obtained through the use 
of these techniques is limited. Another approach would be to assay for OaV and OaV 
fraction-induced release of inflammatory mediators in vivo and in vitro. Apart from 
mast cell histamine release, this approach was not explored in the present study but 
may provide useful information on the role of mediators, which produce prolonged 
algetic responses, in the induction of OaV mediated pain and hyperalgesia. Several
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approaches could be taken. Firstly, systemic (assayed from serum) and local (assayed 
from inflammatory exudate) increases in the levels of cytokines, such as IL-6 and TNF- 
a, and other factors believed to play a role in nociceptor activation, may be assayed 
following the administration of OaV to experimental animals. This could be 
accomplished using commercially available quantitative enzyme linked immunosorbent 
assays (ELISA) (Sofer et al., 1996), or by measuring the ability of antisera raised 
against these factors to attenuate OaV-induced hyperalgesia. Alternatively, in vivo 
inflammatory cell infiltration into subdermal tissue following OaV administration 
could be monitored and may suggest inflammatory pathways (see Fig. 1.1) likely to be 
involved in OaV hyperalgesia.
KLP
The Kunitz-type protease inhibitor-like protein (KLP) from OaV shares some 
homology with certain snake venom neurotoxins, such as the K+ channel blocker 
dendrotoxin (Harvey, 1997). It is therefore possible that KLP may have a similar ion- 
channel-blocking activity. Such an effect may be determined by isolating whole cell K+ 
currents in DRG neurones by, for example, substituting choline-Cl for NaCl and CoCL 
for CaCL, and determining whether KLP is capable of reducing the amplitude of 
remaining currents. These may be further dissected using apamin, which blocks iK(Ca) 
and, dendrotoxin, which blocks Ika (Hille, 1992). An alternative approach would be to 
screen expression systems, such as oocytes or HEK cells, which express particular K+ 
channel subtypes, as Kunitz-like neurotoxins may target specific subtypes not be 
present or detectable in DRG neurones.
The elucidation of both N-terminal and internal segments of amino acid sequence 
from OaV proteins, such as KLP, will facilitate the future cloning and expression of 
OaV proteins and this may confirm the suspected homologies outlined here and
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provide viable quantities of individual components for biological activity screening 
experiments such as those described above.
ovCNP-39
The difference between the ovCNP-39 isoforms, ovCNP-39A and B, was not resolved 
in this study. The heterogeneity is unlikely to be conformational given that their 
sequences and molecular masses are identical. The difference is localised to the N- 
terminal 11 residues and may result from an unusually stable peptidyl-prolyl cis-trans 
isomerisation. Preliminary circular dichroism spectroscopy did not reveal any 
difference and a more highly resolving technique, such as two-dimensional NMR will 
probably be required to resolve the ex vivo ovCNP-39 heterogeneity. However, the 
large (mM) peptide concentrations required limits the feasibility of using NMR until 
larger quantities of material become available.
OaV-activated inward currents
The precise mechanism by which OaV activates inward currents in sensory neurones 
also remains to be elucidated. The delay to the onset of the response, in addition to its 
apparent dependence on Ca2+ release from intracellular stores, suggests the 
involvement of a metabotropic pathway. Furthermore, NGF binding to TrkA has been 
shown to phosphorylate phospholipase C-y (Vetter et al., 1991), leading to 
accumulation of fP3 and release of Ca2+ from intracellular stores (De Bemardi et al., 
1996). Whether or not the OaV current is dependent on this process could be 
investigated by establishing whether an antibody specific to phospholipase C-y can 
modulate the response (e.g. see Yassin and Abrams, 1991). Alternatively, the OaV- 
induced current may involve G-protein activation. This may be established in several 
ways, the most obvious of which would be to determine the effects of pertussis toxin or 
the non-hydrolysable GTP analogue GTP-y-S on the activity. Removal of GTP from
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the patch pipette would also be expected to abolish the response if it involved G- 
protein activation.
The evidence for the dependence of the inward current on Ca2+ release from 
intracellular stores is based solely on the ability of thapsigargin to inhibit the current at 
this point. This could be confirmed using a different Ca2+-ATPase inhibitor, such as 
cyclopiazionic acid. Alternatively, a ratiometric, calcium-sensitive fluorophore- (e.g. 
indo-1) based single-cell microfluorimetry or alternative fluorescence technique may be 
used to quantify elevations in Ca2+ concentration and could be used in combination 
with thapsigargin, cyclopiazonic acid or low extracellular Ca2+, to identify the source of 
Ca2+ contributing to its intracellular elevation. The type of Ca2+ store involved may be 
determined by investigating the relative effects of Ca2+ release channel inhibitors on the 
OaV-activated inward current, such as heparin, which is an IP3 channel inhibitor, or 
ryanodine, which inhibits CICR.
pl2/NGF was not purified to homogeneity and pl2/NGF-containing fractions 
from ion exchange or chromatofocusing fractions appeared not to be as potent as those 
obtained from HP-GPC. This raised the possibility of a synergy between pl2/NGF and 
another OaV component in the HP-GPC active fraction which may elute differently 
during ion-exchange HPLC or chromatofocusing. This possibility may be tested by 
establishing whether inactive OaV fractions, not containing NGF, are able to generate 
inward current activity when combined with mouse ß-NGF. An alternative would be to 
remove OaV NGF from active fractions, using immunoprecipitation or immunoaffinity 
chromatography, and attempt to rescue the resulting loss of activity by adding mouse ß- 
NGF.
120
Concluding comments
Primary amino acid sequences of O. anatinus venom polypeptides were obtained for 
the first time in this work and the data obtained will be indispensable for the future 
synthesis of OaW peptides and the development of expression systems for larger 
proteins. A novel-length C-type natriuretic peptide was identified in OaW and this 
work has demonstrated its likely contribution to the oedemagenic and hypotensive 
effects of OaW. The possibility of a direct effect of a venom on nociceptive neurones 
was investigated. In small-medium diameter dorsal root ganglion neurones, many of 
which are putative nociceptors, a brief application of OaW produces large Ca“ - 
dependent inward currents lasting, on average, for several minutes. Such an effect at 
nociceptive terminals may well be responsible for the intractable, excruciating pain 
which accompanies O. anatinus envenomation. This is the first demonstration that a 
venom may act directly on nociceptive neurones and raises the possibility that it occurs 
following severely painful envenomation by other species. The activity appeared to be 
associated with NGF which, interestingly, is found in many snake venoms and, like 
OaW, produces long-lasting pain and hyperalgesia. Most of its amino acid sequence 
has been elucidated and its close relatedness to other mammalian NGFs has important 
functional and evolutionary implications.
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